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Abstract 
Abstract 
The growth hormone secretagogue receptor (GHS-R) belongs to the G-protein 
coupled receptor (GPC-R) superfamily, GHS-R has two subtypes, a 
7-transmembrane (7-TM) receptor named GHS-Rla and a 5-TM non-signaling 
receptor named GHS-Rlb. Apoptosis is programmed cell death. Preliminary studies 
suggested that human embryonic kidney 293 (HEK293) cells stably expressing black 
seabream GHS-Rla (sbGHS-Rla) and transiently expressed HA-sbGHS-Rlb 
induced anti-apoptotic and pro-apoptotic effects, respectively. This study aims to 
further examine the role of GHS-R in apoptosis regulation using human GHS-R 
(hGHS-R) and to define any functional relationship between hGHS-R subtypes. In 
order to reflect the apoptotic condition in the cells, caspase-3 (apoptosis executioner) 
activity was measured by colorimetric assay. 
GHS-Rla is a Gq-coupled receptor, so the properties of GHS-Rla were further 
'examined by measuring the inositol phosphate (IP) production. There was a 
GHS-Rla concentration-dependent increase in the basal [^H]-IP production, which 
was reduced by GHS-Rla inverse agonist [D-Arg\D-Phe^,D-Trp^'^,Leu^‘]-substance 
P (SPa), indicating that GHS-Rla is a constitutively active receptor. The GHS-Rla 
agonists, ghrelin and GHRP-6 were found to stimulate [ H]-IP production. In 
contrast to GHS-Rla, GHS-Rlb is unresponsive to agonists. 
In HEK293 cells transiently transfected with hGHS-Rla, adenosine was showed to 
be a partial agonist and induced an additive effect to ghrelin-stimulated [^H]-IP 
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production. To determine if part of the ghrelin- and adenosine-stimulated [^H]-IP 
production were due to any endogenous adenosine, the effect of adenosine deaminase 
(ADA), which breakdowns adenosine was studied. Results showed all the tested 
receptor-stimulated [^H]-IP productions were decreased. Therefore, the specificity of 
ADA was determined by using an adenosine blocker theophylline. However, 
theophylline did not block any agonist-stimulated [^H]-IP production. These data did 
not help in reaching conclusions. 
To investigate the functional relationship between hGHS-R subtypes in apoptosis, 
one of the methods is to co-transfect the hGHS-Rla and hGHS-Rlb into the cells. 
However, it was demonstrated that the additional plasmid DNAs in the transfection 
potentiated the GHS-Rla basal and agonist-stimulated [^H]-IP production. This 
phenomenon was also demonstrated in hTPa and transfection reagents. One of the 
explanations is the additional plasmid DNA increased the transfection efficiency. 
This potentiating effect makes data interpretation more complicated, but the 
unsuccessfulness in developing monoclonal HEK293 cells stably expressing 
hGHS-R. In addition, the properties of sbGHS-R were similar to hGHS-R. Therefore, 
HEK293 cells stably expressing sbGHS-Rla (HEK-sbGHS-Rla) or sbGHS-Rlb 
(HEK-sbGHS-Rlb) were used to study the role of GHS-R in apoptosis regulation. 
In HEK293, HEK-sbGHS-Rla and HEK-sbGHS-Rlb cells, in order to get an 
optimized staurosporine- and etoposide-induced caspase-3 activity in colorimetric 
assay, it needed to incubate these cells with staurosporine and etoposide for 8 and 24 
h, respectively. The staurosporine- and etoposide-induced caspase-3 activity were 
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lower in these stable cell lines than in the HEK293 cells, showing that the stable 
expression of sbGHS-Rla and sbGHS-Rlb has an anti-apoptotic effect. However, 
this anti-apoptotic effect did not show in transient transfection systems. It is not 
expected as in the preliminary study, transiently transfected HA-sbGHS-Rlb having 
pro-apoptotic effect. One of the explanations is the difference between the 
HA-tagged and non-tagged sbGHS-R. Therefore, to match the preliminary study, i 
use the HA-sbGHS-Rlb and incubate the cells with staurosporine in the absence of 
serum. 
In summary, this study has studied the cell signaling characteristics of GHS-Rla and 
has assessed the control experiments needed for correct interpretation of experiments 
where cells are co-transfected with different receptors. In addition, it provided the 
optimized condition criteria for the colorimetric assay to monitor caspase-3 activity 














增加，基本的[ 3 H]-IP生產亦會被反向催動素[D-Argi, D-Phe5，D-Trp7, 


















此 ， 穩 定 地 轉 染 了 sbGHS-Rla (HEK-sbGHS-Rla)或 sbGHS-Rlb 
(HEK-sbGHS-Rlb)的HEK293會用作硏究GHS-R在細胞自毁的角色。 
在 HEK293, HEK-sbGHS-Rla 和 HEK-sbGHS-Rlb，想有較好的 staurosporine 禾口 
etoposide所引起的caspase-3活動，在色度計的進行中，細胞分別需要醒釀在 
staurosporine 和 etoposide，八小時和二十四小時。在 HEK-sbGHS-Rla 和 
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[^H]-IP [^H]-inositol phosphates 
TM transmembrane 
A1 adenosine 1 receptor 
A3 adenosine 3 receptor 
AC adenylate cyclase • 
Ac-DEVD-pNA Caspase-3 Substrate I 
Ad Adenosine 
ADA adenosine deaminase 
Apaf-1 apoptotic protease-activating factor-1 
AT2 angiotensin receptor type 2 
ATP Adenosine 5'-triphosphate 
bps base pairs 
BRET� Bioluminescence resonance energy transfer 
CaCl2 Calcium chloride 
CALU-1 lung carcinoma cells 
cAMP cyclic 3��5'-adenosine monophosphate 
Carb Carbachol 
CBl cannabinoid 1 receptor 
CFP cyan fluorescent protein 
CREB cAMP responsive element binding protein 
Ct threshold cycle 
Page viii 
Abbreviations 
CTX cholera toxin 
CXCR4 chemokine receptor 
cyt c cytochrome c 
DAG Diacylglycerol 
DAPI 4，，6-diamidino-2phenylidole 
dsDNA double-strand DNA 
EB/AO ethidium bromide and acridine orange 
ERKl/2 extracellular regulated kinases 1/2 
ET-1 endothelin receptor 
EtBr ethidium bromide 
FBS Fetal Bovine Serum 
F R E T fluorescence resonance energy transfer 
G Ghrelin 
GFp2 green fluorescent protein 
GH growth hormone 
GHD growth hormone deficiency 
GHRP-6 Growth hormone releasing peptide-6 
GHS-R Growth hormone secretagogue receptor 
GHSs growth hormone secretagogues 
GPCR G protein-coupled receptor 
HA-hTPa Hemagglutinin influenza virus epitope-tagged Human 
thromboxane A2 
HEK293 Human Embryonic Kidney 293 cells 
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Abbreviations 
HEK-hGHS-Rl a HEK293 cells stably expressing hGHS-Rl a 
HEK-hGHS-Rlb HEK293 cells stably expressing hGHS-Rlb 
HEK-sbGHS-Rla HEK293 cells stably expressing seabream GHS-Rl a 
HEK-sbGHS-Rlb HEIC293 cells stably expressing seabream GHS-Rlb 
hGHS-R human GHS-R 
hGHSRla Human growth hormone secretagogue receptor 1 a 
hGHSRlb Human growth hormone secretagogue receptor lb 
INOS Inositol 
IP3 Inositol 1,4,5-trisphosphate 
LiCl Lithium chloride 
MAPK mitogen-activated protein kinases 
mDP Mouse prostaglandin D2 receptor 
MEK mitogen-activated protein kinase 
MOR ji-opioid receptor 
mRNA messenger RNA 
P2X7 P2X7 purinergic receptor 
P2Y purinergic P2Y receptors 
P2Y2 P2Y2 purinoceptor 
pCFP-DEVD-YFP FRET caspase-3 biosensor 
PCR polymerase chain reaction 
pEGFP enhanced green fluorescence protein plasmid 
PGD2 Prostaglandin D2 




pGFP -Rluc(h) positive control vector 
PI3K phosphoinositide 3-kinases 
PKA cAMP-dependent protein kinase 
PKBKs protein kinase B kinases 
PKC protein kinase C 
PLC phospholipase C 





PTH/PTHrP parathyroid hormone/ parathyroid hormone-related 
protein 
PTHR parathyroid hormone receptor 
Rluc(h) humanized Renilla luciferase 
RT-PCR reverse-transcriptase polymerase chain reaction 
sbGHS-Rla seabream GHS-Rla 
SPa [D-Argi，D-Phe^ D-Trp^'^ D-Leu"]-substance P 
SSTR2 somatostatin receptor 
Theo theophylline 
TUNEL terminal deoxynucleotide transferase-mediated 
dUTP-biotin nick-end labeling 
YFP yellow fluorescent protein 
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Chapter 1 Introduction 
Chapter 1 
Introduction and project overview 
The growth hormone secretagogue receptor (GHS-R) belongs to the G 
protein-coupled receptor (GPCR) superfamily (Howard et aL, 1996). Many GPCRs 
have been shown to be involved in regulating apoptosis. In addition, many synthetic 
compounds and endogenous ligands, which act on GHS-R, were found to regulate 
apoptosis. - “ 
Preliminary study showed that the staurosporine-induced caspase-3 activity in 
HEK293 cells was higher than the HEK293 cells stably expressing the seabream 
GHS-Rla (sbGHS-Rla) receptor, it suggested that sbGHS-Rla might be 
anti-apoptotic. When HEK293 cells were transfected with epitope-tagged 
sbGHS-Rlb, the staurosporine-induced caspase-3 activity was higher than that in 
HEK293 cells, it suggested that epitope-tagged sbGHS-Rlb might be apoptotic. In 
addition, the apoptotic effect of epitope-tagged sbGHS-Rlb was reduced by stably 
expressing sbGHS-Rla in HEK293 cells. 
In this project, the role of human GHS-R (hGHS-R) subtypes, namely hGHS-Rla 
and hGHS-Rlb and their functional relationship in regulating apoptosis were studied. 
In order to investigate the interaction between GHS-Rla and GHS-Rlb, it is 
necessary to co-transfect GHS-Rla and GHS-Rlb into HEK293 cells. Therefore, it is 
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important to look for possible artifactual results caused by the co-transfection of two 
different plasmids. It was found that co-transfection resulted in a variable 
potentiating effect in both basal and agonist-stimulated [3H]-inositol phosphate 
([H]-IP) production. This potentiating effect makes data interpretation more 
complicated, so we tried to develop HEK293 cells stably expressing hGHS-Rl a 
(HEK-hGHS-Rla) or hGHS-Rlb (HEK-hGHS-Rlb). Using the stable cell line to 
study the receptor subtypes interaction, there is only one of the receptor subtype 
plasmid DNA to be transfected into the cells and then the potentiating effect of 
co-transfection is avoided. However, the development of stable cell lines was 
unsuccessful, therefore HEK293 cells stably expressing seabream GHS-Rla 
(HEK-sbGHS-Rla) or GHS-Rlb (HEK-sbGHS-Rlb) were used to study the role of 
GHS-R in apoptosis regulation. 
Before studying the role of GHS-R in apoptosis regulation by monitoring the 
caspase-3 activity, we need to find out which is the best assay to monitor caspase-3 
activity in HEK293 cells and optimize the assay conditions by determining which 
agonists and apoptotic inducers to use. In addition, we also need to have same 
expression level of sbGHS-R in both transiently transfected cells and the stable cell 
lines, so the amount of sbGHS-R in the stable cell lines and in the transient 
transfection were determined by real-time polymerase chain reaction (PCR). Finally, 
the apoptotic inducer stimulated caspase-3 activities in HEK-sbGHS-Rla and 
HEK-sbGHS-Rlb was measured, it will reflect the role of sbGHS-Rla and 
sbGHS-Rlb in apoptosis regulation. Also these cells were transfected with 
sbGHS-Rla or sbGHS-Rlb and then the caspase-3 activities were monitored, it will 
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indicate the functional relationship of sbGHS-Rla and sbGHS-Rlb. HEK293 cells 
and the cells transfected with sbGHS-Rla and sbGHS-Rlb were used as a control. 
1.1 Ghrelin structure and its synthesis 
Ghrelin is a 28 amino acid peptide and is the endogenous ligand for GHS-R. Under 
the influence of an unknown acyl-transferase, ghrelin has a unique n-octanoyl 
modification on the hydroxyl group of the serine 3 residue (Fig. 1.1) (Kojima et al., 
1999; Kojima et al,, 2001; Smith, 2005). This modification appears to be essential 
for most of its biological activities, such as endocrine activities (Bresson-Bepoldin et 
al, 1994), and activation of GHS-Rla (Kojima et al, 1999) as the unmodified 
ghrelin does not possess these functions. In the human hypothalamus and pituitary 
gland, the binding of -ghrelin was displaced by ghrelin (Asakawa et al, 2001). 
It only showed that ghrelin may bind to GHS-Rla or other non-GHS-R. In COS-7 
cells transfected with hGHS-Rla, ghrelin stimulated [^H]-IP production and 
•‘ competed against [ I]-ghrelin binding (Hoist et al., 2003), it showed ghrelin is an 
agonist of GHS-Rla. Although the octanoylated form has more functions than the 
non-octanoylated form, in human, the major circulating form of ghrelin is the 
non-octanoylated form (Broglio et al, 2003). Not only the non-octanoylated ghrelin 
is the major form in human, but also in other animals, such as rat (Hosoda et al, 
2000). 
Ghrelin is produced and secreted from the stomach，and may circulate in the blood 
stream in order to reach the pituitary where ghrelin stimulates growth hormone 
release (Kojima et al, 1999; Kojima et al, 2001). Ghrelin is not only found in the 
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stomach, but also in most other organs in a relatively small amount, such as intestine, 
pancreas, adrenal, pituitary, lung (Gnanapavan et al, 2002; Kojima et aL, 2001) and 
in different human neoplastic tissues and related cancer cell lines, such as pancreatic 
endocrine tumor (Volante et al., 2002) and thyroid tumor (Volante et al., 2003) 
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Figure 1.1 Chemical structure of ghrelin. The octanoyl group is attached to serine-3. 
/ 
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1.2 Types of growth hormone secretagogues (GHSs) 
In the eighties, a small synthetic hexapeptide, named GHRP-6, was developed and 
based on its structure, many other GHSs with better oral bioavailability and potency 
were developed (Smith, 2005). GHSs can be divided into two groups, synthetic 
peptide and synthetic non-peptide. GHRP-6 and hexarelin belong to the peptide 
group. For the non-peptide group, it can be further sub-divided into benzolactams 
and spiroindanylpiperidines. Benzolactams includes L-692,429 and L692,585, 
spiroindanylpiperidine includes MK-0677. In general, the potency and the oral 
availability are in the following order: synthetic peptide < benzolactams < 
spiroindanylpiperidine. These GHSs are highly selective, even at a concentration 
above 10 jiM (Smith, 2005). Besides ghrelin, GHSs can also bind to and activate 
GHS-Rla. COS-7 cells transfected with hGHS-Rla showed GHS 
(L-692,429)-stimulated [^H]-IP production, but L-692,429 did not displace 
•‘ [:25l]-ghrelin (Hoist et aL, 2003). Some of the GHSs, such as MK-0677 were able to 
1 Q c 
displace [ I]-ghrelin in human hypothalamic membranes (Muccioli et aL, 2001). 
Labeling the porcine GHS-Rla with radioactive GHS ([^^S]-MK-0677), a series of 
GHSs (GHRP-6, L-692,429, MK-0677) displaced the [^^S]-MK-0677 (Pomes et aL, 
1996). These indicated that most of the GHSs can bind to and activate GHS-Rla, but 
in the case of L-692,429 another non-GHS-Rl a receptor appears to be involved. 
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1.3 Characterization of GHS-R 
1.3.1 Cloning of GHS-Rla and GHS-Rlb 
1.3.1.1 GHS-R subtypes 
There are two forms of GHS-R produced by an alternative splicing from a single 
gene (Fig. 1.2). The gene is composed of two exons，named exon 1 and exon 2, and 
there is an intron between the exons. TM I to TM V and TM VI to TM VII are 
encoded by exon 1 and exon 2 respectively. One form of GHS-R contains seven 
transmembrane domains and is encoded by two exons, and is named GHS-Rla, The 
other form of GHS-R contains five transmembrane domains and is encoded by one 
exon together with a part of the intron containing a stop codon, and is named 
GHS-Rlb. In human and seabream, the amino acid sequence of GHS-Rlb diverges 
from GHS-Rla starting at Leu which locates within TM VI (Kojima et al., 1999; 
Smith, 2005). 
1.3.1.2 Properties of GHS-R subtypes 
GHS-Rla is a Gq-coupled receptor which responds to agonists and causes IP 
production, as described in sections 1.1 and 1.2. GHS-Rla also stimulates IP 
production in the absence of agonists that means GHS-Rla is a constitutively active 
receptor. COS-7 cells were transiently transfected with different concentrations of 
‘ hGHS-Rla," the [^H]-IP production was measured in the presence and absence of 
ghrelin. There was a gene dose-dependent increase in the [^H]-IP production, both in 
the presence and absence of ghrelin (Hoist et al., 2004). The constitutive activity was 
not only observed in hGHS-Rla, but also demonstrated in sbGHS-Rla, as in the 
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HEK293 cells stably expressing sbGHS-Rl a, there was a relatively high level of 
basal [^H]-IP production when compared with HEK293 cells (Chan et al, 2004b). 
The use of the inverse agonist is also a good tool to show that GHS-Rla is a 
constitutively active receptor. Inverse agonist means an agonist which reduces the 
constitutive activity of a receptor and has a negative efficacy (Rang, 2003). 
[D-Argi，D-Phe5,D-Trp7’9，Leii"]-siibstance P (SPa) was found to function as a high 
efficacy and high potency inverse agonist of GHS-Rla. One of the evidence is SPa 
inhibited the spontaneous, ligand-independent [^H]-IP production in hGHS-Rla 
expressed in COS-7 cells (Hoist et al., 2003). SPa is not a specific inverse agonist for 
GHS-Rla, it also acts on the tachykinin NKl (Palma et al., 2000) and bombesin 
receptors (Djanani et al., 2003). 
In contrast to GHS-Rla, GHS-R lb is unresponsive to ghrelin or GHS (Ghigo et al., 
2005; van der Lely et al., 2004). In COS-7 cells transfected with hGHS-Rlb, 
.‘ high-affinity saturable binding of [^^S]-MK-0677 was not evident. It indicated that 
GHS-Rlb does not respond to GHS (Smith et al., 1997). Also, there was no 
1 
induction of a Ca -activated CI" current in response to MK-0677 in oocytes injected 
with GHS-Rlb cRNA (Howard et al., 1996). Although GHS-Rlb is unresponsive, it 
can attenuate the signal transduction capacity of GHS-Rla. It was found that there 
was a decrease in the GHS (GHRP-6, LI 63,540 or L692,585) induced intracellular 
calcium release in HEK293 cells stably expressing sbGHS-Rla, when these cells 
were transfected with sbGHS-Rlb (Chan et al” 2004a). 
“ P a g e 8 
Chapter 1 Introduction 
1.3.1.3 Evidence of non-GHS-Rla stimulated by ghrelin and GHSs 
If administration of ghrelin or GHSs causes an alteration in cellular response, it does 
not necessarily imply the presence of GHS-Rla. There are many evidences indicating 
that ghrelin and GHSs can act on a receptor which is different from GHS-Rla. 
[ -Tyr-Ala-hexarel in binding to human breast tumor membranes was displaced by 
different unlabeled GHSs (hexarelin and MK-0677) and human ghrelin, as well as by 
non-octanoyl ghrelin, indicating that there is other receptors which are different from 
GHS-Rla present in human breast tumor, as the non-octanoyl ghrelin does not act on 
GHS-Rla as mention in section 1.1 (Cassoni et al., 2001). In addition, in three 
different human breast carcinoma cell lines (MCF7, T47D, and MDA-MB231), 
GHSs, ghrelin and even non-octanoyl ghrelin caused a significant inhibition of cell 
proliferation, however, there was no GHS-Rla mRNA demonstrated by RT-PCR 
(Cassoni et al., 2001). Other than breast tumor, lung carcinoma cells (CALU-1) and 
human prostate tumors showed the existence of non-GHS-Rla. In CALU-1 cells, 
, GHS-Rla is absent, but CALU-1 cells respond to peptidyl GHS resulting in 
inhibition of cell proliferation (Ghe et al., 2002). In human prostate tumors and 
some prostate cancer cell lines, [^^^IJ-Tyr'^ -ghrelin binding was detected in the cell 
membranes and the binding was displaced by ghrelin, synthetic GHS and 
des-octanoyl ghrelin (Cassoni et al., 2004). 
Non-GHS-Rla was not only present in tumor cells, but also in normal tissues, such 
as cardiovascular tissues, pancreas and thyroid, as the binding of 
[�I]-Tyr-Ala-hexarelin was displaced by unlabeled non-octanoyl ghrelin (Ghigo et 
fl/.,2005). 
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1.3.1.4 Distribution of GHS-R 
Distribution of GHS-R can be studied using different methods, such as radioactive 
binding assay, northern blotting, immunohistochemistry and RT-PCR. Different 
methods have different specificity and sensitivity, therefore results can be variable. 
GHS-Rla is highly expressed in the hypothalamus and pituitary gland (Ghigo et al.’ 
2005). GHS-Rla was also reported in other areas with relatively lower expression 
level (Gnanapavan et al., 2002) by real-time RT-PCR. 
In human, using real-time RT-PCR, GHS-Rla mRNA was found in hypothalamus, 
pituitary gland, thyroid gland, pancreas, spleen, myocardium and adrenal gland. In 
contrast to hGHS-Rla, hGHS-Rlb was not only found in these tissue, but also in 
atrium, bladder, breast, buccal, mucosa, colon, duodenum, fallopian tubes, fat, 
fundus, gall bladder, ileum, jejunum, kidney, liver, lung, lymph node, lymphocytes, 
” muscle, esophagus, ovary, placenta, skin, testis or vein (Gnanapavan et al., 2002). In 
all the prostate cancer cell lines studied, GHS-Rla and GHS-Rlb are co-expressed 
(van der Lely et al., 2004). Using RT-PCR, hGHS-R has been observed in liver, T 
cells, B cells and neutrophils (Hattori et al, 2001; Murata et al, 2002), but it did 
not distinguish the presence of hGHS-Rla or hGHS-Rlb or both. Using 
[i25l]-Try-Ala-hexarelin，there was widespread binding in adrenal gland, gonads, 
arteries, lurig, liver, skeletal muscle, kidney, thyroid, adipose tissue, veins, uterus, 
skin and lymph node, but not in the stomach and colon (Papotti et al., 2000). Using 
[i25i]-His9-ghrelin binding assay, binding was found in the aorta, coronary, 
pulmonary, arcuate arteries in the kidney and saphenous veins (Katugampola et al., 
“ Page 10 
Chapter 1 Introduction 
2001). The presence of binding do not necessarily suggest the presence of hGHS-Rla, 
since hexarelin and ghrelin can bind to non-GHS-Rla receptor, as described in 
section 1.3.1.3. 
In seabream, using radioactive PGR, sbGHS-Rla was predominantly found in 
pituitary, followed by hypothalamus, telencephalon and spinal cord (Chan et aL, 
2004a). sbGHS-Rla was also found in peripheral tissues, such as heart, liver, spleen, 
gill, kidney, stomach, intestine, gall bladder, muscle, testis and ovary. The 
distribution of sbGHS-Rlb was similar to sbGHS-Rla, but sbGHS-Rlb had the 
highest expression level in telencephalon, followed by hypothalamus, pituitary, 
optic-tectum and thalamus and spinal cord. All the periphery tissues had a very low 
expression level of sbGHS-Rla and sbGHS-Rlb. 
1.3.2 Signal transduction pathways of GHS-R 
• Ghrelin or GHSs activates GHS-Rla, and then the ligand-activated GHS-Rla 
interacts with Gq protein and leads to activation of phospholipase C (PLC) / protein 
kinase C (PKC) signaling pathway, results in an increase in IP production and 
intracellular calcium level. This has been shown in transfection systems, for example, 
COS-7 cells transiently transfected with hGHS-Rla and incubated with ghrelin and 
GHS (L-692,429), produced an increase in IP production (Hoist et al, 2003). CHO 
cells, which stably expressed hGHS-Rla, caused intracellular calcium increase in 
response to ghrelin (Kojima et al., 1999). HEK293 cells stably expressed 
sbGHS-Rla caused an increase in intracellular calcium level by GHRP-6. PLC 
inhibitor, U73122, and PKC activator, phorbol 12-myristate 13-aceate (PMA), 
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inhibited GHRP-6 stimulated intracellular calcium (Chan et al., 2004b). 
Ghrelin and GHSs not only activates PLC/PKC signaling pathway, but also cyclic 3', 
5'-adenosine monophosphate (cAMP) / cAMP-dependent protein kinase (PKA) 
pathway. Which pathway will be stimulated depends on the species and cells types? 
In rat pituitary somatotrophs, the GHRP-6 stimulated intracellular calcium increase 
was inhibited by depleting PKC using PMA (Bresson-Bepoldin et al., 1994). It 
indicated that in rat somatotrophs, intracellular calcium increase was a 
PKC-dependent response. In pig pituitary cells, ghrelin-stimulated growth hormone 
(GH) release was reduced by the blockade of PLC, PKC, as well as adenylate cyclase 
(AC) or PKA (Malagon et al.’ 2003). It indicated that ghrelin-stimulated GH release 
requires PLC/PKC and cAMP/PKA pathways. In porcine pituitary cells, the 
ghrelin-stimulated intracellular calcium increase also involved PLC and AC 
pathways (G1 avaski-Joksimovic et al., 2003). In ovine somatotrophs, there is a 
. crosstalk between PKC and cAMP/PKA pathway in the action of GHRP-2 (Wu et al., 
1997). In these experiments, one can not concluded that the activation of PLC/PKA 
and cAMP/PKA pathways by ghrelin or GHSs, is through the direct activation of 
GHS-Rla or other non-GHS-Rla. 
1.3.3 Comparison between human and seabream GHS-R 
sbGHS-R is very similar to hGHS-R, in terms of the subtype structures and their 
signaling properties. As the same as hGHS-R, sbGHS-R has two subtypes, namely, 
sbGHS-Rla and sbGHS-Rlb, results from the alternative splicing of the single gene 
(Chan et al, 2004a). sbGHS-Rla with seven transmembrane domains, while 
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sbGHS-Rlb is a truncated receptor, only has five transmembrane domains. Like 
hGHS-Rla, sbGHS-Rla is a constitutively active receptor and responds to GHSs 
such as GHRP-6 and L163，540, leading to elevation of [^H]-IP production and 
intracellular calcium level (Chan et al., 2004b). It also showed that the GHS induced 
an increase in the intracellular calcium level was PLC- and PKC-dependent. 
However, the potency of these GHSs was less than that showed in human GHS-Rla 
studies (Palyha et al., 2000). Besides GHSs can activate sbGHS-Rla, ghrelin was 
also demonstrated to be an agonist of sbGHS-Rla. Unlike hGHS-Rla, ghrelin is a 
weak ligand of sbGHS-Rla, it needed 10 |iM ghrelin to give a measurable signal 
(Chan et al., 2004b). 
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Figure 1.2 Component of GHS-R gene and the alternative splicing of GHS-R 
subtypes. Gray boxes represent exons. Black boxes represent the seven 
transmembrane domains marked with roman numbers. Figure adapted from 
Korbonits et al (2004). 
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1.4 Is adenosine a partial agonist at GHS-Rla? 
Adenosine induces intracellular calcium release by acting directly onto GHS-Rla, as 
the GHS-Rla inverse agonist ([D-Arg\ D-Phe^ D-Trp^'^ D-Leu'^]-substance P) 
inhibited the adenosine-mediated calcium release in HEK293 or BHK cells stably 
expressing hGHS-Rla (Carreira et aL, 2004; Tullin et aL, 2000). In BHK/hGHS-Rla 
cells, the 100 nM adenosine-indiiced calcium response was measured by Fura-2, and 
was not blocked by 200 [iM theophylline, which is an adenosine receptor blocker 
(Tullin et aL, 2000). In contrast to BHK/hGHS-Rla cells, in HEK293 cells stably 
expressing pig GHS-Rla with bioluminescence reporter gene, aequorin, the 2 \xM 
adenosine-stimulated calcium response was blocked by 10 |iM theophylline, as 
shown by the decrease in the bioluminescence signal (Smith et aL, 2000; Ungrin et 
aL, 1999). The contradictory results from theophylline may be due to the different 
concentrations of adenosine and theophylline, different sensitivity in the two assays 
fpr calcium measurement and different GHS-Rla species. 
It has been suggested that adenosine binds to GHS-Rla and then GHS-Rla couples 
to Gs protein, it was supported by the inhibition effect of cholera toxin (CTX), an 
activator of Gs, on the adenosine-stimulated calcium response (Carreira et aL, 2004). 
Also it was showed the adenosine-stimulated calcium response passes through the 
typical Gs pathway invol ving the activation of AC and PKA, results in the production 
of cAMP. In HEK-hGHS-Rla cells, the calcium signal elicited by adenosine was 
blocked by an AC inhibitor, MDL-12,330A, and a PKA inhibitor, H-89. Also, there 
was cAMP level elevated in response to adenosine (Carreira et aL, 2004). These 
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indicated adenosine-induced calcium response through Gs pathway. The signaling 
pathway of adenosine is different from the one activated by ghrelin and GHS. It 
suggested that depending on the agonist that activates GHS-Rla, different 
intracellular signaling pathways were activated. 
Partial agonist means a drug with a lower efficacy than full agonist and it only 
induces a submaximal cellular response even there is 100% receptor occupation 
(Rang, 2003). By comparing the potency and the maximum response of GHS and 
adenosine, it indicated that adenosine is less potent and the adenosine agonist 
activation curves reach a plateau at a lower level than the one activated by GHS. In 
addition, at the concentrations of adenosine that maximized activation of GHS-Rla, 
GHS did not provide additional stimulation. These suggested that adenosine is a 
partial agonist of GHS-Rla (Smith et al., 2000). 
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1.5 Physiological effects of ghrelin 
Ghrelin has lots of physiological actions, including GH-releasing activity, food 
intake stimulation, glucose metabolism, sleep behaviors, proliferation regulation and 
apoptosis regulation (Ghigo et al., 2005; Korbonits et al, 2004; van der Lely et al, 
2004). Therefore, ghrelin has been suggested to act as a drug to cure the growth 
hormone deficiency (GHD) in childhood, obesity, and cancer." In this section, it 
focuses on the regulation of proliferation and apoptosis. 
Ghrelin inhibits cell proliferation in some cancer cells. In human breast cancer cell 
lines，after incubating the cells with ghrelin for 48 hours, there was a significant 
decrease in the cell number (Cassoni et al, 2001). In human medullary thyroid 
carcinomas, ghrelin binding sites were significantly higher density than the normal 
thyroid tissue (Kanamoto et al, 2001) and ghrelin inhibited cell proliferation in 
“ thyroid tumor cell lines (Volante et al., 2003). However, ghrelin also promotes cell 
proliferation in other cancer cells. In human pancreatic cancer cell lines, the cells 
were incubated with ghrelin, there was a dose-dependent increase in cell proliferation 
up to 10 nM (Duxbury et al, 2003). This cell proliferation effect of ghrelin was also 
observed in prostate cancer cell lines (Jeffery et al., 2002) and hepatoma (Murata et 
al, 2002). Besides cancer cells, ghrelin also promotes cell proliferation on adrenal 
(Andreis et al, 2003), cardiac (Pettersson et al., 2002), adipose cells (Choi et al., 
2003; Kim et al, 2004; Thompson et al., 2004) and pituitary (Nanzer et al, 2004). In 
general, ghrelin promotes cell proliferation in normal cells, and inhibits cell 
proliferation in abnormal cells. 
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Ghrelin protects different types of cells from apoptosis, such as cardiomyocytes, 
endothelial cells (Baldanzi et al., 2002; Benso et al., 2004) and adipocytes (Kim et 
al, 2004). Taking adipocytes as an example, in 3T3-L1 preadipocytes, apoptosis was 
induced by 48 hours serum starvation. In the presence of ghrelin, the DNA 
fragmentation caused by serum starvation decreased, suggesting that ghrelin protects 
preadipocytes from apoptosis. Ghrelin can also induce a pro-apoptotic effect to the 
cells. In human aldosteronoma, ghrelin enhances apoptosis, as indicated in the 
TUNEL assay, more DNA fragments in the adrenocortical carcinoma-derived cell 
lines than in the normal human adrenocortical cells, so ghrelin can be a drug to cure 
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1.6 Apoptosis 
1.6.1 Introduction 
The word apoptosis is derived from Greek and means "falling o f f � � a s of leaves from 
trees. Apoptosis is an active process of gene-directed cellular self-destruction, which 
is important in homeostasis function providing the balance between cell survival and 
cell death (Tomei et al., 1991). Apoptosis is very important to mammals, as it can 
maintain a relatively constant cell population by balancing between apoptosis and 
mitosis. Apoptotic cell death plays an important role in eliminating the cells whose 
survival may be harmful to the body, such as the cells are mutants, DNA-damaged or 
virus-infected (Tomei et al, 1991). Furthermore，apoptosis plays an important role in 
embryo development, for example, in the formation of interdigital webs (Hammar et 
al., 1971). As apoptosis is a process, which causes cell death, if it is not normally 
regulated, it will cause harm to our organs. 
.. Mitogens and survival factors have been shown to play important roles in regulating 
cell proliferation and apoptosis. These factors, first binding to cell surface receptors, 
trigger phosphorylation of various molecular targets, which activate the downstream 
signaling cascades, leading to changes in cell death-regulating proteins and resulting 
in the survival or death of a cell (Wu-Wong et al, 2000). 
I 1.6.2 Apoptosis versus necrosis 
The onset of apoptosis is heralded by compaction and segregation of chromatin into 
sharply uniform masses that lie against the nuclear envelope, condensation of the 
cytoplasm and mild convolution of nuclear and cellular outlines. In the next few 
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minutes, there is nuclear and DNA fragmentation and marked convolution of the 
cellular surface with budding. In the final stage, separation of the membrane-bound 
apoptotic bodies occurs, which are then phagocytosed and digested by macrophages 
(Tomei et al, 1991). In contrast, the onset of necrosis is heralded by the injured cells, 
which cannot be repaired. At the beginning stage, chromatin clumps into less 
uniform masses and the organelles swell. At final stage, cell membranes break down 
and the nuclear chromatin disappears, that is, cell disintegration occurs (Tomei et al.’ 
1991). 
Apoptosis is a programmed cell death, which is different from necrosis. By 
comparing these two, necrosis involves the swelling of the organelles, while 
apoptosis involves condensation only. Both contain the DNA fragmentation, while in 
apoptosis, the cleavage of DNA occurs at the linker regions between nucleosomes to 
produce fragments with approximately 185 base pairs (Tomei et al., 1991), but in 
“ necrosis, the cleavage of DNA is in a random manner. Apoptosis is not associated 
with inflammation, as there have not internal constituents released into the cell's 
surroundings, all the materials are phagocytosed by macrophages. Whereas necrosis 
is accompanied by inflammation, as after the disorganized disintegration of cells, the 
resulting products which are released trigger the inflammatory response (Rang, 
2003). 
,1 
1.6.3 Mechanisms of apoptosis 
There are many apoptosis pathways which have been discovered. Here, it just focus 
on two main pathways, one involving the stimulation of death receptors and the other 
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one involving the mitochondria, both of them involve the activation of caspases 
(Rang, 2003). 
Caspase refers to ICE/CED-3 family of cysteine proteases, and is highly conserved 
among species. In human, about two-third of caspases have been suggested to 
function in apoptosis (Hengartner, 2000) and the other caspases have another 
physiological functions, for example, caspase-12 has been suggested to be involved 
in regulating inflammation (Tracey et al, 2004). It cleaves its substrates after an 
aspartate residue at the carboxyl terminal and the caspase's distinct substrate 
specificity is determined by the four residues amino-terminal to the cleavage site. All 
caspases exist as zymogens, which are composed of three domains, they are the 
N-terminal prodomain, and the p20 and plO domains. Zymogens require proteolytic 
processing to become active, it usually involves the removal of the N-terminal 
pro-domain (Hengartner, 2000). Once activated, caspase can initiate a diverse 
cleavage of other cellular proteins, and then lots of physiological effects occur, 
including apoptosis. In human, eleven caspases have been identified (caspase 1 to 
caspase 11) to be involved in apoptosis regulation and they can be divided into two 
classes according to the presence of the amino-terminal pro-domain. Class I caspases 
(caspase-1, 2, 4，5, 8，9, 10 and 11) contain long pro-domain. They are usually in the 
upstream part of the apoptotic cascade, so they are also called initiator caspases. 
Class II caspases (caspase-3, 6, 7) contain short or absent pro-domains. They are 
usually in the downstream part of the apoptotic cascade, so they are also called 
effector caspases. The activity of caspases can be regulated by transcription, 
proteolytic activation, alternative splicing to produce truncated protein and 
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localization of caspases (Tomei et al., 1991). 
One of the main apoptosis pathways is the death receptor pathway. Death receptors 
have 'death domain' in their cytoplasmic tail (Rang, 2003). Upon binding of an 
external ligand, adapter protein is recruited and associated with the death domain on 
the membrane. Then this complex recruits many procaspase-8. Under this close 
proximity, procaspase-8 gets activated by mutual cleavage and then activates each 
other. The activated caspase-8 is an initiator caspase, it activates effector caspases 
and induces apoptosis (Hengartner, 2000). 
Mitochondrial pathway is another major apoptosis pathway. It involves the release of 
cytochrome c from the mitochondria by the activity of the Bcl-2 protein family. 
Bcl-2 family can be divided into three groups, based on their structural similarities. 
The first group includes bcl-2 and bcl-XL, all of them possess anti-apoptotic activity. 
•‘ They are characterized by four short, conserved bcl-2 homology domains (BHl -
BH4). They also possess a C-terminal hydrophobic tail, by which this group 
members can localize on the outer surface of the mitochondria. The second group 
possesses apoptotic activity, includes bax and bak. Their structure is similar to the 
first group, except the missing of BH4. The third group also possesses apoptotic 
activity, include bid and bik. Their structure is very diverse and they only have a 
BH3 domain in common with the previous groups. Among these three groups, they 
can form heterodimer between groups and homodimer within group. These groups 
meet at the surface of the mitochondria, if the pro-apoptotic signals from the second 
and third group are stronger than the anti-apoptotic signals from the first group, and 
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then cytochrome c is released from the mitochondria. In the cytosol, the released 
cytochrome c will associate with apoptotic protease-activating factor-1 (Apaf-1) and 
procaspase-9 to form an apoptosome. In the apoptosome, procaspase-9 gets activated. 
Procaspase-3 is activated by caspase-9, and apoptosis is executed (Hengartner, 2000) 
(Fig. 1.3). 
1.6.4 Methods to study apoptosis 
There are many methods to study apoptosis, such as recognition of the apoptotic cells 
morphology, assessment of intemucleosomal DNA fragmentation, quantification of 
the Bcl-2 family proteins amount and detection of caspases activity. The objective of 
the study determines which techniques are chosen. 
To recognize the apoptotic cell morphology, several stains are used such as ethidium 
bromide and acridine orange (EB/AO) (Cohen, 1993; Coligan, 1995), 
•• 4;,6-diamidino-2phenylidole (DAPI) (Coligan, 1995) or Hoechst staining (Coligan, 
1995). After staining, the apoptotic cells were different from the normal cells. Take 
the EB/AO staining as an example, after staining, the live cells have a normal green 
nucleus; early apoptotic cells have bright green nucleus with condensed or 
fragmented chromatin; late apoptotic cells display condensed and fragmented orange 
chromatin; cells that have died from direct necrosis have a structurally normal orange 
'' nucleus (Reiivoize et al., 1998; Ribble et al., 2005; Wang et al., 2005). 
To assess the DNA fragmentation from apoptosis，the most common methods are 
DNA laddering on an agarose gel and the terminal deoxynucleotide 
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transferase-mediated dUTP-biotin nick-end labeling, usually known by the acronym 
TUNEL. TUNEL assay is based on the specific binding of the enzyme and the 
incorporation ofbiotin. Then the biotinylated-labelled bases on the fragmented DNA 
are detected by the anti-biotin immunogloblins (Gavrieli et al., 1992). 
There are several ways to detect the Bcl-2 family members, such as immunoblotting, 
northern blot analysis, reverse-transcriptase polymerase chain reaction (RT-PCR) and 
immunohistochemical detection. 
Detection of the apoptosis induction by the measurement of the caspases activity, 
usually makes use of the specific cleavage sites of each caspase and a fluorogenic or 
chromogenic compound, such as a colorimetric assay using compound 
(Ac-DEVD-pNA) (Chae et al” 2004). If there is an activation of caspase, and then 
the cleavage site will be recognized and cleaved by the caspase, as a result a release 
,, of,the fluorogenic or chromogenic compound, which can be detected. 
1.6.5 Different types of apoptotic inducers 
Apoptotic inducers pass through various mechanisms to disturb the cells and initiate 
apoptosis. These mechanisms include the death receptor, calcium influx, oxidative 
stress, inhibition of protein synthesis, perturbation of DNA integrity and inhibition of 
protein kinases, therefore, apoptotic inducers can be divided based on their 
mechanism. 
Intracellular calcium increase can lead to apoptosis, it is indicated in the parathyroid 
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hormone/ parathyroid hormone-related protein (PTH/PTHrP) receptor. PTH-induced 
apoptosis through PTH/PTHrP receptor was inhibited by a calcium-binding protein, 
calbindin (Turner et aL, 2000). This group of apoptotic inducers includes the calcium 
ionophore. 
In murine lymphoma cell line, apoptosis was induced by nitric oxide (Hu et aL, 
2005). Nitric oxide induces apoptosis by imposing an oxidative stress to the cells. 
Apoptotic inducers using this pathway include some of the nitric oxide donors 
(Fiscus et aL, 2002). . 
DNA breaks result in apoptosis. One of the methods to produce DNA breaks is to 
inhibit topoisomerase. For examples, etoposide inhibits topoisomerase II by forming 
a ternary complex with the cleaved DNA, in order to prevent the religation of 
double-strand DNA breaks (Sai Krishna et aL, 2005). The other apoptotic inducers 
” fall into this group include topoisomerase I inhibitors. 
Some of the drugs induce apoptosis by inhibiting protein kinases. For example, 
phosphoinositide 3-kinases (PI3K) inhibitor blocks the PI3K/Akt anti-apoptotic 
pathway to induce apoptosis. Other apoptosis inducers of this group include 
staurosporine. 
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Figure 1.3 Mitochondrial pathways of apoptosis. In the apoptotic cells, on the 
mitochondria surface, the pro-apoptotic subtype (BH3) of Bel-2 family inhibits the 
.. anti-apoptotic subtype (bcl-2). It causes the release of cytochrome c (cyt c) and then 
the apoptosome (composed of caspase-3: c3, caspase-9: c9 and cyt c) formed. In the 
apoptosome, the pro-caspase-3 gets activated and the caspase-3 induced apoptosis 
occurs in the cells. Figure modified from Adams, (2003). 
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1.7 Apoptotic and anti-apoptotic pathways regulated by GPCRs 
1.7.1 Bcl-2 family pathway 
GPCRs have been demonstrated to regulate apoptosis by determining the expression 
level and the phosphorylation of bcl-2 family. GPCRs induce apoptosis by 
down-regulation of pro-apoptotic member in bcl-2 family and up-regulation of the 
apoptotic member, it has been demonstrated in cannabinoid 1 (CBl) receptor 
(Femandez-Ruiz et al., 2004), somatostatin (SSTR2) receptor (Kumar et al., 2004) 
and angiotensin (AT2) receptor (Tejera et al, 2004). GPCRs induce anti-apoptotic 
effect by the opposite pattern as the apoptotic pathway, that is by increasing the 
expression level of proapoptotic bcl-2 family and decreasing the expression level of 
apoptotic bcl-2 family, such as P2Y2 purinoceptor (P2Y2) (Choma et al., 2004), 
adenosine 1 (Al) and adenosine 3 (A3) (Das et al., 2005). GPCRs regulate the bcl-2 
family by activating PI3I<7Akt pathway (Das et al., 2005; Di lorio et al, 2004; 
•“ Iwai-Kanai et aL, 2004) as described in section 1.7.4，and mitogen-activated protein 
kinases (MAPK), such as extracellular signal-regulated kinases (ERKl/2) pathways 
(Di lorio et al., 2004; Iwai-Kanai et al., 2004) as described in section 1.7.3， or 
inhibiting the caspase cascades as described in section 1.7.2 (Kippenberger et al” 
2005). cAMP responsive element binding (CREB) protein-dependent pathway can 
induce (Iwai-Kanai et al., 2004) or inhibit (Choma et al, 2004; Das et al, 2005) 
apoptosis, depending on the cell types. 
1.7.2 Caspase pathway 
GPCRs regulate apoptosis through caspases cascade. One of the pathways is through 
“ Page 27 
Chapter 1 Introduction 
the Gq-coupled receptor to raise the intracellular calcium level, and then the calcium 
activates caspase-1 and caspase-3 activity through mitochondria pathway, as 
described in section 1.6.3. P2X7 purinergic receptor (P2X7) (Kippenberger et al., 
2005) and parathyroid hormone receptor (PTHR) (Turner et al, 2000) were shown to 
make use of this pathway to execute apoptosis. The other two pathways in which 
GPCRs initiate or inhibit caspases cascade are the MAPK kinase pathways, such as 
ERKl/2 and p38, and PI3K/Akt pathway. Some of the GPCRs reduce the activity of 
ERKl/2, results in the increasing caspase-3 activity in the cells (Jaleel et al., 2004; 
Katsuma et al, 2005). Similar to ERKl/2, inhibition ofPBK/Akt pathway results in 
an increase of caspase-3 activity (Bar-Yehuda et al., 2005; Germack et al.’ 2004a; 
Vassiliou et al., 2004). 
1.7.3 ERK pathway 
GPCR activation can lead to activation ofERKs. ERKl (44 kDa) and ERK2 (42 kDa) 
are well-established mitogen-activated protein kinase (MEK) substrates (Sugden et 
al., 1997). Activation of ERKl and ERK2 leads to activation of several transcription 
factors and causes cellular proliferation and cell survival (Somai et al., 2002). Many 
of the GPCRs were shown to protect the cells against apoptosis through the 
activation of ERKl/2 pathways, such as endothelin receptor (ET-1) (Iwai-Kanai et al, 
2004; Wu-Wong et al., 2000), GPR120 (Katsuma et al, 2005)), chemokine receptor 
(CXCR4) (Jaleel et al, 2004) and neurotensin receptor (Somai et al, 2002). For 
example, in MCF-7 cells, activation of neurotensin receptor inhibited apoptosis and 
stimulated cell proliferation through activation of ERKl and ERK2 (Widmann et al., 
1999). Studies showed that stimulation of neurotensin receptor activated ERKl and 
“ Page 28 
Chapter 1 Introduction 
ERK2 (Ehlers et al, 2000) and bcl-2 gene expression was promoted by ERKl and 
ERK2 (Liu et al., 1999). As a result, bcl-2 inhibits apoptosis. That is, GPCR 
activates ERKl and ERK2 and leads to cell survival by promoting gene expression 
of anti-apoptotic factor. 
1.7.4 PBK/Akt pathway 
On the interior cell surface, phosphoinositide 3-kinases (PI3K) converts 
phosphatidylinositol-4,5-bisphosphate (PtdIns-4,5-P2) into 
phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3), and then it is further 
converted to phosphatidylinositol-3,4-bisphosphate (PtdIns-3’4-P2) by phospholipids 
phosphatase. Akt is a serine/theronine protein kinase. Akt recruits to the membrane 
and gets conformational change. Then Akt gets activation by phosphorylation at 
serine and threonine by protein kinase B kinases (PKBKs). Subsequently, the 
phosphorylated Akt is released from the membrane and phosphorylates its specific 
• targets (Hemmings, 1997). One of the effects is the induction of an anti-apoptotic 
effect in the cells. There are many GPCRs which can induce anti-apoptotic effect 
through PI3K/Akt pathway, including adenosine A3 receptor (Das et al., 2005; 
Germack et al, 2004b), ET-1 (Iwai-Kanai et al., 2004), EP2 and EP4 (Vassiliou et al, 
2004), and p2-adrenergic receptor (Singh et al., 2001). In adult mouse cardiac 
myocytes, p2-adrenergic receptors activate PBK/Akt through PTX-sensitive G, 
proteins. This activation is a cell survival signal, because inhibition of Gi protein by 
PTX or inhibition of PI3K by LY294002 caused DNA fragmentation (Zhu et al., 
2001). Therefore, PBK/Akt is an important cell survival intermediate. Akt mediates 
survival effect by several mechanisms, which include phosphorylation of BAD, 
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releasing Bcl-2 family member (Datta et al., 1997), phosphorylation and inactivation 
of caspase-9 (Datta et al., 1999) and phosphorylation of the forkhead transcription 
factor, FKHLl (Romashkova etal, 1999). 
I 
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Materials and solutions 
2.1. Materials 
0.25% Trypsin/EDTA (Sigma) 
1 kb DNA ladder (0.5 mg DNA/ml, Fermentas) 
2myc-hGHSRla plasmid DNA (HW/8/72) was cloned in pcDNA3.1(+) expression 
vector. 
2myc-hGHSRlb plasmid DNA (HW/8/72) was cloned in pcDNA3.1(+)/Zeocin 
expression vector. 
6x loading buffer (Fermentas) 
Adenosine (Sigma) 
Adenosine deaminase (Sigma) 
Agar powder (Sigma) 
Agarose (genetic technology grade, FMC) 
Ammonia solution (25%, BDH) 
Ammonium formate (Sigma) 
Ampicillin (Sigma) was dissolved in ultra-pure water at 50 mg/ml, aliquoted and 
stored at -20°C and thawed no more than twice. 
Antibiotic G418 sulfate, geneticin (USB) was dissolved in autoclaved ultra-pure 
water at 50 mg/ml, aliquoted and stored at -20°C and thawed no more than twice. 
ATP (Adenosine 5'-triphosphate, Sigma) was freshly prepared by dissolving in. 
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ultra-pure water at 100 mM. 
Bam HI (New England Biolab) 
Buffer B (Roche) 
Buffer H (Roche) 
Calcium chloride, dihydrate (CaC1.2H20，Sigma) 
Caspase-3 biosensor (pGFP -DEVD-Rluc(h), BioSignal Packard) was reconstituted 
at 1.0 |ig/ml with 10 mM Tris-HCl, pH 8.0, 1 mM EDTA，and stored at -20°C. 
Caspase-3 Substrate I (Ac-DEVD-pNA, Calbiochem) was dissolved in 100% 




DAMGO ([D-Ala^ NMe-Phe^ Gly-ol^] enkephalin DAGO, Tocris) 
DeepBIueC (50 |ig, BioSignal Packard) was dissolved in absolute ethanol at 1 mM 
” aqd stored at -20°C. 
DMEM (Dulbecco's Modified Eagle Media, Cat no. 12800-017, Gibco) 
DMSO (Dimethyl sulfoxide, Sigma) 
DTT (Dithiothreitol, Pharmacia Biotech) 
Dulbecco's Modified Eagle Medium without serum, glutamine and phenol red 
(Cat no. 31053-028, Gibco) 
Eco RI (Roche) 
EDTA (Ethylenediamine-tetraacetic acid, disodium salt; Dihydrate, Sigma) 
Escherichia coli DH5a 
Escherichia coli ToplOF， 
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Ethanol (absolute, Merck) 
Ethidium bromide (Sigma) 
Etoposide (Biomol) was dissolved in DMSO at 40 mM, aliquoted and stored at -20 
°C. 
Fetal bovine serum (Gibco) was heat treated 65°C, aliquoted and stored at -20°C 
and thawed no more than twice. 
Fluorescence resonance energy transfer (FRET) caspase-3 biosensor 
(pCFP-DEVD-YFP, a gift from Prof. Donald C. Chang, HKUST) 
Formic acid (BDH) 
Ghrelin (Bachem) was dissolved in ultra-pure water at 1 mM, aliquoted and stored 
at -20°C and thawed no more than twice. 
GHRP-6 (Growth hormone releasing peptide 6，Bachem) was dissolved in ultra-pure 
water at 30 mM, aliquoted and stored at -20°C and thawed no more than twice. 
Glacial acetic acid (Riedel-de Haen) 
Glycerol (Sigma) 
GaqRC plasmid DNA (a gift from Prof. Y.H. Wong, HKUST) was cloned in 
pcDNAl expression vector. 
HA-tagged Human thromboxane A! (HA-hTPa) receptor plasmid DNA (a gift 
from Takuya Kobayashi, Kyoto University) was cloned in pcDNA3.1(+). 
HEPES (N-(2-Hydroxyethyl)piperazine-N�-(2-ethanesulfonic acid, Sigma) 
‘ Hindlll (Roche) 
Human growth hormone secretagogue receptor la (hGHSRla) plasmid DNA 
(Guthrie) was cloned in pcDNA3.1(+) expression vector. 
Human growth hormone secretagogue receptor lb (liGHSRlb) plasmid DNA 
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(Guthrie) was cloned in pcDNA3.1(+) expression vector. 
Hydrochloric acid (35.4%, BDH) 
Isopropanol (BDH) 
Kanamycin (Sigma) was dissolved in ultra-pure water at 40 mg/ml and stored at -20 
�C. 
Lipofectamine2000 reagent (Invitrogen) 
Lithium chloride (Sigma) was prepared as a 1 M solution in ultra-pure water and 
stored at 4�C. 
Magnesium chloride, hexahydrate, ACS (MgCl2'6H20, USB) 
mDP (mouse prostaglandin D2 receptor) plasmid DNA (a gift from Takuya 
Kobayashi, Kyoto University) was cloned in pCMV expression vector. 
Micro BCATM Protein Assay Kit (PIERCE) 
MOR (ji-opioid receptor) plasmid DNA (a gift from Prof. Y.H. Wong, HKUST) 
was cloned in pRcCMV expression vector. 
M>;o-inositol-[2-^H(N)] (specific activity 22.2 Ci/mmol, NEN) stored at 4°C • 
Na2HP04 (Sodium phosphate, dibasic, anhydrous, Sigma) 
Not I (Roche) 
Opti-Mem I reduced serum medium (Gibco) 
Optiphase Hisafe-3 (Pharmacia Biotech) 
pBK-CMV vector DNA (Stratagene) 
pcDNA3.1(+)/Zeocin vector DNA (Invitrogen) 
pcDNA3.1(+)vector DNA (Invitrogen) 
pEGFP-Nl plasmid DNA (clontech) 
Penicillin/Streptomycin solution (Sigma) was reconstituted with 20 ml sterile 
一 Page 34 
Chapter 2 Materials and solutions 
ultra-pure water and stored at 4°C. 
PIPES (1,4-Piperazinediethanesulfonic acid, Sigma) 
/7-nitroaniIine (Sigma) was dissolved in absolute ethanol at 5 mM, aliquoted and 
stored at-70°C. 
Poly-D-lysine (Sigma) was dissolved in PBS A at 5 mg/ml, aliquoted and stored at 
-20°C. 
Positive control vector for bioluminescence resonance energy transfer (BRET^) 
assay (pGFP^-Rluc(h), BioSignal Packard) 
Potassium chloride (KCl, Sigma) 
Potassium dihydrogen phosphate (KH2PO4, Merck) 
Prostaglandin D2 (PGD2, Cayman) was dissolved in ethanol at 1 mM and stored at 
-20°C. 
QIAGEN Plasmid Maxi Kit (QIAGEN) 
Sal I (Roche) 
Seabream growth hormone secretagogue receptor la (sbGHSRla) plasmid DNA 
(a gift from Dr Chi-Bun Chan, CUHK) was cloned in pBK-CMV expression vector. 
Seabream growth hormone secretagogue receptor lb (sbGHSRlb) plasmid DNA 
(a gift from Dr Chi-Bun Chan, CUHK) was cloned in pBK-CMV expression vector. 
Sodium bicarbonate (NaHCOa, Sigma) 
Sodium chloride (NaCl, Sigma) 
Sodium hydroxide (NaOH, Sigma) 
Staurosporine (Biomol) was dissolved in DMSO at 10 mM, aliquoted and stored at 
-20°C. 
Substance P analog (D-Arg^D-Phe^D-Trp^' ^Leu'^Substance P，Bachem) was 
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dissolved in ultra-pure water at 10 mM，aliquoted and stored at -20°C and thawed no 
more than twice. 
superscript™ First-Strand Systhesis System (Invitrogen) 
SYBR Green RT-PCR Kit (Applied Biosystems) 
Tetracycline (Sigma) was dissolved in ultra-pure water at 10 mg/ml and stored at 
-20°C. 




TRIzol reagent (Invitrogen) stored at 4°C. 
Trypan blue (Sigma) 
Tryptone (Oxoid) 
U46619 (Sigma) was dissolved in absolute ethanol at 2.85 mM and stored at -20°C. 
Wizard® Plus SV Minipreps DNA Purification System (Promega) 
Xhol (New England Biolab) 
Yeast extract (Oxoid) 
Zeocin (Invitogen) 
All the disposable culture dishes and culture plates were supplied by Corning. 
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2.2. Culture medium, buffers and solutions 
2.2.1. Culture medium 
Dulbecco's Modified Eagle's Medium DMEM (Gibco) was reconstituted with 
1000 ml ultra pure water, and supplemented with NaHCOs (3.7 g/L). The pH was 
adjusted to 7.2 with 1 M HCl and filter sterilized through a 0.22 pm filter into 1000 
ml bottle to give a final pH of around 7.4. It was stored at 4�C. Heat-treated fetal 
bovine serum (10% v/v) was added to form complete medium, 
2.2.2. Buffers 
Assay buffer for caspase-3 colorimetric assay was prepared with the following 
reagents: HEPES (50 mM), NaCl (100 mM), CHAPS (0.1%), DTT (10 mM), EDTA 
(0.1 mM) and glycerol (10%) in ultra-pure water. The pH was adjusted to 7.4 and the 
solution was stored at -70°C. 
Cell lysis buffer for caspase-3 colorimetric assay was prepared with the following 
reagents: HEPES (50 mM), NaCl (100 mM), CHAPS (0.1%), DTT (1 mM) and 
EDTA (0.1 mM) in ultra-pure water. The pH was adjusted to 7.4 and the solution was 
stored at-70°C. 
Dulbecco's PBS (PBSA: Ca^^/Mg^^ free) was prepared with the following ACS 
reagents supplied by Sigma: KCl (2.7 mM), KH2PO4 (1.4 mM), NaCl (137 mM) and 
Na2HP04 (8.1 mM) in ultra-pure water. The pH was adjusted to 7.5 with 1 M NaOH 
and the solution was filter sterilized giving a final pH of 7.4 and stored at 4°C. 
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HEPES buffered saline (HBS) was prepared with the following ACS reagents 
supplied by Sigma: CaCl-2H20 (2.2 mM), HEPES (15 mM), KCl (4.7 mM), 
KH2PO4 (1.2 mM), MgCl2'6H20 (1.2 mM), NaCl (140 mM) in ultra-pure water. The 
pH was adjusted to 7.5 with 1 M NaOH and the solution was filter sterilized giving a 
final pH of 7.4 and stored at 4°C. Glucose (11 mM) was added on the day of 
experiment. 
2.2.3. Solutions 
1 M formic acid was prepared by adding 37.73 ml 26.5 M formic acid stock solution 
to ultra-pure water and the volume was made up to 1000 ml. The solution was stored 
at room temperature. 
20 mM formic acid was prepared by adding 20 ml 1 M formic acid to ultra-pure 
water and the volume was made up to 1000 ml. The solution was stored at 4°C. 
••• 
2 M ammonium formate / 0.1 M formic acid was prepared by dissolving 252.24 g 
ammonium formate in 200 ml 1 M formic acid, and the volume was made up to 2000 
ml using ultra-pure water. The solution was stored at room temperature. 
40 mM ammonium formate / 0.1 M formic acid was prepared by dissolving 5.04 g 
ammonium formate and adding 200 ml 1 M formic acid, and the volume was made 
up to 2000 ml using ultra-pure water. The solution was stored at room temperature. 
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0.05% ammonia solution was prepared by adding 2 ml 25% ammonia solution to 
ultra-pure water and the volume was made up to 1000 ml. The solution was stored at 
room temperature. 
LB broth was prepared by dissolving 10 g NaCl, 10 g tryptone and 5 g yeast extract 
in 1000 ml ultra-pure water. The LB broth was autoclaved and antibiotic was added 
as required to the solution after cooling. The solution was stored at 4�C. 
LB broth (low salt) was prepared by dissolving 5 g NaCl, 10 g tryptone and 5 g 
yeast extract in 1000 ml ultra-pure water. The LB broth was autoclaved and antibiotic 
was added as required to the solution after cooling. The solution was stored at 4°C. 
Agar plates were prepared by dissolving 10 g NaCl, 10 g tryptone, 5 g yeast extract 
and 15 g agar powder in 1000 ml ultra-pure water. The agar solution was autoclaved 
•“ and the antibiotic was added as required to the solution after cooling. 15 ml agar 
solution was poured into each 100 mm dish and left to solidify at room temperature. 
The agar plates were stored up side down at 4°C. 
Agar plates (low salt) were prepared by dissolving 5 g NaCl, 10 g tryptone, 5 g 
yeast extract and 15 g agar powder in 1000 ml ultra-pure water. The agar solution 
was autoclaved and the antibiotic was added as required to the solution after cooling. 
15 ml agar solution was poured into each 100 mm dish and left to solidify at room 
temperature. The agar plates were stored up side down at 4°C. 
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50 X TAE was prepared by dissolving 48.4 g Tris-base, 11.71 ml glacial acetic acid 
and 7.44 g EDTA in 200 ml ultra-pure water and stored at room temperature. 
1 X TAE was prepared by adding 20 ml 50 X TAE to 980 ml ultra-pure water and 
stored at room temperature. 
TE was prepared as 10 mM Trizma-hydrochloride and 1 mM EDTA in ultra-pure 
water at pH 8.0 and stored at 4°C. 
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Chapter 3 
Methods 
3.1. Maintenance of cell lines 
3.1.1. Human Embryonic Kidney (HEK293) cells 
HEK293 cells were cultured in DMEM medium supplemented with 10% FBS, 100 
units/ml penicillin and 100 ng/ml streptomycin in a humidified atmosphere of 5% 
CO2/950/0 air at 37°C. Cells were passaged weekly at 90% confluency, and the 
medium was refreshed every two to three days. When subculturing the cells, the 
medium was removed from 100 mm culture dish and the cells were rinsed with 10 ml 
PBSA. Then, PBSA was aspirated and 1 ml trypsin/EDTA was added to the dish for 
3 to 5 min at room temperature. When the cells were completely detached from the 
“ dish, 9 ml complete DMEM was added to neutralize the trypsin. The cell suspension 
(1 ml) was added to a new dish with 9 ml complete DMEM (split ratio 1 : 1 0 ) . When 
counting cells, 10 [d of cell suspension was mixed with 10 \i\ of trypan blue solution. 
Then，10 [i\ of the mixture was transferred to a hemocytometer slide and counted 
under a microscope. Normal viability was over 90%. 
3.1.2. HEK293 cells stably expressing black seabream growth hormone 
secretagogue receptors (HEK-sbGHS-Rla and HEK-sbGHS-Rlb) 
HEK-sbGHS-Rla and HEK-sbGHS-Rlb cells were cultured as described in section 
3.1.1 but with the addition of 500 ^g / ml G418. 
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3.2. Preparation of plasmid DNA 
3.2.1. Preparation of competent E. coli 
Five ml of the non-competent E.coli (TopiOF' or DH5a) was added to 200 ml LB 
with appropriate antibiotic as necessary. The growth of E, coli was monitored until 
the absorbance at 600 run reached between 0.4 and 0.6. The E. coli culture was 
aliquoted into prechilled falcon tubes and incubated on ice for 10 min. The E. coli 
were then centrifuged at 1600 x g at 4°C for 7 min. The supernatant was removed 
and the pellet was resuspended in 10 ml ice-cold CaCb solution (60 mM CaCb, 10 
mM PIPES and 15% glycerol). The E. coli suspension was centrifiiged at 1100 x g at 
4°C for 5 min and the pellet was resuspended in 20 ml ice-cold CaCl2 solution. Then, 
the resuspended E. coli were incubated on ice for 30 min followed by centrifugation 
at 1100 X g at 4°C for 5 min and the pellet was resuspended in 3 ml ice-cold CaCl2 
solution. The competent cells were aliquoted and stored at -70°C. 
3.2.2. Transformation of DNA into competent cells 
Plasmid DNA (10 ng) was mixed with 100 suitable competent cells and incubated 
on ice for 30 min to allow the plasmid DNA to surround the competent cells. Then, 
the competent cells were heat shocked at 42�C for 2 min, so the plasmid DNA enters 
the competent cells. The heat shocked competent cells were incubated with 500 j^ l 
I 
LB at 37°C with shaking for 1 h and collected by centrifugation at maximum speed 
(about 13000 x g) for 30 sec using micro-centrifuge (Sigma 113). The cell pellet was 
resuspended in approximately 100 |j,l LB and spread on an agar plate which 
contained suitable antibiotic for selection of positive clones. Colonies were 
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developed by overnight incubation at 37°C and individual colonies were picked and 
inoculated to 5 ml of antibiotic-containing LB for small scale DNA preparation. 
3.2.3. Small-scale and large-scale plasmid DNA preparation 
Wizard® Plus SV Minipreps DNA Purification System was used to prepare 
small-scale plasmid DNA suitable for characterizing the plasmid DNA and 
transfection. QIAGEN Plasmid Maxi Kit was used to prepare a large-scale plasmid 
DNA. All the procedures followed supplier's instructions. 
3.2.4. Confirmation of the purity and the identity of the plasmid DNA 
In order to confirm the purity of the plasmid DNA, the ratio of the absorbance 
measurements at 260 nm and 280 nm were used. As the absorbance at 260 nm and 
280 nm indicate the amount of DNA and protein present in the sample respectively. 
An absorbance ratio between 1.6 and 2.0 was regarded as suitable plasmid DNA 
“ purity for use. 
Restriction enzyme digestion was used to confirm the identity of plasmid DNA. 
Restriction enzymes used in each plasmid DNA digestion and the band sizes of each 
DNA fragment after restriction enzyme digestion are shown in Table 3.1. 
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Plasmid Restriction enzyme(s) Size of DNA fragment(s) (kb) 
hGHS-Rla Eco Rl + Xhol 1.1,5.4 
hGHS-Rlb Eco Rl + Xhol 0.9，5.4 
pBK-CMV Hind III 4.5 
pcDNA3.1(+) Hind III 5.4 
pEGFP-Nl Hind III 4.7 
pGFP-DEVD-Rluc(h) Hind III + Bam HI 1.0，4.2 
sbGHS-Rl a Not I and Sal I 1.2, 4.4 
sbGHS-Rlb Not I and Sal I 0.9，4.4 
Table 3.1. Band sizes of plasmid DNA after digestion by different restriction 
enzymes. 
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3.3. Transient transfection of mammalian cells 
Cells were seeded in the plates and maintained in complete medium without 
antibiotic for 2 days. Cells were transfected at 80% to 90% confluency using 
Lipofectamine2000 reagent and Opti-Mem I reduced serum medium following 
manufacturer's instructions. Briefly, 0.8 |ig DNA and 2 \i\ lipofectainine2000 reagent 
were each diluted in 25 |xl Opti-Mem I medium. After 5 min, the solutions were 
combined to form a transfection cocktail and allowed to stand at room temperature 
for 20 min. After that, the correct DNA concentration was achieved by adding 
suitable volume of Opti-Mem I medium to the transfection cocktail. The resulting 
transfection cocktail was added to the cells in the culture dishes or culture plates 
which were then incubated at 37°C for 5 h before replacing the cocktail with 
complete medium without antibiotic. Cells were assayed 48 h post-transfection. 
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3.4. Development of stable cell lines 
3.4.1. Determination of the optimum concentration of each antibiotic used in 
selection of clones 
Cells in 100 mm dish at 80 - 90% confluency were split at 1:50 or 1:300 dilutions, 
and seeded in 6-well plates. After 24 h，the cells were incubated with different 
concentrations of G418 (0，200, 300，400，500, 600，800 and 1 ^^ml) for one and a 
half weeks. The medium containing G418 was refreshed every 3 - 4 days. At last, the 
percentages of the surviving cells at each G418 concentration were estimated under 
microscope. 
Cells were seeded in 24-well plate (300,000 cells per well). After 24 h, the cells were 
incubated with different concentrations of Zeocin (0，100，150, 200，250，300，350, 
400，500，600，800 i^g/ml) for one and a half weeks. The medium contained Zeocin 
w^s refreshed every 3 - 4 days. At last，the percentages of the surviving cells at each 
Zeocin concentration were estimated under microscope. 
3.4.2. Development of monoclonal stable cell line 
Two transfection methods were used in developing stable cell lines. The first one was 
that the cells were seeded in 100 mm dish and transfected with 0.25 |ig/ml 
2myc-hGHS-Rla plus 0.75 |ag/ml pcDNA3.1(+) or 1 |ig/ml 2myc-hGHS-Rlb, as 
described in section 3.3. 
The other method was that the cells were seeded in 6-well plates and transfected with 
Page 46 
Chapter 3 Methods 
2 |ig/ml either linearized or circular hGHS-Rla or hGHS-R lb using lipofectamine. 
Using lipofectamine transfection reagent, the procedures are similar to the use of 
lipofectamine2000. Basically, 2 |ig DNA and 4 [d lipofectamine were diluted in 100 
\i\ Opti-Mem I reduced serum medium separately. Then the two solutions were 
mixed together and incubated at room temperature for 30 min. At last, the 
transfection cocktail was made up to 1 ml by adding Opti-Mem I reduced serum 
medium and overlaid onto the cells. The cells were incubated at 37°C for 6 h and 
then the transfection cocktail was replaced by complete medium without antibiotic. 
After 48 h post-transfection, the cells transfected in 100 mm dish were split at 1:8 or 
1:50，and transferred to a new 100 mm dish. After 72 h post-transfection, the cells 
transfected with 2myc-hGHS-Rla in the 100 mm dish and 6-well plate were 
incubated with 600 [ig/m\ G418. The cells transfected with 2myc-hGHS-Rlb were 
incubated with 300 [ig/m\ Zeocin. The medium was refreshed every 3 - 4 days, and 
the antibiotic selection was last for two and a half weeks, until no more cells died. 
The remaining surviving cells were called polyclonal stable cell line. 
After antibiotic selection, surviving cells were transferred to 96-well plate at a cell 
density of 1 cell per well. After 2 weeks, single colonies were selected and each 
- colony was transferred to a well in the 12-well plate. When the cells grew to 90% 
‘ ； / 
confluency in 12-well plate, cells were transferred to 6-well plate. At last, the cells 
grew in 100 mm dish. Besides using 96-well plate to select single colonies, clonal 
ring is another technique that was used to select single colonies. In this method, after 
antibiotic selection, surviving cells were seeded in 100 mm dish at different cell 
Page 47 
Chapter 3 Methods 
numbers (10, 20, 30，50, 100 cells per dish). After one week, delineated single colony 
border by drawing a circle on the bottom of the culture dish around each colony. 
Then the medium was aspirated from the dish and a clonal ring (the top of the pipette 
tip) with silicon grease at the bottom was placed onto the dish, in order to 
surrounding an individual clone. Single colony inside the clonal ring was detached 
by adding 100 |il complete medium and pipetting up and down. The single colony 
was transferred to 96-well plate for growth. 
3.4.3. Confirmation the expression of 2myc-hGHS-Rla and 2myc-hGHS-Rlb 
To check the expression of 2myc-hGHS-Rla and 2myc-hGHS-Rlb in the 
monoclonal stable cell lines, [^H]-inositol phosphates assay and RT-PCR were 
carried out respectively, as described in sections 3.5 and 3.7. 
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3.5. Measurement of phospholipase C activity 
3.5.1. Introduction 
Activation of a Gq-coupled receptor results in the stimulation of phospholipase C 
(PLC). The activity of PLC leads to the formation of inositol 1,4,5-trisphosphate (IP3) 
and diacylglycerol (DAG). IP3 can be further metabolized to a variety of inositol bis-
and monophosphates. IP degradation is inhibited by the presence of lithium chloride 
(LiCl). Therefore, the accumulation of [^H]-inositol phosphates was measured in this 
assay by inclusion of LiCl. 
3.5.2. Preparation of columns 
Dowex resin (Bio-Rad AG 1 - X8) was washed twice with distilled water. Resin 
suspension was transferred to each polyprep column (Bio-Rad), until there was 
approximately 1 ml resin packed in each polyprep column. 
3.5.3. [^H]-inositol phosphate assay 
Cells were transfected as described in section 3.3, in 12-well plates coated with 50 
l^ g/ml poly-D-lysine (SOOjil per well), using 300 |xl transfection cocktail per well. 
After 24 h post-transfection, cells were labeled with 2 |xCi/ml m>;o-[^H]-inositol at 
37°C overnight. The medium was then aspirated and the cells were washed twice 
with 1 ml HBS buffer to remove the free m>;o-[^ H]-inositoL Then the cells were 
incubated in 1 ml assay buffer containing 20 mM LiCl for 10 min at 37°C. The assay 
buffer was replaced by another 1 ml assay buffer and 10 [d tested compound, and 
then incubated for 1 h at 37°C. The reactions were terminated by aspiration of assay 
buffer and the addition of 750 [d ice-cold 20 mM formic acid solution. Cells samples 
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were kept at 4°C for at least 1 h before processing. 
3.5.4. Measurement of [^HJ-inositol phosphates production 
[^H]-inositol phosphates were separated from total [^H]-inositol by column 
chromatography using dowex resin. Before loading the cells lysates onto the dowex 
columns, the columns were washed with 5 ml 2 M ammonium formate/0.1 M formic 
acid，2 ml of distilled water and then 2 ml 0.05% ammonia solution. The washed 
dowex columns were positioned on the top of a set of scintillation vials, then each 
cell lysate was loaded onto the column, followed by the immediate addition of 3 ml 
ammonia solution. The fraction collected in the vials contained [^H]-inositol and was 
mixed with 7.5 ml scintillant (Optiphase Hisafe-3). The columns were then placed 
over a waste container and washed with 4 ml 40 mM ammonium formate/O.l M 
formic acid. Next, the washed columns were positioned on the top of another set of 
scintillation vials, and 5 ml 2 M ammonium formate/O.l M formic acid was added to 
each column. The fraction collected in the vial is [^H]-inositol phosphates, which 
were then mixed with 10 ml scintillant. Blank samples (i.e. no cells) were processed 
in parallel to the test cells samples, in order to determine the background count for 
the columns; these values were subtracted from all the test values. All the samples in 
the vials were counted in a liquid scintillation counter (Packard LS2900TR). 
... 
3.5.5. Data analysis 
Assays were performed in duplicate or triplicate. [^H]-inositol phosphates production 
is expressed as (IP/[INOS+IP]) x 100, where IP is inositol phosphates and INOS is 
inositol. 
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3.6. Determination of transient transfection efficiency 
Cells were transfected with enhanced green fluorescence protein plasmid (pEGFP) in 
24-well plates as described in section 3.3, using 200 |xl transfection cocktail per well. 
After 48 h post-transfection, the medium was aspirated and the cells in each well 
were washed with 1 ml HBS. Then another 1 ml HBS was added to each well. Cells 
were observed under fluorescent microscope and the images of the cells were 
captured. If cells express EGFP, they glow in green colour under fluorescent 
microscope, as the fluorescent microscope excite the EGFP at 488 nm and then 
EGFP will have emission at 510 nm. By estimating the percentage of the fluorescent 
cells per field, the transfection efficiency can be estimated. The fluorescence of the 
same batch of cells was quantified and also counted by a counter (Victor-2 multilabel 
counter). 
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3.7. Reverse-transcription polymerase chain reaction (RT-PCR) 
3.7.1. RNA extraction and first strand cDNA production 
Cells were transfected in 6-well plates as described in section 3.3，using 600 |il 
transfection cocktail per well. After 48 h post-transfection, total RNA from the cells 
were extracted by TRIzol reagent, following manufacturer's instructions. Three [ig of 
the extracted total RNA was used to make the first-strand cDNA, using 
superscript™ II reverse transcriptase and oligo-dTi2-i8 as primer. All the procedures 
followed "superscript™ First-Strand Systhesis System" manufacturer's instructions. 
3.7.2. PCR and visualization of amplicons 
PCR was carried out in 50 volume containing 1 -1 .5 mM MgCl】，200 |iM dNTP， 
200 - 400 nM primers, 2.5 U Taq polymerase, and 150 ng first-strand cDNA. Using 
the primers listed in table 3.2 to amplify part of the hGHS-Rla, hGHS-Rlb, 
2myc-hGHS-Rlb, sbGHS-Rla and sbGHS-Rlb. The places where the primers bind 
to are illustrated in figure 3.1 to figure 3.4. After an initial denaturation at 94°C 5 
min, the PCR for GHS-Rs except the 2myc-hGHS-Rlb, were performed at 94°C for 
45 sec, 55°C for 45 sec and 72°C 1.5 min. The PCR for 2myc-hGHS-Rlb was 
performed at 94°C for 45 sec, 59°C for 1 min and 72°C 1 min. At the end of each 
PCR cycle, there was an elongation step performed at 72°C for 10 min. The PCR 
cycle number used 
is 25. Amplification of cellular hGADPH was carried out in 
parallel as an internal positive control. 
The PCR products were loaded and resolved in 1% agarose gel at llOV for 45 min. 
Page 52 
Chapter 3 Methods 
The gel was then stained in ethidium bromide (EtBr) solution for about 15 min and 
the EtBr stained PCR products were visualized by UV exposure and the bands were 
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atgtggaacg cgacgcccag cgaagagccg gggt tcaacc tcacactggc cgacctggac 
t ggga tgc t t cccccggcaa cgac tcgc tg ggcgacgagc tgc tgcagc t c t t ccccgcg 
ccgctgc tgg cgggcgtcac agccacctgc g tggcac tc t tcgtggtggg t a t cgc tggc 
aacc tgc tca cca tgc tgg t ggtgtcgcgc t tccgcgagc tgcgcaccac caccaacc tc 
t a c c t g t c c a gca tggcc t t c t c c g a t c t g c t c a t c t t c c t c t g c a t g c c cc tggacc t c 
g t t c g c c t c t ggcagtaccg gccctggaac t tcggcgacc t c c t c t g c a a a c t c t t c c a a 
t t c g t c a g t g agagctgcac c tacgccacg g tgc tcacca tcacagcgct gagcgtcgag 
c g c t a c t t c g c c a t c t g c t t cccactccgg gccaaggtgg tggtcaccaa ggggcgggtg 
aagc tggtca t c t t c g t c a t c tgggccgtg g c c t t c t g c a gcgccgggcc c a t c t t c g t g 
c tagtcgggg tggagcacga gaacggcacc gaccc t tggg acaccaacga gtgccgcccc 
a c c g a g t t t g cggtgcgctc t ggac tgc t c acggtca tgg t g t g g g t g t c c a g c a t c t t c 
t t c t t c c t t c c t g t c t t c t g t c t c a c g g t c c t c t a c a g t c tca tcggcag gaagctg tgg 
cggag|aggc gcggcgatgc tg t cg tggg t gcc tcgc tca gggaccagaa ccacaagcaa 
accgtgaaaa t g c t g g c t g t a g t g g t g t t t g c c t t c a t c c t c t g c t g g c t c c c c t t c c a c 
gtagggcgat a t t t a t t t t c c a a a t c c t t t gagcctggct cc t tggaga t t g c t c a g a t c 
agccagtac t gcaacc tcg t g t c c t t t g t c c t c t t c t a c c t c ag tgc tgc ca tcaacccc 
a t t c t g t a c a a c a t c a t g t c caagaagtac cgggtggcag t g t t c a g a c t t c t g g g a t t c 
g a a c c c t t c t cccagagaaa g c t c t c c a c t c tgaaaga tg a a a g t t c t c g ggcctggaca 
g a a t c t a g t a t t a a t a c a t g a 
Figure 3.1. Coding sequence for hGHS-Rla (1101 bps, genebank no:NM198407). 
Key: Arrows above the coding sequence are the position of primers for amplification 
of 806 bps PCR product. 
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atgtggaacg cgacgcccag cgaagagccg gggttcaacc tcacactggc cgacctggac 
tgggatgctt cccccggcaa cgactcgctg ggcgacgagc tgctgcagct cttccccgcg 
ccgctgctgg cgggcgtcac agccacctgc gtggcactct tcgtggtggg tatcgctggc 
aacctgctca ccatgctggt ggtgtcgcgc ttccgcgagc tgcgcaccac caccaacctc 
tacctgtcca gcatggcctt ctccgatctg c tcatct tcc tctgcatgcc cctggacctc 
gttcgcctct ggcagtaccg gccctggaac ttcggcgacc tcctctgcaa actcttccaa 
ttcgtcagtg agagctgcac ctacgccacg gtgctcacca tcacagcgct gagcgtcgag 
cgctacttcg ccatctgctt cccactccgg gccaaggtgg tggtcaccaa ggggcgggtg 
aagctggtca tcttcgtcat ctgggccgtg gccttctgca gcgccgggcc catct tcgtg 
ctagtcgggg tggagcacga gaacggcacc gacccttggg acaccaacga gtgccgcccc 
accgagtttg cggtgcgctc tggactgctc acggtcatgg tgtgggtgtc cagcatcttc 
t t c t t c c t t c c tg tc t tc tg tctcacggtc ctctacagtc tcatcggcag gaagctgtgg 
cggaggaggc ^cggcgatgc tgtcgtgggt gcctcgctca gggaccagaa ccacaagcaa 
accgtgaaaa tgctgggtgg gtctcagcgc gcgctcaggc t t tc tc tcgc gggtcctatc 
ctctccctgt gccttctccc t tc tc tc tga 
Figure 3.2. Coding sequence for hGHS-Rlb (870 bps, genebank no:NM004122) Key: 
Arrows (••) above the coding sequence are the position of primers for amplification 
of 807 bps hGHS-Rlb PGR product. Arrow (— ••) above the coding sequence is the 
position of reverse primer for amplification of 943 bps 2myc-hGHS-Rlb PGR 
product, the position of the forward primer has not been shown, because the forward 
primer bind to the 2myc sequence. 
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tgc 
cctcttggcc aaatctctcg gagtgcctct cccttaactg cagctgggag gagacccgca 
acgccacaag gaagtttgat cttggcctgc ctcctctcaa ctactactca atccctc t tc 
ttacaggcat caccatcgcc tgcacgctgc tgtt tctggt cggggtggcc ggtaatgtca 
tgaccatttt ggtggtcagt aagtaccggg acatgcgcac aaccactaac c t t tacctgt 
gcagcatggc agtatccgac ctgctcatct tcctctgtat gccgctggac ctctaccgta 
tgtggaggta caggccctgg cggtttgggg acgcgctctg caagctcttt cagttcgtgt 
cagagtcatg cacctactcc accatcctca gcatcaccgc gctgtcagtg gagagatacc 
tagcgatctg t t tcccgctg cgtgccaaag ct t tggttac caaaaggcgg gtacgcgccc 
tca t tc t tc t tctctggaca gtgtctctac tgagcgccgg tcccgtgttt gtcatggtgg 
gagtggagcg tgacagcatg tggccaggaa atctcagttg ggtgggaatg aatgggactg 
ggttct tccc ggaggaagga gacacccggg agtgtaaaat gacccattac gcagtggagt 
ccggcctgat gggggccatg gtgtggctga gctctgtgtt c t t c t t ca tg ccggtgttct 
gtctcacagt gctctacagc ctcatcggtc ggcggctgtg gcaaagacac agagaaacga 
acataaactc ccgtgtggcg catcgggaga aaagcaacag acagaccatc aagatgttgg 
tggtggtggt gt tggcctt t gtcctgtgct ggctgccgtt tcatgtagga cgctacctgc 
agttccgttc tctggacgct ccatccccgc tgctgtctct gttgtccgag tactgcagct 
tagtgtctgt gg t tc tc t t c tacctgagcg ccgccatcaa ccccatcctc tacaacatca 
tgtcctggaa ataccggggc gcagcggcgc gtctcttcgg cctgatcgac agccagccgc 
cccgaggccg cacagccagc accgtgaagg gagacggctc gaacggctgg acggaatcca 
caatcagctt ctaa 
Figure 3.3. Coding sequence for sbGHS-Rla (1157 bps, genebank no:AY151040) 
Key: Arrows (—•) above the coding sequence are the position of primers for 
amplification of 1200 bps sbGHS-Rla PGR product. 
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atgccctc^ 
tggccaaatc tctcggagtg cctctccct t aactgcagct gggaggagac ccgcaacgcc 
acaaggaagt ttgatcttgg cctgcctcct ctcaactact actcaatccc tc t tc t taca 
ggcatcacca tcgcctgcac gctgctgtt t ctggtcgggg tggccggtaa tgtcatgacc 
att t tggtgg tcagtaagta ccgggacatg cgcacaacca ctaaccttta cctgtgcagc 
atggcagtat ccgacctgct catc t tcc tc tgtatgccgc tggacctcta ccgtatgtgg 
aggtacaggc cctggcggtt tggggacgcg ctctgcaagc tc t t tcagt t cgtgtcagag 
tcatgcacct actccaccat cctcagcatc accgcgctgt cagtggagag atacctagcg 
a tc tg t t tcc cgctgcgtgc caaagctttg gttaccaaaa ggcgggtacg cgccctcatt 
c t t c t t c t c t ggacagtgtc tctactgagc gccggtcccg tgtt tgtcat ggtgggagtg 
gagcgtgaca gcatgtggcc aggaaatctc agttgggtgg gaatgaatgg gactgggttc 
ttcccggagg aaggagacac ccgggagtgt aaaatgaccc attacgcagt ggagtccggc 
ctgatggggg ccatggtgtg gctgagctct g tg t t c t t c t tcatgccggt g t t c tg tc tc 
acagtgctct acagcctcat cggtcggcgg ctgtggcaaa gacacagaga aacgaacata 
aactcccgtg tggcgcatcg g^agaaaagc aacagacaga ccatcaagat gttgggtaag 
ttacgcaaat tacgcacacg cataacttta tccatgtag 
Figure 3.4. Coding sequence for sbGHS-Rlb (887 bps genebank no:AY151041) Key: 
Arrows (—•) above the coding sequence are the position of primers for amplification 
of 900 bps sbGHS-Rlb PGR product. 
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3.7.3. Real-time PGR 
SYBR Green RT-PCR Kit was chosen to perform real-time PGR, one of the 
advantages that SYBR Green over TaqMan，is SYBR do not need a specific probe to 
detect the PCR product. However, SYBR Green binds to any double-strand DNA 
generated during PCR. Therefore, it is important to make sure there is only a single 
PCR product produced, without any primer-dimer or non-specific amplification. 
After 48 h post-transfection, total RNA was extracted by TRIzol reagent and 
converted to first-strand cDNA as described in section 3.7.1. Then the cDNA was 
diluted by 1:5 with water and 2 |LI1 of the diluted cDNA was used to carry out 
real-time PCR following manufacturer's instruction. Real-time PCR was carried out 
in 25 \i\ volume containing SYBR green PCR buffer, MgCl2, dNTP blend, AmpHTaq 
Gold，AmpErase UNQ primers, water and template (diluted cDNA). Using the 
primers listed in table 3.3 to amplify part of the sbGHS-Rla and sbGHS-Rlb, the 
PCR amplification of the epitope-tagged sbGHS-Rla and sbGHS-Rlb was used the 
same primer as the non-tagged sbGHS-R. Before the PCR cycle started, the PCR 
mixture was incubated at 50°C for 2 min and then 95°C for 10 min, in order to 
activate AmpliTaq Gold, and the PCR condition is 94°C for 45 sec, 64°C for 45 sec 
(40 cycles). At the end of PCR, a dissociation curve was constructed to make sure 
there is no primer dimer. For the dissocation curve, the PCR product was first melted 
at 95°C，and then equilibrated at 60°C before being slowly dissociated back to 95°C. 
In addition, the PCR product was loaded and resolved by 1% agarose gel. DNA 
ladder was used as a marker. 
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3.7.3.1. Construction of standard curve 
Plasmid DNAs (sbGHS-Rla, sbGHS-Rlb, HA-sbGHS-Rla and HA-sbGHS-Rlb) 
was serial diluted into different concentrations (10 ng/|xl, 100 pg/|il, and from 10 
pg/jjl to 100 ag/|il by 10 fold dilutions) and real-time PCR was performed as 
described in section 3.7.3. 
3.7.3.2. Data analysis 
To calculate the number of molecules in each dilution of plasmid DNA in the 
standard curve, the following equations were used and then the standard curve was 
plotted by Ct value against log of number of molecules of the plasmid DNA. Ct 
value is the threshold cycle, at which a significant increase in the PCR product was 
measured by the real-time PCR machine (Applied Biosystems). 
Equation 1: Calculation of pmol of ends of a double-strand DNA (dsDNA) molecules 
[2 X 10^ X |xg (ofdsDNA)] / (Nbp x 660 Da) 
Key : Nbp : number of base pairs 
Equation 2: Conversion of the unit of equation 1 from pmol to number of molecules 
pmol X 6.02 xl023 / ( l x l 0 9 ) 
From the standard curve, the amount of messenger RNA (mRNA) in the unknown 
samples was found using the following equations. 
一 Page 60 
Chapter 3 Methods 
Equation 3: Calculation of the log mRNA amount in samples 
(Ct value - b ) / m 
Keys: b = y-intercept of standard curve line 
m = slope of standard curve line 
Equation 4: Calculate the amount of mRNA in sample 
10 八(log mRNA amount) 
Equation 5: Calculate the mRNA amount per fxg of total RNA 
Amount of mRNA / amount of total RNA used 
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Gene Name Primer PGR product size 
(bps) 
sbGHS-Rla Forward: GTG GGA ATG AAT GGG ACT 275 
GG 
Reverse: GCC AAC ACC ACC ACC ACC 
A ^ 
sbGHS-Rlb Forward: GTG GGA ATG AAT GGG ACT 189 
GG 
Reverse: GGA TAA AGT TAT GCG TGT 
G^ 
Table 3.3 Primers for PGR and the PGR product size 
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tgc 
cctcttggcc aaatctctcg gagtgcctct cccttaactg cagctgggag gagacccgca 
acgccacaag gaagtttgat cttggcctgc ctcctctcaa ctactactca atccctc t tc 
ttacaggcat caccatcgcc tgcacgctgc tgtt tctggt cggggtggcc ggtaatgtca 
tgaccatttt ggtggtcagt aagtaccggg acatgcgcac aaccactaac c t t tacctgt 
gcagcatggc agtatccgac ctgctcatct tcctctgtat gccgctggac ctctaccgta 
tgtggaggta caggccctgg cggtttgggg acgcgctctg caagctcttt cagttcgtgt 
cagagtcatg cacctactcc accatcctca gcatcaccgc gctgtcagtg gagagatacc 
tagcgatctg t t tcccgctg cgtgccaaag c t t tggt tac caaaaggcgg gtacgcgccc 
tcat tc t tc t tctctggaca gtgtctctac tgagcgccgg tcccgtgttt gtcatggtgg 
gagtggagcg tgacagcatg tggccaggaa atctcagttg ggtgggaatg aatgggactg 
ggttct tccc ggaggaagga gacacccggg agtgtaaaat gacccattac gcagtggagt 
ccggcctgat gggggccatg gtgtggctga gctctgtgtt c t t c t t ca tg ccggtgttct 
gtctcacagt gctctacagc ctcatcggtc ggcggctgtg gcaaagacac agagaaacga 
acataaactc ccgtgtggcg catcgggaga aaagcaacag acagaccatc aagatgttgg 
tggtggtggt gt tggcct t t gtcctgtgct ggctgccgtt tcatgtagga cgctacctgc 
agttccgttc tctggacgct ccatccccgc tgctgtctct gttgtccgag tactgcagct 
tagtgtctgt gg t t c t c t t c tacctgagcg ccgccatcaa ccccatcctc tacaacatca 
tgtcctggaa ataccggggc gcagcggcgc gtctcttcgg cctgatcgac agccagccgc 
cccgaggccg cacagccagc accgtgaagg gagacggctc gaacggctgg acggaatcca 
caatcagctt ctaa 
Figure 3.5. Coding sequence for sbGHS-Rla (1157 bps, genebank no:AY151040) 
Key: Arrows (—•) above the coding sequence are the position of primers for 
amplification of 275 bps sbGHS-Rla real-time PCR product. 
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atgccctct 
tggccaaatc tctcggagtg cctctccct t aactgcagct gggaggagac ccgcaacgcc 
acaaggaagt t tgatcttgg cctgcctcct ctcaactact actcaatccc tc t tc t taca 
ggcatcacca tcgcctgcac gctgctgtt t ctggtcgggg tggccggtaa tgtcatgacc 
attt tggtgg tcagtaagta ccgggacatg cgcacaacca ctaaccttta cctgtgcagc 
atggcagtat ccgacctgct catct tcctc tgtatgccgc tggacctcta ccgtatgtgg 
aggtacaggc cctggcggtt tggggacgcg ctctgcaagc tc t t tcagt t cgtgtcagag 
tcatgcacct actccaccat cctcagcatc accgcgctgt cagtggagag atacctagcg 
a tc tg t t tcc cgctgcgtgc caaagctttg gttaccaaaa ggcgggtacg cgccctcatt 
c t t c t t c t c t ggacagtgtc tctactgagc gccggtcccg tgt t tgtcat ggtgg^agtg 
gagcgtgaca gcatgtggcc aggaaatctc agttgggtgg gaatgaatgg gactgggttc 
ttcccggagg aaggagacac ccgggagtgt aaaatgaccc attacgcagt ggagtccggc 
ctgatggggg ccatggtgtg gctgagctct g t g t t c t t c t tcatgccggt g t t c tg t c t c 
acagtgctct acagcctcat cggtcggcgg ctgtggcaaa gacacagaga aacgaacata 
aactcccgtg ；ggcgcatcg ggagaaaagc aacagacaga ccatcaagat gttgggtaag 
ttacgcaaat tacgcacacg cataacttta tccatgtag 
Figure 3.6. Coding sequence for sbGHS-Rlb (887 bps genebank no:AY151041) Key: 
Arrows (—•) above the coding sequence are the position of primers for amplification 
of 189 bps sbGHS-Rlb real-time PGR product. 
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3.8. Measurement of caspase-3 activity 
3.8.1. Determination of caspase-3 activity using colorimetric assay 
3.8.1.1. Introduction 
In this colorimetric assay, a caspase-3 substrate, which is composed of the caspase-3 
recognition cleavage site (DEVD) and a coloured compound />-nitroaniline (pNA), 
was used. If caspase-3 is activated, it will cleave the substrate within the DEVD 
sequences, and the pNA will be released. Then, by monitoring the pNA absorbance at 
405 nm, the caspase-3 activity can be studied. 
3.8.1.2. Induction of apoptosis 
Cells were seeded in 6-well plates. If there was transfection carried out, the 
procedures were as described in section 3.3, using 600 \i\ transfection cocktail per 
well. After 48 h post-transfection, medium was aspirated. One and a half ml 
•“ complete medium without antibiotic and 15 of an apoptotic inducer or solvent 
control (DMSO) were added to each well and incubated for different time periods at 
37°C. 
3.8.1.3. Preparation of cell lysates 
At the end of each incubation time, the medium was removed and the cells were 
washed with 1 ml PBSA. Next, another 1 ml PBSA was used to collect the cells from 
6-well plate to a 1.5 ml eppendorfby pipetting up and down. Cells were collected by 
centrifugation at 2000 rpm (about 530 x g) for 5 min using micro-centrifuge 
(eppendorf) at 4°C. The cell pellets were resuspended in 40 |xl ice-cold lysis buffer 
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and incubated on ice for 5 min. The cell suspensions were centrifuged at 10,000 x g 
for 10 min at 4°C, and the supernatant (i.e. cell lysate) was collected and stored at -70 
°C for not more than one week. 
3.8.1.4. Quantification of caspase-3 activity by measuring pNA absorbance 
The protein content in cell lysates was determined by a colorimetric method using 
Micro BCA™ Protein Assay Kit. Cell lysates were diluted 100-fold using 0.9% NaCl. 
Then 150 \x\ of each diluted cell lysates and BSA standards (0，1，2.5, 5，7.5, 10，15， 
20，40，200 ^ig/ml) were mixed with 150 of BCA working reagent, which 
contained 25 parts of MA, 24 parts of MB and 1 part of MC. The resulting mixtures 
were incubated at 37°C for 2 h in 96-well plate. The absorbances of the protein 
samples at 562 nm were recorded. Samples were assayed in duplicate and the 
corresponding mean was fitted into the BSA standard curve by linear regression to 
estimate the protein concentration. 
Determination of the microtiter-plate reader conversion factor. 100 |J1 of assay buffer 
and 50 |iM pNA were added to a 96-well microliter plate separately. Then the 
corresponding absorbances at 405 nm were recorded in duplicate. The conversion 
factor (CF) was calculated as follows: 
CF = 50 |iM / (average absorbance at 405 nm of 50 jiM pNA 一 average absorbance at 
405 nm of assay buffer) 
The caspase-3 activity was measured by the absorbance of pNA. Appropriate volume 
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of assay buffer was added to each well of the microtiter plate and incubated at 37°C 
for 10 min. Then cells lysate containing 10 - 30 |ig protein were added to each well, 
and incubated for another 10 min at 37°C. Finally, 10 |il of 2 mM caspase-3 substrate 
I was added to give a total reaction volume of 100 |il. The absorbances at 405 run 
were measured immediately. Data were recorded at 5 min intervals for 2 h. 
Background absorbance was the absorbance of the mixture of assay buffer and 
caspase-3 substrate 1. 
3.8.1.5. Data analysis 
The slopes (Vmax) from the plot of absorbances at 405 run versus time of each 
sample were determined. Then the caspase-3 activity was calculated as follows: 
Caspase-3 activity (pmol/min/|ig protein) = {(Vmax x CF x 100)/ 1000} / ([protein] 
X vol) 
Keys: 
[protein]: Cell lysate protein concentration (|ig/fil) 
vol: Volume of cell lysate (|il) 
3.8.2. Determination of caspase-3 activity using bioluminescence resonance 
energy transfer (BRET】）assay 
3.8.2.1. Introduction 
r\ 
BRET assay makes use of the caspase-3 biosensor (pGFP -DEVD-Rluc(h)) to 
monitor the caspase-3 activity in living cells, which uptake and co-express the target 
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receptor and the caspase-3 biosensor. Caspase-3 biosensor made up of three 
components: green fluorescent protein (GFP^), a caspase-3 recognition cleavage site 
(DEVD) and humanized Renilla luciferase (Rluc(h)). The intact caspase-3 biosensor 
produces a strong BRET signal in the presence of the Rluc coelenterazine substrate, 
DeepBlueC. If there is caspase-3 activity, the caspase-3 biosensor will be cleaved 
within the DEVD sequences, and then the BRET^ signal between Rluc and GFP^ will 
be disrupted, and the BRET� signal will decrease. 
3.8.2.2. Quantification of caspase-3 activity using BRET^ assay 
Cells were transfected with caspase-3 biosensor (pGFP^-DEVD-Rluc(h)) or positive 
control vector (pGFP^-Rluc(h)) together with the targeted plasmid DNA. 
Transfection procedures were as described in section 3.3. The non-transfected cells 
were used to measure the background BRET^ signal. 
After 24 hours post-transfection, medium was removed and the cells were rinsed 
V-
once with PBSA. The cells were incubated with trypsin/EDTA for 3 - 5 min. When 
the cells were completely detached from the culture plate or culture dish, complete 
medium without antibiotic was added to the cells, in order to inactivate the trypsin. 
The cells were collected by centrifligation at 1000 rpm for 5 min at room temperature 
using bench-top centrifuge (Jouan C412). The cell pellets were resuspended with a 
suitable volume of complete medium without antibiotic. Cells were counted using a 
hemocytometer, as described in section 3.1.1. Then, a working dilution of 300,000 
cells/ml was prepared and 100 |il of this working dilution (i.e. 30,000 cells) was 
added to each well of a 96-well white CulturPlate. 
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After the cells were incubated in 96-well white CulturPlate for 24 h, medium was 
removed and the cells in each well were rinsed with 100 \i\ DMEM medium without 
serum, glutamine and phenol red. Then, 100 |il of DMEM medium without serum, 
glutamine and phenol red were added to each well. Fifty |il of an apoptotic inducer or 
DMSO was added to each well and the cells were incubated at 37°C for a period of 
time as indicated in each graph. 
At the end of each incubation time, 50 \il of 20 \iM DeepBIueC was added to each 
well, and the plate was immediately read on the Fusion™ Universal Microplate 
Analyzer using the following settings: one second per well, PMT: 1100 volts and 
gain: 50. The 410 nm/515 nm filter pairs were used. 
3.8.2.3. Data analysis 
Assays were performed in duplicate or triplicate. The average counts obtained with 
.. non-transfected cells were subtracted from the counts of the transfected cells in 
individual wells, in order to obtain the corrected counts at 410 nm (Rluc(h) emission) 
or 515 nm (GFP^ emission). The BRET] signal was then determined as the ratio 
between the corrected counts at 515 nm and 410 nm. When subtraction of the 
background counts yields negative values, a BRET^ ratio of zero is assigned. The 
equation as follows: 
BRET^ signal = (GFP^ emission at 515 nm - GFP^ emission of non-transfected cells) 
/ (Rluc(h) emission at 410 nm - Rluc(h) emission of non-transfected cells) 
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3.8.3. Determination of caspase-3 activity using fluorescence resonance energy 
transfer (FRET) assay 
3.8.3.1. Introduction 
FRET assay is a technique similar to BRET^ assay, as FRET assay also makes use of 
the energy transfer between two different types of GFR FRET caspase-3 biosensor 
made up of three components: cyan fluorescent protein (CFP)，a caspase-3 
recognition cleavage site (DEVD) and yellow fluorescent protein (YFP) (Luo et al” 
2001b). In this assay, when the doner (CFP) is excited, there is an energy transfer 
from the CFP to the acceptor (YFP). If there is activated caspase-3, then the 
caspase-3 will cleave the DEVD site, and then the energy transfer will be disrupted. 
3.8.3.2. Quantification of caspase-3 activity using FRET assay 
Cells were transfected with FRET caspase-3 biosensor (pCFP-DEVD-YFP) together 
with the target plasmid DNA. Transfection procedures were as described in section 
3.3. The non-transfected cells were used to measure the background FRET signal. 
After 24 h post-transfection, the cells were transferred into 96-well white CulturPlate, 
and incubated for another 24 h. Then the cells were incubated with apoptotic inducer 
or DMSO at 37°C for different period of time as described in section 3.8.2.2. At the 
end of the incubation, the cells in the plate were read on the Fusion™ Universal 
Microplate Analyzer using the following settings: one second per well, PMT: 1100 
volts and gain: 50. The excitation filter is 440 nm, and the emission filter is 485 nm 
and 535 nm for CFP and YFP, respectively. 
Page 70 
Chapter 3 Methods 
3.8.3.3. Data analysis 
Assays were performed in duplicates. The calculations are similar to BRET^ assay, 
the equation as follows: 
FRET signal (YFP/CFP ratio) = (YFP emission at 526 nm - YFP emission of 
non-transfected cells) / (CFP emission at 480 nm - CFP emission of non-transfected 
cells) 
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Chapter 4 
Results 
In the following experiments, the cells were usually transfected with 0.25 |xg/ml 
target plasmid DNA plus 0.75 |ig/ml empty vector, as it gave an optimal basal and 
agonist-stimulated [^H]-IP production, as showed in figure 4.8. The epitope-tagged 
receptors were used, as through the epitope-tag, the receptor expression level can be 
quantified in protein level. 
4.1 Characterization of GHS-R 
4.1.1 Properties of GHS-Rla 
4.1.1.1 Constitutively active receptor 
hGHS-Rla has been demonstrated having a constitutive activity, when hGHS-Rla 
was transiently transfected in COS-7 cells (Hoist et al” 2004). To further examine the 
constitutive activity of hGHS-Rla and sbGHS-Rla, different concentrations of 
GHS-Rla plasmid DNA were transfected into HEK293 cells. After 48 hours 
post-transfection, [^H]-inositol phosphate ([^H]-IP) productions were measured as 
described in Chapter 3. If hGHS-Rla and sbGHS-Rla are constitutively active 
receptors, then in the absence of GHS-R agonists, there should still be an increase in 
[^H]-IP production with increasing concentration of DNA transfection. From figure 
4.1, concentration-dependent increase in receptor expression was observed in basal 
[^H]-IP production in both hGHS-Rla and sbGHS-Rla. It implies that GHS-Rla of 
both species are constitutively active receptors, and this property will not be affected 
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by the epitope-tag. 
Using SPa can also show hGHS-Rl a is a constitutively active receptor. SPa has been 
shown to act as an inverse agonist of hGHS-Rl a receptor in COS-7 cells with IC50 
value of 5.2 士 0.7 nM (Hoist et al, 2003). In our study, HEK293 cells were 
transfected with 0.25 |ig/ml hGHS-Rla/2myc-hGHS-Rla/HA-hGHS-Rla plasmid 
DNA plus 0.75 |ag/ml empty vector, named pcDNA3.1(+). After 48 hours, the cells 
were incubated with 1 }xM SPa alone or together with different concentrations of 
ghrelin. If hGHS-Rl a is a constitutively active receptor, in the presence of SPa, the 
basal activity will be decreased. From figure 4.2，the basal [^H]-IP production among 
the non-tagged and epitope-tagged hGHS-Rl a receptors were inhibited by incubation 
with SPa. There were 86.53 士 0.98，84.84 士 0.84，85.27 士 1.04o/o inhibition, n=3, in 
HEK293 cells transfected with hGHS-Rl a, 2myc-hGHS-Rla or 3HA-hGHS-Rla, 
respectively. It showed epitope-tag did not affect hGHS-Rl a constitutively active 
..property. SPa not only affects GHS-Rla basal activity, but also the 
agonist-stimulated response. From figure 4.3，co-administration of ghrelin and SPa, 
the ghrelin-stimulated [^H]-IP production was reduced, but the dose-response curve 
neither shift to the right nor left, it indicated that SPa acts as an inverse agonist of 
GHS-Rla. 
4.1.1.2 Characterization of epitope-tagged hGHS-Rl a 
hGHS-Rl a transiently transfected in COS-7 cells showed an EC50 for ghrelin of 0.19 
土 0.06 nM (Hoist et al, 2003). To show that hGHS-Rl a transiently transfected in 
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HEK293 cells has a similar EC50 for ghrelin and to observe whether the epitope-tags 
(myc, HA) on the hGHS-Rla affect the affinity of hGHS-Rla for ghrelin, the 
following experiment was performed. HEK293 cells were transiently transfected 
with 0.25 |ig/ml hGHS-Rla/2myc-hGHS-Rla/3HA-hGHS-Rla plus 0.75 ^ig/ml 
pcDNA3.1(+) and then the transfected cells were incubated with different 
concentrations of ghrelin and [^H]-IP production was measured as described in 
Chapter 3. From figure 4.4，the cells transfected with hGHS-Rla, 2myc-hGHS-Rla 
and 3HA-hGHS-Rla, the EC50 for ghrelin is 0.56 土 0.04 nM, 0.85 土 0.50 nM and 
1.34 士 0.36 nM, n=3, respectively. It indicated that the potency of hGHS-Rl a in our 
system is very similar to Hoist et al, (2003). Among the hGHS-Rla, 
2myc-hGHS-Rla and HA-hGHS-Rla, the EC50 were not statistical significantly 
different, indicating that the epitope-tag did not affect hGHS-Rla. In addition, the 
position of 3HA-hGHS-Rla log concentration-response curve is lower than that of 
hGHS-Rla and 2myc-hGHS-Rla, suggesting that the expression level of 
3HA-hGHS-Rla is less than the other types of hGHS-Rla or 3HA-hGHS-Rla has 
lower constitutive activity. 
Human and seabream GHS-Rla can respond to agonists in order to increase IP 
production. HEK293 cells stably expressed sbGHS-Rla showed a log 
concentration-dependent increase in GHRP-6-stimulated [^H]-IP production (Chan et 
al, 2004b). From figure 4.5，in HEK293 cells transiently transfected with 1 |ig/ml 
hGHS-Rla or sbGHS-Rla and then incubated with 30 \iM GHRP-6, there was an 
increase in GHRP-6-stimulated [^H]-IP production. HEK293 cells transfected with 1 
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|ig/ml pcDNA3.1(+) was used to show the increase in the [^H]-IP production is due 
to the presence of GHS-Rla. 
4.1.2 Properties of GHS-Rlb 
To determine whether hGHS-Rlb responds to GHS-R agonists or not, HEK293 cells 
were transfected with 0.25 )ig/ml hGHS-Rlb plasmid DNA plus 0.75 |ig/ml 
pcDNA3.1(+). Then the cells were incubated with agonist and the [^H]-IP production 
was measured. The basal and the agonist-stimulated [^H]-IP production in the cells 
transfected with hGHS-Rlb were the same as the cells transfected with pcDNA3.1(+) 
(Fig. 4.6). It indicated that hGHS-Rlb is not a constitutively active receptor and is 
unresponsive to agonists, under the assumption that hGHS-Rlb is a Gq-coupled 
receptor. The epitope-tag did not alter hGHS-Rlb property (Fig. 4.7). 
4.1.3 Conclusions 
. In HEK293 cells transiently transfected with different concentrations of hGHS-Rla 
or sbGHS-Rla, there was an increase in the basal [^H]-IP production, and there was 
an increase in GHRP-6 or ghrelin-stimulated [^H]-IP production. This shows that 
hGHS-Rla and sbGHS-Rla are constitutively active and responsive to agonists. The 
inverse agonist, SPa, inhibited the basal [^H]-IP production of hGHS-Rla and 
affected the ghrelin-stimulated [^H]-IP production, but without shifting the 
dose-response curve of ghrelin to the right. These data also indicated that hGHS-Rla 
is a constitutively active receptor. In HEK293 cells transfected with hGHS-Rlb, 
there were no changes in the basal and the agonist-stimulated [^H]-IP production. 
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There was a similar EC50 among hGHS-Rla, 2myc-hGHS-Rla and HA-hGHS-Rla, 
indicating that the epitope-tags did not affect hGHS-Rla signaling. Also, the property 





















































































































































































































































































































































































































































































































Chapter 4 Results 
35"! _ * _ 
T Basal 
§ § 3 0 - 丁 B U S P a O ^ i M ) 
3 互 25- p L j I 
I T 20- 广 
i t i�_ h 
OI I 
non-tagged 2myc-tagged 3HA-tagged 
hGHS-R1a 
Figure 4.2 Effect of [D-Argi，D-Phe5，D-Trp7,9，Leuii]-substance P (SPa) on the basal 
[^H]-IP production. HEK293 cells transiently transfected with 0.25 \xg/m\ 
hGHS-Rla/2myc-hGHS-Rla/3HA-hGHS-Rla plus 0.75 \ig/m\ pcDNA3.1(+). After 
24 h post-transfection, the cells were labeled with 2 jiCi/ml m_yo-[3H]-inositol and 
incubated overnight, and then [^H]-IP production was measured as described in 
Chapter 3. The cells were lysed following 1 h incubation with SPa or buffer. Results 
in figure represent mean 土 S.E.M.，n=3, of experiments performed in duplicate. (* 
P<0.05, unpaired t-test) 
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Figure 4.3 Effect of SPa on ghrelin-stimulated [^H]-IP production. HEK293 cells 
transfected with 0.25 |ag/ml hGHS-Rla plus 0.75 ^ig/ml pcDNA3.1(+). After 24 h 
post-transfection, the cells were labeled with 2 |iCi/ml m;^o-[^H]-inositol and 
incubated overnight, and then [^H]-IP production was measured as described in 
. Chapter 3. The cells were lysed following 1 h incubation with ghrelin or together 
with SPa. Results come from one experiment performed in duplicate, data shown are 
mean 土 S.D. 
.1 
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Figure 4.4 Characterization of epitope-tagged hGHS-Rla using ghrelin-stimulated 
[^H]-IP production. HEK293 cells transiently transfected with 0.25 ^ig/ml 
hGHS-Rla/2myc-hGHS-Rla/3HA-hGHS-Rla plus 0.75 ng/ml pcDNA3.1(+). After 
24 h post-transfection, the cells were labeled with 2 ^iCi/ml -inositol and 
incubated overnight, and then [^H]-IP production was measured as described in 
Chapter 3. The cells were lysed following 1 h incubation with ghrelin. Results in 
figure represent mean 士 S.E.M.，n=3, of experiments performed in duplicate. 
Page 81 
Chapter 4 Results 
12.5"| 
1=1 Basal 
0 I 10.0- A • GHRP-6 (30 |iM) 
'云芝 J L • 
1 I 7.5- 门 • _ I I 
• A I 
0.0 • — • • • — ~ — ~ 
pcDNA3.1(+) hGHS-R 1a sbGHS-R1a 
Figure 4.5 Comparsion between hGHS-Rla and sbGHS-Rla on GHRP-6 stimulated 
[3H]-IP production. HEK293 cells transiently transfected with 1 |ig/ml pcDNA3.1(+) 
as a control, or with 1 pig/ml hGHS-Rla or sbGHS-Rla. After 24 h post-transfection, 
the cells were labeled with 2 |iCi/ml w;;o-[^H]-inositol and incubated overnight, and 
then [3H]-IP production was measured as described in Chapter 3. The cells were 
lysed following 1 h incubation with buffer or GHRP-6. Results come from one 
experiment performed in duplicate, data shown are mean 土 S.D. 
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Figure 4.6 Comparison of hGHS-Rla and hGHS-Rlb. HEK293 cells transiently 
transfected with 1 \ig/m\ pcDNA3.1(+) or 1 |ig/ml hGHS-Rla was used as a negative 
and positive control, respectively. HEK293 cells were transiently transfected with 1 
|ig/ml hGHS-Rlb were the test group. After 24 h post-transfection, the cells were 
labeled with 2 ^iCi/ml m;;o-[^H]-inositol and incubated overnight, and then [^H]-IP 
production was measured as described in Chapter 3. The cells were lysed following 1 
h incubation with buffer or GHRP-6. Results come from one experiment performed 
in duplicate, data shown are mean 土 S.D. 
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Figure 4.7 Characterization of epitope-tagged hGHS-Rlb on the ability of the 
responsiveness to GHRP-6. HEK293 cells transiently transfected with 1 |ig/ml 
pcDNA3.1(+) or 1 M-g/ml hGHS-Rl a was used as a negative and positive control, 
“respectively. HEK293 cells were transiently transfected with 1 ^g/ml hGHS-Rlb or 
epitope-tagged (2myc- or 3HA-) hGHS-Rlb. After 24 h post-transfection, the cells 
were labeled with 2 ^iCi/ml m;;o-[^H]-inositol and incubated overnight, and then 
[3H]-IP production was measured as described in Chapter 3. The cells were lysed 
following 1 h incubation with buffer or ghrelin. Results in figure represent mean 土 
S.E.M., n=3, of experiments performed in duplicate. 
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4.2 Effect ofco-transfection of HEK293 cells 
4.2.1 Effect of balancing DNA concentrations transfected into HEK293 cells 
To investigate the interaction between GHS-Rla and GHS-Rlb, one of the methods 
is to co-transfect GHS-Rla and GHS-Rlb into HEK293 cells. Therefore, it is very 
important to look for artifactual results caused by the co-transfection of 2 different 
plasmids. To study the co-transfection effect, HEK293 cells were transfected with 
different concentrations of GHS-Rla plasmid DNA, and the total DNA concentration 
transfected was maintained at 1 }ig/ml by balancing with an empty vector. 
For the cells transfected with hGHS-Rla or 2myc-hGHS-Rla alone, it showed a 
receptor concentration-dependent increase in both basal and agonist-stimulated 
[3H]-IP production, it also occurred in sbGHS-Rla and HA-sbGHS-Rla (Fig. 4.8). 
However, when the cells were co-transfected with hGHS-Rla or 2myc-hGHS-Rla 
and pcDNA3.1(+)，then the effect of 0.25 |ig/ml and 0.5 |xg/ml hGHS-Rla or 
‘ 2myc-hGHS-Rla in both basal and agonist-stimulated [^H]-IP production were 
greater than they were when transfected alone, and even greater than the effect of 1 
|ig/ml hGHS-Rla or 2myc-hGHS-Rla (Fig. 4.8A and 4.8B). A similar effect was 
seen with HA-sbGHS-Rla. For example, in figure 4.8A, the basal [^H]-IP production 
for the cells transfected with 0.25 |ag/ml or 0.5 |ig/ml hGHS-Rla was 1.53 and 2.37， 
respectively, but when the cells co-transfected with 0.25 |ig/ml or 0.5 |ig/ml 
hGHS-Rla and pcDNA3.1(+) to 1 ng/ml，the basal [^H]-IP production was 10.35 and 
9.07，respectively. The 30 |iM GHRP-6-stimulated [^H]-IP production for the cells 
transfected with 0.25 |ig/ml or 0.5 |xg/ml hGHS-Rla was 2.65 and 3.62，respectively, 
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but when the cells co-transfected with 0.25 |_ig/ml or 0.5 |ig/ml hGHS-Rla and 
pcDNA3.1(+) to 1 jig/ml, the 30 |aM GHRP-6-stimulated [^H]-IP production was 19 
and 21.2, respectively. 
For the cells co-transfected with sbGHS-Rla and empty vector, the effect of 0.25 
^ig/ml and 0.5 \ig/m\ sbGHS-Rla in the 30 i^M GHRP-6 stimulated [^H]-IP 
production were greater than they were transfected alone, but they were not greater 
than 1 |ag/ml sbGHS-Rla. However, the basal [^H]-IP production was not affected by 
co-transfection (Fig. 4.8C). As the data variation at 0.5 |ag/ml was too large, so it 
needs more experiments to reach conclusion. 
To determine whether the co-transfection potentiating effect on [^H]-IP production is 
specific to the additional empty vector, pcDNA3.1(+), HEK293 cells were 
co-transfected with 0.25 \ig/m\ hGHS-Rla plasmid DNA plus 0.75 |ig/ml hGHS-Rlb 
, o r a Gq-coupled receptor, human thromboxane A2 receptor (hTPa). Then GHS-R 
agonist (1 |xM ghrelin) was used to stimulate the IP production through hGHS-Rla. 
When the cells were co-transfected with hGHS-Rla plus hGHS-Rlb or hTPa, the 1 
|j,M ghrelin-stimulated [^H]-IP production was 5.26 士 0.52 and 8.85 士 1.23，n=2, 
respectively, which were greater than the cells transfected with hGHS-Rla alone (4.1 
士 0.28，n=2) (Fig. 4.9). The cells co-transfected with hGHS-Rla plus hTPa, the basal 
[H]-IP production was 3.80 士 0.08，n=2, which was slightly greater than the cells 
transfected with hGHS-Rla alone (2.73 士 0.04，n=2). However, the basal [^H]-IP 
production was not affected by co-transfecting hGHS-Rla with hGHS-Rlb. All the 
Page 86 
Chapter 4 Results 
potentiating effects of the different addition plasmid DNA were smaller than the 
addition of empty vector. 
In conclusion, there was a potentiating effect in both basal and agonist-stimulated 
[3H]-IP production, when HEK293 cells were co-transfected hGHSR-la, 
2myc-hGHS-Rla or HA-sbGHS-Rla with pcDNA3.1(+). This potentiation effect in 
sbGHS-Rla need more experiments to confirm. Also, this co-transfection 
potentiating effect was not specific for the additional empty vector, it also occur in 
the addition of other plasmid DNA, but the increase in the [^H]-IP production varies. 
4.2.2 Effect of balancing DNA concentration using another Gq-coupled 
receptor 
To investigate the specificity of DNA concentration balancing effect in hGHS-Rla 
signaling, hTPa was used as a target receptor. Similar to hGHS-Rla, hTPa couples to 
“ . G q protein and leads to production of inositol phosphates and increase in intracellular 
calcium level (Foley et aL, 2001; Kinsella et aL, 1997). The experiment design was 
similar to that used to study the balancing effect in hGHS-Rla, just interchange the 
position of hGHS-Rla and hTPa, and using hTPa agonist, U46619. The cells 
co-transfected hTPa plus hGHS-Rlb or hGHS-Rla, the U46619-stimulated [^H]-IP 
production was 7.30 土 0.84 and 9.76 士 6.92，n=2, respectively, which were greater 
than the cells transfected with hTPa alone (2.97 土 0.48，n=2) (Fig. 4.10). The basal 
[^H]-IP production was also increased when the cells were co-transfected with hTPa 
plus hGHS-Rla, it is due to the constitutive activity of hGHS-Rla, but not due to the 
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DNA concentration balancing effect in transfection. Taken together, the DNA 
concentration balancing effect in co-transfection was not specific to hGHS-Rla, but 
also occurred with another Gq-coupled receptor, hTPa. 
4.2.3 Effect of Q- and Gs-coupled receptor on GHS-Rla signaling 
To determine if the variable potentiating effect of the balancing DNA concentration 
occurs using Gi- and Gs-coupled receptors, HEK293 cells were co-transfected with 
0.25 f^g/ml hGHS-Rla plus 0.75 |ag/ml Gi-coupled receptor, p,-opioid receptor (MOR) 
or Gs-coupled receptor, mouse prostaglandin D2 receptor (mDP). Then the cells were 
incubated with buffer or 1 jiM ghrelin. For the cells co-transfected with hGHS-Rla 
mDP or MOR, both the basal and the ghrelin-stimulated [^H]-IP productions were 
greater than the cells transfected with hGHS-Rla alone (Fig. 4.11). The cells 
co-transfected with hGHS-Rla and mDP, the basal and ghrelin-stimulated [^H]-IP 
productions was 19.31 and 24.42，respectively, which were greater than the cells 
.transfected with hGHS-Rla alone. The HEK293 cells co-transfected hGHS-Rla with 
MOR, the basal and ghrelin-stimulated [^H]-IP productions were 8.31 and 13.27， 
respectively, which were also greater than the cells transfected with hGHS-Rla alone. 
These data indicated that the co-transfection potentiating effect in [^H]-IP production 
was not only in response to Gq-coupled receptor, but also for Gi- and Gs-coupled 
receptors. 
,1 
4.2.4 Potentiating effect of co-transfection appeared using different 
transfection reagents 
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The above experiments (section 4.2.1 to 4.2.3) used Lipofectamine2000 to carry out 
transient transfection of HEK293 cells. To determine the specificity of the DNA 
concentration balancing effect in transfection reagents, four different transfection 
reagents were used. The potentiating effect in co-transfection as also observed when 
different transfection reagents such as Lipofectamine, Lipofectamine2000, Fugene 6 
and Genejuice were used. The GHRP-6-stimulated [^H]-IP production was greater in 
the cells co-transfected with hGHS-Rla plus pcDNA3.1(+) than the cells transfected 
with hGHS-Rla alone (Fig. 4.12)，but using Fugene 6，the GHRP-6-stimulated 
[3H]-IP production was only slightly potentiated. The basal [^H]-IP productions were 
also potentiated, when Lipofectamine and Lipofectamine2000 were used, but not 
when using Fugene 6 or Genejuice. These data suggested that using different 
transfection reagents, the potentiating effect was also observed in agonist-stimulated 
[^H]-IP productions, but may not occur in the basal [^H]-IP production. It is unclear 
why some of the transfection reagents resulted in a potentiated basal [^H]-IP 
.production but some of them did not. 
4.2.5 Co-transfection improves transfection efficiency 
The transfection efficiency can be demonstrated using enhanced green fluorescent 
protein (EGFP) as a reporter gene (Zhang et al., 1997). The transfection efficiency in 
HEK293 cells was quantified by EGFP expression using a counter (Victor-2 
Multilabel) to measure the fluorescence intensity or fluorescence microscope to 
estimate the percentage of fluorescent cells (Jiang et al” 2005). Using these 
techniques, the transfection efficiency difference between one type of plasmid DNA 
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transfection and co-transfection procedure was studied. HEK293 cells were 
transfected with 0.1 |ag/ml EGFP plasmid (pEGFP) DNA alone or plus other plasmid 
DNA, they were 0.25 |ig/ml, 0.5 |xg/ml and 1 |ig/ml 2myc-hGHS-Rla alone or 
maintained the DNA concentration at 1 fig/ml by balancing with pcDNA3.1(+). If the 
transfection efficiency increases, the fluorescent reading records from the counter 
(Victor-2 Multilabel) will increase, and under the fluorescent microscope, an increase 
in the number and the brightness of fluorescent cells will also be observed. 
Transfection efficiency was not affected by transfecting different concentrations of 
2myc-hGHS-Rla alone, as the fluorescence reading kept at around 9400 (Fig. 4.13). 
However, when co-transfecting 2myc-hGHS-Rla with pcDNA3.1(+) to a the final 
DNA concentration of 1.1 |ig/ml, the transfection efficiency of 0.25 |ig/ml and 0.5 
^ig/ml 2myc-hGHS-Rla were increased, as there were 2.02 and 1.58 fold-increase in 
the fluorescent readings, respectively. Also, reducing the amount of pcDNA3.1(+) 
..used in maintaining the DNA concentration at 1.1 |ig/ml，the transfection efficiency 
also decreased. In addition, the HEK293 cells transfected with 0.1 |ig/ml pEGFP plus 
1 ng/ml pcDNA3.1(+), the fluorescent reading was higher than the HEK293 cells 
transfected with 0.1 ^ig/ml pEGFP plus 1 \ig/m\ 2myc-hGHS-Rla. These 
observations indicated that the presence of the pcDNA3.1(+) increase the 
transfection efficiency in HEK293 cells. Under the fluorescence microscope, this 
phenomenon was also observed (Fig. 4.14). 
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4.2.6 Conclusions 
In conclusion, there was a potentiating effect in both basal and agonist-stimulated 
[^H]-IP production, when HEK293 cells were co-transfected hGHS-R-la, 
2myc-hGHS-Rla or HA-sbGHS-Rla with pcDNA3.1(+). It indicated that this 
potentiating effect was not affected by the epitope-tag. This potentiation effect in 
sbGHS-Rla need more experiments to confirm. One of the explanations for this 
phenomenon is the presence of pcDNA3.1(+) improves the transfection efficiency, as 
there was an gradually increase in the fluorescent signal came from the cells 
transfected with fixed amount of pEGFP plus increasing amount of pcDNA3.1(+). 
Also, this co-transfection potentiating effect was not specific for the additional empty 
vector, it also occur in the addition of other plasmid DNA (hTPa and hGHS-Rlb), 
but the increase in the [^H]-IP production varies and the basal [^H]-IP production 
may not be potentiated. The DNA concentration balancing effect in co-transfection 
• was not specific to hGHS-Rla, but was seen with another Gq-coupled receptor, hTPa. 
In addition, the co-transfection potentiating effect in [^H]-IP production not only 
occurred in balancing DNA with one type of GPCR, Gq-coupled receptor, but also 
when using Gi- or Gg-coupled receptors, as in the HEK293 cells co-transfected with 
hGHS-Rla and MOR or mDP, the agonist-stimulated [^H]-IP production was greater 
than the HEK293 cells transfected with hGHS-Rla alone. Also, the potentiating 
effect was also observed in agonist-stimulated [^H]-IP productions using different 



























































































































































































































































































































































































































































































































































































































































































































































































































Chapter 4 Results 
20-1 Basal 
• | o 15- ™ Ghrelin (1 i^M) 
o i l 
10- T 
( n I 
Jnl III ni nl n. 
0.25 |Lig/ml hGHS-R1a + + + + -
0.75 fxg/ml pcDNA3.1(+) + + (1 ug/ml) 
0.75 |Ltg/ml hGHS-R1b + 
0.75 |ig/ml hTPa + 
Figure 4.9 Effect of co-transfection on hGHS-Rla signaling. HEK293 cells 
transfected with 0.25 ^ig/ml hGHS-Rla or 1 ^g/ml pcDNA3.1(+) were used as the 
controls. HEK293 cells were transfected with 0.25 |ig/ml hGHS-Rla plus 0.75 |ig/ml 
pcDNA3.1 (+)/hGHS-Rlb/Gq-coupled receptor (hTPa). After 24 h post-transfection, 
the cells were labeled with 2 ^iCi/ml m少0-[3H]-inositol and incubated overnight, and 
then [ H]-IP production was measured as described in Chapter 3. The cells were 
lysed following 1 h incubation with buffer or ghrelin. Results in figure represent 
mean 士 S.D.，n=2, of experiments performed in duplicate. 
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0.25 pg/ml hTPa + + + + _ 
0.75 |ug/ml pcDNA3.1(+) + . _ + M ng/ml) 
0.75 |ag/ml hGHS-R1b . _ + . 
0.75 |ag/ml hGHS-R1a + 
Figure 4.10 Effect of co-transfection on hTPa signaling. HEK293 cells transfected 
with 0.25 iig/ml hTPa or 1 ^g/ml pcDNA3.1(+) were used as the controls. HEK293 
cells were transfected with 0.25 [ig/ml hTPa plus 0.75 |ig/ml 
pcDNA3.1 (+)/hGHS-Rl b/Gq-coupled receptor (hGHS-Rla). After 24 h 
post-transfection, the cells were labeled with 2 |iCi/ml -inositol and 
incubated overnight, and then [^H]-IP production was measured as described in 
Chapter 3. The cells were lysed following 1 h incubation with buffer or U46619. 
Results in figure represent mean 士 S.D.，n=2, of experiments performed in duplicate. 
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0.25 |ig/ml hGHS-R1a + + + -
0.75 |Lig/ml mDP + 
0.75 |ig/ml MOR + 
1.00 |Lig/ml pcDNA3.1(+) + 
Figure 4.11 Effect of co-transfection on hGHS-Rla signaling with Gi- or Gg-coupled 
receptors. HEK293 cells transfected with 0.25 |ig/ml hGHS-Rla or 1 jag/ml 
pcDNA3.1(+) were used as the controls. HEK293 cells were transfected with 0.25 
M-g/ml hGHS-Rla plus 0.75 |j,g/ml Gi-coupled receptor (MOR)/Gs-coupled receptor 
(mDP). After 24 h post-transfection, the cells were labeled with 2 |iCi/ml 
, - i n o s i t o l and incubated overnight, and then [^H]-IP production was 
measured as described in Chapter 3. The cells were lysed following 1 h incubation 
with buffer or ghrelin. Results come from one experiment performed in duplicate, 
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o 5 10000- J , r ^ _ 
U. (0 
5000-
( 4 1 _ U _ U _ U _ U _ U _ L i L 
pEGFP (fxg/ml) 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
2myc-hGHS-R1a (|xg/ml) - 0 . 2 5 0 . 5 1 - o . 2 5 0 . 5 
pcDNA3.1(+) (|ig/ml) - 1 0.75 0.5 
Figure 4.13 Effect of co-transfection on transfection efficiency. HEK293 cells 
transfected with 0.1 i^g/ml EGFP plasmid (pEGFP) DNA alone was used as a control. 
HEK293 cells transfected with 0.1 ^g/ml pEGFP plus increasing amounts of 
‘ 2myc-hGHS-Rla alone or with pcDNA3.1(+) to maintained the DNA concentration 
at 1.1 jxg/ml. After 48 h post-transfection, the cells in the 24-well plate were washed 
with buffer and excited by 488 nm light and then the fluorescence produced by EGFP 
was measured by the counter (Victor-2 Multilabel). Results come from one 






























































































































































































































































































































































































































































































































































































































Chapter 4 Results 
4.3 Development of cell lines stably expressing hGHS-Rla or 
hGHS-Rlb 
4.3.1 Advantages of using a monoclonal cell line 
Monoclonal cell lines are derived from a single cell, so they are all identical to each 
other, the result between experiments will therefore be more consistent than using 
transient transfection methods to express the study target in a cell. Transfection 
efficiency varies from experiment to experiment, many factors can affect it, for 
example, cell density and cell culture health condition (Dalby et al., 2004). Also, not 
all the cells can take,, up and express the target protein. In addition, as described in 
section 4.2, there is a variable potentiating effect resulting from co-transfection, so 
when studying the interaction between two proteins, using a monoclonal cell line 
which is already expressing one of the target proteins, will make the data easier to 
interpret. 
4.3.2 Sensitivity of HEK293 cells to antibiotics 
To generate a stable cell line that expresses a target protein from an expression 
plasmid carrying an antibiotic resistance gene, it is necessary to determine the 
minimum antibiotic concentration required to kill the non-transfected cells. 
Mammalian cells exhibit a wide range of susceptibility to antibiotics, and many 
factors affect the stable cell line selection process, such as cell line, growth rate and 
cell density. Therefore, before the selection of the stable cell line, the susceptibility of 
HEK293 cells to G418 and Zeocin''^ needed 
to be determined, as described in 
Chapter 3. 2myc-hGHS-Rla was inserted into pcDNA3.1(+) vector, which carries 
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the Neomycin resistance gene, therefore the cells expressing 2myc-hGHS-Rla are 
G418-resistant. From figure 4.15A, 600 |ig/ml G418 was sufficient to kill HEK293 
cells, so this concentration was used to select the cells that stably expressed 
2myc-hGHS-Rla. 2myc-hGHS-Rlb was inserted into pcDNA3.1(+)/Zeo vector, 
which carries the Zeocin resistance gene, so the cells expressing 2myc-hGHS-Rlb 
are Zeocin-resistant. From figure 4.15B, 300 jig/ml Zeocin was sufficient to kill 
HEK293 cells, so 300 jig/ml Zeocin™ was used to select the cells that stably 
expressed 2myc-hGHS-Rlb. 
4.3.3 Production of polyclonal stable cell line 
Development of stable cell lines involves the uptake and the integration of 
transfected plasmid DNA into the chromosome at random sites, making the 
transfected plasmid DNA a permanent part of the genetics of the cell. Before the 
plasmid DNA integration, the plasmid DNA is cleaved by the endonucleases, which 
• make random internal cuts in the DNA molecule (Snustad et al., 1997)，so it may 
result in a linearized DNA sequence, such as the cutting site in the middle of the 
target gene, which can not code for the target protein. Therefore, in the development 
of stable cell line, the 2myc-hGHS-Rla DNA plasmid and 2myc-hGHS-Rlb DNA 
plasmid were linearized using Sail and Seal restriction enzymes, respectively, to 
make sure the circular plasmid DNAs were cleaved at the right position. In addition, 
the plasmid DNA integration is also a random process, if the integration occurred at 
the transcriptionally silent genomic locus, it will also result in no expression of the 
target protein. 
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To confirm if the establishment of the polyclonal 2myc-hGHS-Rla and 
2myc-hGHS-Rlb HEK293 stable cell lines were successful or not, IP assay and 
RT-PCR were used to confirm the presence of 2myc-hGHS-Rla and 
2myc-hGHS-Rlb, respectively, as described in Chapter 3. There was an increase in 
both basal and the ghrelin-stimulated [^H]-IP production in 2myc-hGHS-Rla 
HEK293 stable cell line, it indicating the presence of 2myc-hGHS-Rla (Fig. 4.16). 
For the RT-PCR, using primers named 2myc-hGHS-Rlb as described in Chapter 3 
Table 3.2, there was around 1000 base pairs (bps) PGR product which matched the 
expected size (983 bps), it therefore showed the presence of 2myc-hGHS-Rlb in 
2myc-hGHS-Rlb HEK293 stable cell line (Fig. 4.17A). From Fig. 4.17B, it showed 
that there was absence of hGHS-Rla and hGHS-Rlb in HEK293 cells. 
4.3.4 Monoclonal stable cell line selection 
.There are two methods to develop a monoclonal cell line, one of the methods is to 
transfer cells into 96-well plates at 1 cell per well (Mounier et al., 2004), as 
described in Chapter 3. This method is very convenient, the cells were left in the 
plate until single colonies were observed, then the single colony in each well was 
selected and bulked up. However, many wells contained more than one cell or had no 
cell. Although there were two discrete single colonies in the well, the colonies could 
not be selected. Also, cells are difficult to grow alone, it took very long time to 
develop a colony from a single cell. In addition, many cells transfected with 
2myc-hGHS-Rlb died at few cells per well, as floating cells were observed. 
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Therefore, another method was used, that is the use of the cloning ring (Russell, 
1998)，as described in Chapter 3, as it may overcome the previous problems. In this 
method, the cells grew in a 100 mm dish and had other cells in the surrounding 
environment during the development of the single colony. The single colony was 
bounded by cloning ring when the colony was large enough. Using this method, cells 
do not need to grow alone and one can select more single colonies, as long as the 
colonies are discrete and not too close to each other. 
Although there were lots of improvements tried in the development of 
2myc-hGHS-Rla and 2myc-hGHS-Rlb HEK293 stable cell lines, it was still 
unsuccessful. After the screening of the 2myc-hGHS-Rla HEK293 stable cell lines 
by IP-assay, as described in Chapter 3，both the basal and the ghrelin-stimulated 
[H]-IP production were as the same as the control, indicating that none of the 
monoclonal clones express 2myc-hGHS-Rla despite showing antibiotic resistance 
(data not shown). The clonal screening of 2myc-hGHS-Rlb HEK293 stable cell lines 
by RT-PCR as described in Chapter 3，also indicated that none of the clones have the 
expression of 2myc-hGHS-Rlb, as there was no band in the agarose gel (data not 
shown). 
4.3.5 Discussions 
Although many improvements had been made in order to increase the successfulness 
in the development of stable cell lines, including use of linearized circular plasmid 
DNA by specific restriction enzymes before transfection to prevent the random 
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cutting by endonucleases inside the cells and using cloning ring during selection of 
monoclonal cell line in order to prevent the cell to grow alone for a long time in 
96-well plate, but i still could not obtain any monoclonal stable cell line. The 
unsuccessfulness might be due to the random integration of the linearized target 
plasmid DNA into the chromosome. 
Recently, there is a new technique developed by a company (Invitrogen), called 
Flp-In™ system. This system eliminates the random integration of the plasmid DNA 
into chromosome during the development of the stable cell line. Briefly, a host cell 
line stably expressing a vector, called pFRTZ/acZeo has been generated. This vector 
contains a Zeocin resistance gene for antibiotic selection and a FRT site which serves 
as the binding and cleavage site for the Flp recombinase. The pFRT//acZeo stably 
expressed cell line can be developed on your own or obtained from the company. 
After this host cell line is ready, co-transfection of a vector called pcDNA5/FRT, 
• which contains the gene of interest and FRT site, with another vector called pOG44, 
which constitutively expresses the Flp recombinase, into this stably expressed 
pFRT//^zcZeo host cell. Upon co-transfection, the Flp recombinase expressed in 
pOG44 mediates homologues recombination between the FRT sites, such that 
pcDNA5/FRT inserts into the integrated FRT site in the chromosome (Craig, 1988; 
Sauer, 1994). This method makes sure the vector containing the target gene is 
inserted into the correct position of chromosome, at which the target gene is 
transcribed. 
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Figure 4.15 Antibiotic susceptibility curve of HEK293 cells to G418 and Zeocin™. 
The cell confluency was estimated after incubating the cells with antibiotic for 10 
days. 
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6-1 
I a control 
• ghrelin (0.1 ^iM) 
• 一 
HEK293 HEK-2myc-hGHS-R1a 
Figure 4.16 Determination of the presence of 2myc-hGHS-Rl a in polyclonal 
HEK293 stable cell line. The HEK293 and polyclonal stable cells were labeled with 
2 |xCi/ml m>;o-[^H]-inositol and incubated overnight, and then [^H]-IP production was 
measured as described in Chapter 3. The cells were lysed following 1 h incubation 
with buffer or ghrelin. Results come from one experiment performed in triplicate, 
. data shown are mean 土 S.E.M. 
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Figure 4.17 Ethidium bromide stained agarose gel showing (A) the presence of 
2myc-hGHS-Rlb in HEK-sbGHS-Rlb cells and (B) the absence of hGHS-Rla and 
hGHS-Rlb in HEK293 cells. The total RNA was extracted from (A) the polyclonal 
HEK-sbGHS-Rlb stable cells line, (B) hGHS-Rla transfected HEK293 cells (lane 2), 
hGHS-Rlb transfected HEK293 cells (lane 4) and HEK293 cells (lane 3 and 5), and 
then converted to first-strand cDNA and PGR was performed as described in Chapter 
3. The PGR product was resolved in agarose gel. The expected size of control band, 
2myc-hGHS-Rlb, hGHS-Rla and hGHS-Rlb are 500 bps, 983 bps, 806 bps and 807 
bps, respectively. Control product was amplified by RT-PCR, using the cDNA 
provided in the SuperScript™ First-Strand Synthesis System (Invitrogen). 
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4.4 Effect of adenosine on GHS-Rla signaling 
4.4.1 Adenosine acts as a partial agonist 
To investigate the effect of adenosine on 2myc-hGHS-Rla, HEK293 cells were 
transiently transfected with 0.25 |ig/ml 2myc-hGHS-Rla plus 0.75 |ig/ml 
pcDNA3.1(+)，and then incubated with 0.1 |iM ghrelin and 0.1 mM adenosine alone 
or together. The concentration of ghrelin and adenosine used here, were expected to 
give a maximum activation of 2myc-GHS-Rla. As indicated in the figure 4.4，the 
ghrelin-stimulated [^H]-IP production reached plateau at 10 nM, and 0.1 mM 
adenosine stimulated maximum intracellular calcium increase in HEK293 cells 
expressing hGHS-Rla (Carreira et al, 2004). From figure 4.18A, the 
adenosine-stimulated [^H]-IP production was 37.54 士 1.47，n=4, the response size of 
the basal and the ghrelin-stimulated [^H]-IP production was 32.54 土 2.00 and 47.64 士 
2.50，n=4, respectively. It indicated that adenosine is a partial agonist of 
• 2myc-hGHS-Rla, as adenosine increased the [^H]-IP production, but the response 
size is not as large as the ghrelin-stimulated [^H]-IP production. When the 
2myc-hGHS-Rla expressed cells were incubated with ghrelin together with 
adenosine, there was a further increase in the ghrelin-stimulated [^H]-IP production 
(Fig. 4.18A). A further increase is not expected, as adenosine is a partial agonist of 
hGHS-Rla, the use of the maximum concentration of a partial agonist, the full 
agonist response should be reduced as many of the binding sites were also occupied 
by the partial agonist. In other paper, it demonstrated in HEK293 cells which stably 
expressed pig GHS-Rla, at the maximal concentration of adenosine, MK-0677 did 
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not cause a further activation of GHS-Rla (Smith et al, 2000). Non-transfected 
HEK293 cells were not affected by 0.1 [iM ghrelin or 0.1 mM adenosine (Fig. 4.18B)’ 
indicating that the changes in the [^H]-IP production were due to the expression of 
2myc-hGHS-Rla. 
4.4.2 Effect of substance P analog on adenosine-mediated GHS-Rla signaling 
SPa has been suggested to be an inverse agonist of GHS-Rla and it has also been 
shown in our system (Fig. 4.2). In addition, ghrelin-stimulated [^H]-IP production 
was affected by SPa (Fig. 4.3). Adenosine was shown to increase [^H]-IP production 
in our system, therefore it was interesting to investigate whether 
adenosine-stimulated [^H]-IP production will also be affected by SPa. HEK293 cells 
were transfected with 2myc-hGHS-Rla as described in section 4.4.1，and then the 
cells were incubated with buffer, 0.1 jj,M ghrelin, 0.1 mM adenosine alone or 
together with 1 i^M SPa. The basal [^H]-IP production was significantly inhibited by 
68.86 士 9.110/0，n=2, when the cells were incubated with SPa, indicating that SPa is 
an inverse agonist of 2myc-hGHS-Rla (Fig. 4.19). The adenosine-stimulated [^H]-IP 
production was also significantly affected by SPa, it was inhibited by 78.56 土 3.03%， 
n=2, the response size of SPa plus adenosine-stimulated [^H]-IP production (7.79 士 
1.85，n=2) was similar to the [^H]-IP production (9.57 士 3.59，n=2) in HEK293 cells 
incubated with SPa only. However, the 0.1 }J,M ghrelin-stimulated [^H]-IP production 
was not affected by SPa, as the ghrelin concentration is too high that the effect of 1 
|xM SPa cannot be observed. If using a lower concentration of ghrelin, the effect of 
SPa should be observed, as described in figure 4.3. Although in figure 4.3，the 0.1 
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jiM ghrelin-stimulated [^H]-IP production was still affected by the presence of 1 i^M 
SPa, it might be due to the low transfection efficiency，as indicated by the lower 
[^H]-IP production in figure 4.3 than in figure 4.19. 
4.4.3 Effect of adenosine deaminase (ADA) on adenosine- and 
ghrelin-stimulated GHS-Rla signaling ‘ 
In section 4.4.1，it showed that there was an adenosine-stimulated [^H]-IP production 
in the HEK293 cells transiently transfected with 2myc-hGHS-Rla. As there are 
many cells which endogenously produce adenosine, such as mast cells (Feoktistov et 
al” 2003), so it is interesting to see if there was a component of the 
adenosine-stimulated [^H]-IP production in 2myc-hGHS-Rla transfected HEK293 
cells due to any endogenous adenosine. In order to investigate this, ADA was used. 
ADA is an enzyme of the purine metabolism which catalyzes the irreversible 
deamination of adenosine to inosine (Cristalli et al” 2001). HEK293 cells were 
. t ransfected with 2myc-hGHS-Rla as described in section 4.4.1，and then the cells 
were preincubated with lU/ml ADA or buffer for 30 min before incubating with 0.1 
|iM ghrelin or 0.1 mM adenosine. In figure 4.20, pretreatment of cells with ADA 
caused a decrease in the basal, ghrelin- and adenosine-stimulated [^H]-IP production, 
it indicating that there may be an endogenous release of adenosine due to the 
expression of 2myc-hGHS-Rla, and then the endogenous adenosine will bind to the 
2myc-hGHS-Rla and gives a further stimulation of basal and ligand-stimulated 
[^H]-IP production. If there were no endogenous release of adenosine, then only the 
adenosine-stimulated [^H]-IP production should be reduced, the basal and the 
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ghrelin-stimulated [^H]-IP production should remain unchanged. Another possible 
implication is that ADA produces a non-specific inhibition effect on [^H]-IP 
production. 
To investigate whether the expression of 2myc-hGHS-Rla and other Gq-coupled 
receptors will cause the release of endogenous adenosine, HEK293 cells were 
transiently transfected with 0.25 )j,g/ml hTPa plus 0.75 |ig/ml pcDNA3.1(+). In 
addition, HEK293 cells have an endogenously expressed muscarinic receptor, which 
when stimulated by 0.1 mM carbachol results in an increase in the intracellular 
calcium level (Luo et al, 2001a). Both the hTPa and muscarinic receptor are 
Gq-coupled receptors. HEK293 cells were also transiently transfected with 0.25 
|ig/ml GaqRC, which is a constitutively active Gq-protein, plus 0.75 |ig/ml 
pcDNA3.1(+). GaqRC is used to show if the endogenous adenosine released is due to 
the receptor-dependent activation of Gq-protein or not. Cells were pre-incubated with 
, l U / m l ADA or buffer for 30 min and then the hTPa, endogenous muscarinic receptor 
and GaqRC transfected HEK293 cells were incubated with 1 |iM U46619, 0.1 mM 
carbachol and buffer, respectively. Pretreatment with ADA caused reductions in 
agonist-stimulated [^H]-IP production in the cells transiently transfected with hTPa 
and endogenously expressing muscarinic receptors (Fig. 4.21). There was also a 
decrease in ligand-independent [^H]-IP production in GaqRC transfected cells. Taken 
together, the endogenous adenosine release may not only be due to the expression of 
2myc-hGHS-Rla, but also other Gq-coupled receptors. In addition, this endogenous 
adenosine release is not necessary to have a receptor-dependent activated Gq protein. 
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Alternatively, a non-specific effect of ADA still needs to be considered. 
4.4.4 Specificity of ADA 
To investigate the specificity of ADA in the inhibition of [^H]-IP production, the 
adenosine receptor antagonist theophylline was used. There is evidence to show that 
10 \ M theophylline can block the pig GHS-Rla signaling induced by 2 i^M 
adenosine (Smith et al, 2000). Also, theophylline can block the signaling activated 
by all the subtypes of adenosine receptor, as it is a non-selective adenosine receptor 
blocker (Germack et al” 2004b). However, there has not been any evidence to show 
that theophylline can block the signaling mediated by hTPa receptor, GaqRC, 
muscarinic receptors and purinergic (P2Y) receptors. Therefore, if the ADA inhibition 
effect on [^H]-IP production was specific, then after the pretreatment with 
theophylline, only the cells expressing 2myc-hGHS-Rla and incubated with 
adenosine alone or together with ghrelin, will show the decrease in the 
, agonist-stimulated [^H]-IP production. 
HEK293 cells were transiently co-transfected with 0.25 |^g/ml 2myc-hGHS-Rla, 
hTPa or GaqRC with 0.75 ^ig/ml pcDNA3.1(+). The transiently transfected and the 
non-transfected HEK293 cells were pre-incubated with 0.1 mM theophylline or 
buffer for 30 min, and then these cells were incubated with appropriate agonist alone 
for the receptor expressed in the cells or together with 0.1 mM adenosine. That 
means, the cells expressed 2myc-hGHS-Rla, hTPa, GaqRC were incubated with 0.1 
|iM ghrelin, 1 i^M U46619 and buffer, respectively. The non-transfected HEK^93 
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cells, which endogenously express muscarinic receptors and purinergic P2Y receptors 
(P2Y), were incubated with 0.1 mM carbachol and 0.1 mM ATP, respectively. From 
figure 4.22，the pre-treatment of cells with theophylline did not cause any changes in 
any of the agonist-stimulated [^H]-IP production. It implicated that the ADA 
inhibition effect may not be specific and that the adenosine-sensitive site on 
hGHS-Rl a is not recognized by theophylline. Tullin et al (2000) also showed that in 
BHK cells which stably expressed GHS-Rla, theophylline did not show any effect 
on adenosine- or MK-0677-induced calcium response. 
4.4.5 Conclusions 
HEK293 cells transfected with 2myc-hGHS-Rla and incubated with a high 
concentration adenosine, which expect to show a maximum activation of hGHS-R la, 
showed that there was an increase in the [^H]-IP production and the response size is 
not as large as ghrelin, suggesting that adenosine is a partial agonist of hGHS-Rl a. 
. When adenosine was co-admins仕ated with ghrelin, there was an additive increase in 
the ghrelin-stimulated [^H]-IP production, this result is not expected as adenosine is a 
partial agonist, as activation of a receptor by the high concentration of partial agonist 
plus the full agonist, the full agonist-stimulated response should be decreased. In 
Smith et al. (2000), it demonstrated in HEK293 cells which stably expressed pig 
GHS-Rla, at the maximal concentration of adenosine, MK-0677 did not cause a 
further activation of GHS-Rla. Besides ghrelin-stimulated [^H]-IP production, the 
"•J 
adenosine-stimulated [ H]-IP production was affected by SPa, but this could just be 
affect on the basal activity, as there was only a slight increase in the [^H]-IP 
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production by adenosine. 
There is not enough evidence here to show that part of the ghrelin-stimulated [^H]-IP 
production is due to the endogenously release adenosine, as there were decrease in 
basal, ghrelin- and adenosine-stimulated [ H]-IP production in 2myc-hGHS-Rla 
transfected cells after pretreatment of ADA. Also, muscarinic receptor-, hTPa- and 
GaqRC-activated [^H]-IP production were also decreased. In addition, pretreatment of 
cells with theophylline did not inhibit any agonist-stimulated [^H]-IP production in 
2myc-hGHS-Rla, hTPa and GaqRC transfected HEK293 cells and non-transfected 
HEK293 cells which endogenously express muscarinic receptor and P2Y receptors. 
In Tullin et al (2000) was also showed that in BHK cells which stably expressed 
GHS-Rla, theophylline did not show any effect on adenosine- or MK-0677-induced 
calcium response. 
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Figure 4.18 Effect of 0.1 mM adenosine alone or on 0.1 \iM ghrelin-stimulated 
[^H]-IP production in (A) HEK293 cells transiently transfected 0.25 |ig/ml 
2myc-hGHS-Rla plus 0.75 jxg/ml ppDNA3.1(+). After 24 h post-transfection, the 
cells were labeled with 2 |xCi/ml m>'o-[^H]-inositol and incubated overnight, and then 
[^H]-IP production was measured as described in Chapter 3. The cells were lysed 
following 1 h incubation with buffer, adenosine, ghrelin or adenosine plus ghrelin. (B) 
Non-transfected HEK293 cells were used to show ghrelin and adenosine did not 
affect the cells. Results in figure represent mean 士 S.E.M.，n=4, of experiments 
performed in duplicate. (*p<0.05, **<0.01, ***<0.001, one-way ANOVA was used.) 
““ Page 118 
Chapter 4 Results 
• Control 
• S P a O i i M ) 
50-1 了 -T-
I ** 
•！4。- — I I^ T" 
I ” - I a • • 
10- i I _ 
Control Ghrelin Adenosine 
Figure 4.19 Effect of 1 |iM SPa on basal, 0.1 ghrelin- and 0.1 mM 
adenosine-stimulated [^H]-IP production. HEK293 cells were transiently transfected 
with 0.25 |ig/ml 2myc-hGHS-Rla plus 0.75 \xg/m\ pcDNA3.1(+). After 24 h 
post-transfection, the cells were labeled with 2 jiCi/ml -inositol and 
• incubated overnight, and then [^H]-IP production was measured as described in 
Chapter 3. The cells were lysed following 1 h incubation with buffer, ghrelin, 
adenosine alone or together with SPa. Results in figure represent mean 士 S.D.，n=2， 
of experiments performed in duplicate. (*P<0.05, **P<0.01, one-way ANOVA was 
used.) , 
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Figure 4.20 Effect of 1 U/ml ADA on basal, 0.1 |iM ghrelin- and 0.1 mM 
adenosine-stimulated [^H]-IP production. HEK293 cells were transiently transfected 
with 0.25 |ig/ml 2myc-hGHS-Rla plus 0.75 昭/ml pcDNA3.1(+). After 24 h 
post-transfection, the cells were labeled with 2 jxCi/ml w少o-[3H]-inositol and 
incubated overnight, and then [^H]-IP production was measured as described in 
. C h a p t e r 3. The cells were lysed following pre-incubated with ADA or buffer for 30 
min and then 1 h incubation with buffer, ghrelin, adenosine alone. Results in figure 
represent mean 士 S.D.，n=2, of experiments performed in duplicate. 
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Figure 4.21 Effect of 1 U/ml ADA on [^H]-IP production activated by Gq-coupled 
receptors (muscarinic receptor, mAChR and TPa) and constitutively active Gq 
protein (GaqRC). HEK293 cells were endogenously expressed muscarinic receptor. 
HEK293 cells were transiently co-transfected 0.25 |ig/ml TPa or GaqRC with 0.75 
|ig/ml pcDNA3.1 (+). All the cells were pre-incubated with buffer or 1 U/ml ADA for 
30 min then the HEK293 cells expressing endogenous mAChR, TPa and GaqRC 
were incubated with 0.1 mM carbachol, 1 \iM U46619 and buffer, respectively. 
[^H]-IP production was determined as chapter 3. Results come from one experiment 
performed in duplicate, data shown are mean 土 S.D. 








































































































































































































































































































































































































































































































































































Chapter 4 Results 
4.5 Role of GHS-R in apoptosis 
Preliminary result in our laboratory showed that sbGHS-Rla and HA-sbGHS-Rlb 
may be involved in the regulation of apoptosis (Fig. 4.23). The 
staurosporine-induced caspase-3 activity in HEK293 cells was higher than that in 
HEK-sbGHS-Rla cells, regardless of the transfected plasmid DNA (Fig. 4.23). It 
suggested that stably expressed sbGHS-Rla protected the cells against 
staurosporine-induced apoptosis and that sbGHS-Rla has anti-apoptotic properties. 
HEK293 cells transfected with HA-sbGHS-Rlb had a higher basal and 
staurosporine-induced caspase-3 activity than that in HEK293 cells, suggesting that 
HA-sbGHS-Rlb is pro-apoptotic. In addition, the pro-apoptotic effect of 
HA-sbGHS-Rlb was masked by the anti-apoptotic effect of sbGHS-Rla, as the 
caspase-3 activity did not change much when HEK-sbGHS-Rla cells were 
transfected with HA-sbGHS-Rlb. In conclusion, these results suggested that 
. s b G H S - R l a is anti-apoptotic, while HA-sbGHS-Rlb is pro-apoptotic. The following 
experiments were performed to optimize the conditions for further study of the role 
ofhGHS-R subtypes in the regulation of apoptosis. 
4.5.1 Different methods to measure caspase-3 activity 
4.5.1.1 Colorimetric assay 
In the following colorimetric assay experiments, the caspase-3 activities were 
measured as described in Chapter 3. The cells were incubated with apoptotic inducer 
in the presence of FBS. DMSO treatment group showed the caspase-3 activity .was 
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not affected by the solvent of apoptotic inducers, as the caspase-3 activity remain 
unchanged after DMSO incubation. 
4.5.1.1.1 Time course for staurosporine and etoposide in HEK293 cells 
The optimal incubation time for each apoptotic inducer was determined so that the 
apoptotic inducer will induce a measurable caspase-3 activity in HEK293 cells. 
HEK293 cells were incubated with 10 |xM staurosporine or 100 |xM etoposide in the 
presence of FBS for different incubation times as stated in figure 4.24A and 4.24B. 
A time-dependent increase in caspase-3 activity was observed for both staurosporine 
and etoposide treatment of HEK293 cells (Fig. 4.24). For the staurosporine-induced 
caspase-3 activity, it reached maximum at 8 h, there was 9.77 士 1.94 fold increase, 
n=2, in caspase-3 activity (Fig. 4.24A) compared to the caspase-3 activity at 0 h 
staurosporine incubation and 0.1% DMSO used in dissolving the staurosporine did 
- not affect the caspase-3 activity in HEK293 cells. For the etoposide-induced 
caspase-3 activity, 48 h incubation induced 8.10-fold increase, n=l, when compared 
to the caspase-3 activity at 0 h etoposide incubation, it was better than 24 h treatment 
which induced 2.51-fold increase, n=l (Fig. 4.24B). Although 24 h etoposide 
treatment did not induce a highest caspase-3 activity, the size of the 
etoposide-induced caspase-3 activtiy is clearly measurable. In addition, 48 h 
treatment may not be ideal to use, as it may need the etoposide replacement after 24 
hours. Therefore, in the following experiments, HEK293 cells were incubated with 
10 [M staurosporine or 100 i^M etoposide for 8 h and 24 h respectively, in order to 
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have an optimal measurement of caspase-3 activity. The staurosporine-induced 
caspase-3 activity was very small in this experiment because a small amount of 
caspase-3 substrate (4 jiM) was used. In the experiment using etoposide, 200 |xM 
caspase-3 substrate was used, and the absolute level of etoposide-induced caspase-3 
activities was larger than that in staurosporine experiment. Therefore, 200 |iM 
caspase-3 substrate was used in the following experiments. 
When HEK293 cells were incubated with 100 [lM etoposide for 24 h, there was only 
2.51-fold increase in caspase-3 activity, however, in 8 h staurosporine-induced 
caspase-3 activity, there was 9.77 士 1.94 fold increase. Therefore, higher 
concentrations of etoposide were used, to see whether it gives a greater caspase-3 
activity. In this experiment, HEK293 cells were incubated with 100 ^M, 150 i^M and 
200 |xM etoposide for 24 h in the presence of serum. The etoposide-induced 
caspase-3 activity did not increase further by using higher etoposide concentrations 
. , ( F i g . 4.25), and the DMSO concentrations used in dissolving the staurosporine did 
not affect the caspase-3 activity in HEK293 cells. Therefore, in the following 
experiments, HEK293 cells were incubated with 100 \iM etoposide for 24 h to have 
an optimal caspase-3 activity. 
Serum starvation was also used to induced caspase-3 activity in HEK293 cells, 
however incubated the cells in the medium without serum for 24 h, there was still no 
increase in the caspase-3 activity (Fig. 4.26). 
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4.5.1.1.2 Effect of 2myc-hGHS-Rla on staurosporine- and etoposide-induced 
caspase-3 activity 
To investigate the role of 2myc-hGHS-Rla in the regulation of apoptosis, 
HEK-2myc-hGHS-Rla polyclonal cells were used. The cells were incubated with 10 
\iM staurosporine for 4 h and 100 |iM etoposide for 24 and 48 h in the presence of 
serum. Wild type HEK293 cells were used as a reference. The caspase-3 activity in 
all the DMSO treated groups of HEK-2myc-hGHS-Rla polyclonal cells was as the 
same as the HEK293 cells, were around 0.02 pmol/min/|ig protein (Fig. 4.27). In 
HEK-2myc-hGHS-Rla cells, the staurosporine-induced caspase-3 activity was lower 
than that in HEK293 cells (Fig. 4.27A). It suggested that the expression of 
2myc-hGHS-Rla might protect the HEK293 cells to undergo staurosporine-induced 
apoptosis by 25.1% inhibition. It is expected, as from the preliminary results 
described in section 4.5，it suggested that the stably expressing sbGHS-Rla in the 
HEK293 cells, the staurosporine-induced caspase-3 activity was lower than that in 
, . H E K 2 9 3 cells, that is stably expression of sbGHS-Rla induced an anti-apoptotic 
effect to HEK293 cells. In addition, as demonstrated in section 4.1，the properties of 
hGHS-Rla and sbGHS-Rla were the same. 
In contrast to staurosporine, etoposide-induced caspase-3 activity was higher in the 
HEK-2myc-hGHS-Rla (Fig. 4.27B). It suggested that 2myc-hGHS-Rla might 
enhance etoposide-induced apoptosis in HEK293 cells by 0.34 土 0.38 fold, n=2, and 
0.68 fold for 24 and 48 h, respectively. However, there was a large variation in 24 h 
etoposide incubation data, and the other two treatment groups were only tested once, 
“一 — Page 127 
Chapter 4 Results 
so it needs more experiments to conclude the role of 2myc-hGHS-Rla in 
staurosporine- and etoposide-induced caspase-3 activity. 
4.5.1.1.3 Time course for staurosporine and etoposide in sbGHS-R monoclonal 
stable cell line 
There was the failure of the development of monoclonal HEK-2myc-hGHS-Rl a and 
HEK-2myc-hGHS-Rlb cells lines and the variable potentiating effect in 
co-transfection. In addition, the properties between human and seabream GHS-R are 
similar as described in section 4.1. Therefore, HEK-sbGHS-Rla and 
f 
HEK-sbGHS-Rlb monoclonal stable cell lines were used to study the role of GHS-R 
in apoptosis regulation. To optimize the colorimetric assay conditions used in the 
sbGHS-R monoclonal stable cell lines, the apoptotic inducers incubation time was 
determined. The experimental design is similar to section 4.5.1.1.1，in these 
experiments not only HEK293 cells were used, but also HEK-sbGHS-Rla and 
• . HEK-sbGHS-Rlb. 
Among these three cell lines, in order to have an optimized 10 |xM staurosporine- and 
100 \iM etoposide-induced caspase-3 activity, the cells were incubated for 8 h and 24 
h respectively (Fig. 4.28 and Fig. 4.29). Compared to the caspase-3 activity in 0 h 
staurosporine incubation, for 8 h staurosporine-induced caspase-3 activity, there were 
14.57-fold increase and 13.30-fold increase, n=l, for HEK-sbGHS-Rla and 
HEK-sbGHS-Rlb cells, respectively. Compared to the caspase-3 activity at 0 h 
etoposide incubation, for 24 h etoposide-induced caspase-3 activity, there were 
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0.91-fold increase and 0.45-fold increase, n=l，for HEK-sbGHS-Rla and 
HEK-sbGHS-Rlb cells, respectively. 
The staurosporine-induced caspase-3 activity in HEK293 cells was greater than that 
in the HEK-sbGHS-Rla and HEK-sbGHS-Rlb cell lines (Fig. 4.28)，the similar 
pattern was also observed in 24 h etoposide-induced caspase-3 activity (Fig. 4.29). 
That suggests that the stably expressed sbGHS-Rla and sbGHS-Rlb caused an 
anti-apoptotic effect to HEIC293 cells. This phenomenon was also observed in later 
experiments, such as figure 4.31. By comparing the two stable cell lines, 
HEK-sbGHS-Rla has a greater staurosporine-induced caspase-3 activity than the 
HEK-sbGHS-Rlb (Fig. 4.28); This was also observed in etoposide-induced 
caspase-3 activity at 24 h (Fig. 4.29). It suggested that the anti-apoptotic effect raised 
by sbGHS-Rlb may be greater than sbGHS-Rla, or it is just due to the difference in 
the receptor expression level. In general, the staurosporine-induced caspase-3 activity 
, w a s greater than the one induced by etoposide. 
4.5.1.1.4 Effect of sbGHS-Rs on staurosporine- and etoposide-induced 
caspase-3 activity in HEK293 cells 
To determine the role of sbGHS-Rla and sbGHS-Rlb on apoptosis, HEK293 cells 
were transfected with 1 |xg/ml sbGHS-Rla and sbGHS-Rlb, and then the cells were 
incubated with 10 fxM staurosporine for 8 h or 100 [lM etoposide for 48 h in the 
presence of serum. HEK293 cells transfected with 1 ^ig/ml empty vector, namely 
pBK-CMV, was used as the control. 
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The expression of sbGHS-Rla or sbGHS-Rlb did not make any marked changes on 
the staurosporine-induced caspase-3 activity (Fig. 4.30A). It indicated that sbGHS-R 
does not affect the staurosporine-induced caspase-3 activity, but it might be because 
the transiently expressed receptor level is not high enough to cause an observable 
effect on caspase-3 activity. For the etoposide-induced caspase-3 activity, 
sbGHS-Rla and sbGHS-Rlb expressed in the cells slightly increased the caspase-3 
activity (Fig. 4.30B). In this experiment, the fold increase in etoposide-induced 
caspase-3 activity is much smaller than the previous experiments, so it needs further 
experiments to conclude the role of sbGHS-R in etoposide-induced caspase-3 
activity. 
4.5.1.1.5 Effect of sbGHS-Rs on staurosporine-induced caspase-3 activity in 
sbGHS-R monoclonal stable cell line 
, T o investigate the role of sbGHS-Rla and sbGHS-Rlb on the staurosporine-induced 
apoptosis in HEK293, HEK-sbGHS-Rla and HEK-sbGHS-Rlb cells, these cells 
were transfected with 1 |ag/ml sbGHS-Rla or sbGHS-Rlb, and then the cells were 
incubated with 10 |iM staurosporine for 8 h in the presence of serum. Cells were 
transfected with 1 |ig/ml empty vector, namely pBK-CMV, was used as a control. 
The staurosporine-induced caspase-3 activity was less in the HEK-sbGHS-Rla and 
HEK-sbGHS-Rlb cells than that in HEK293 cells, this pattern did not alter by the 
transiently expressed pBK-CMV, sbGHS-Rla and sbGHS-Rlb (Fig. 4.31). The 
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transiently expression of pBK-CMV (Fig. 4.31 A), sbGHS-Rla (Fig. 4.3IB) and 
sbGHS-Rlb (Fig. 4.3 IC) did not make any changes on the staurosporine-induced 
caspase-3 activity in HEK293, HEK-sbGHS-Rla and HEK-sbGHS-Rlb cells. It 
indicated that sbGHS-R did not affect the staurosporine-induced caspase-3 activity. 
From the preliminary results described in section 4.5, HA-sbGHS-Rlb is 
pro-apoptotic and stably expressed sbGHS-Rla is anti-apoptotic, therefore, part of 
the expected results is the HEK293 transfected with sbGHS-Rlb results in an 
increase in staurosporine-induced caspase-3 activity in HEK293 cells and the 
caspase-3 activity in the HEK-sbGHS-Rla transfected with sbGHS-Rlb is lower 
than that in the HEK293 cells transfected with sbGHS-Rlb. 
4.5.1.1.6 Differences between epitope-tagged and non-tagged sbGHS-Rs in 
staurosporine-induced caspase-3 activity 
To investigate whether the presence of the epitope-tag will alter the function of 
‘ . s b G H S - R in apoptosis, HEK293 and HEK-sbGHS-Rla were transfected with 1 
|j,g/ml HA-tagged or non-tagged sbGHS-Rla and sbGHS-Rlb, and then the cells 
were incubated with 10 \iM staurosporine for 8 h in the absence of serum. HEK293 
cells transfected with 1 |ig/ml empty vector, namely pBK-CMV or 
pcDNA3.1(+)/Zeo，were used as controls. 
In general, the caspase-3 activities were higher than the previous experiments, it is 
because the cells incubated with apoptotic inducers in the absence of serum. The 
expression of HA-sbGHS-Rla or HA-sbGHS-Rlb in both HEK293 , and 
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HEK-sbGHS-Rla cells caused a slight increase in staurosporine-induced caspase-3 
activity (Figs. 4.32A and 4.32C). In contrast to epitope-tagged sbGHS-R, the 
expression of sbGHS-Rla and sbGHS-Rlb did not affect the staurosporine-induced 
caspase-3 activity (Figs. 4.32B and 4.32D). It indicated that the epitope-tag may alter 
the properties of sbGHS-R in the regulation of apoptosis. 
4.5.1.1.7 The role of epitope-tagged sbGHS-Rlb in staurosporine-induced 
caspase-3 activity 
The epitope-tagged sbGHS-R seems involved in regulating the 
staurosporine-induced caspase-3 activity, as described in section 4.5.1.1.6. The role 
of HA-sbGHS-Rlb in regulating apoptosis was studied and tried to repeat the 
preliminary result stated in section 4.5. HEK293 and HEK-sbGHS-Rla cells were 
transfected with 1 |ig/ml HA-sbGHS-Rlb, and then the cells were incubated with 10 
fiM staurosporine for 8 h in the absence of serum. Cells transfected with 1 ^ig/ml 
• . pcDNA3.1 (+)/Zeo were used as controls. 
When HEK293 cells were transfected with HA-sbGHS-Rlb, the 
staurosporine-induced caspase-3 activity increased by 15.29-fold compared to basal 
caspase-3 activity, but there was just 10.49-fold increase in the HEK293 cells 
transfected with empty vector (Fig. 4.33). It suggested that the expression of 
HA-sbGHS-Rlb enhances the HEK293 cells to undergo apoptosis. The transient 
expression of HA-sbGHS-Rlb in HEK-sbGHS-Rla cells caused a slight increase in 
the staurosporine-induced caspase-3 activity. In addition, the staurosporine-induced 
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caspase-3 activity was less in the HEK-sbGHS-Rla than HEK293 cells. It indicated 
that sbGHS-Rla stably expressed in HEK293 cells protects against apoptosis as seen 
in figure 4.23. 
These results were as the same as the preliminary data described in section 4.5， 
except the basal caspase-3 activity in the HEK293 cells transfected with 
HA-sbGHS-Rlb did not increase when compared to HEK293 cells transfected with 
empty vector, it is still unknown why it is the case. In addition, it indicated that using 
HA-tagged GHS-R, rather than the non-tagged GHS-R and induced caspase-3 
activity by apoptotic inducer in the absence of serum, the same conclusion can be 
obtained as the preliminary data described in section 4.5. 
4.5.1.1.8 Effect of staurosporine and etoposide on GHS-Rla signaling 
It is useful to choose an apoptotic inducer which does not affect the signaling 
•• response to 2myc-hGHS-Rla. HEK-2myc-hGHS-Rl a polyclonal cells were 
incubated with the 10 \iM staurosporine or 100 [M etoposide alone and together with 
0.1 \iM ghrelin. The cells just incubated with or without ghrelin were used to show 
the basal and the ghrelin-stimulated [^H]-IP production in the 2myc-hGHS-Rla 
signaling in the absence of apoptotic inducer. The DMSO treatment groups were 
used to show that any changes in the apoptotic inducer treatment groups are due to 
inducer itself, and are not due to the solvent. Then the [^H]-IP production was 
measured, as described in chapter 3. A similar experiment was carried out to 
determine the effect of apoptotic inducers on sbGHS-Rla signaling, just using 
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HEK-sbGHS-Rla cells and 3.6 |iM GHRP-6, instead of HEK-2myc-hGHS-Rla and 
ghrelin, respectively. 3.6 |iM GHRP-6 is the EC50 concentration in [^H]-IP 
production in HEK-sbGHS-Rla cells (Chan et al, 2004b). 
The basal [^H]-IP production in the HEK-2myc-hGHS-Rl a polyclonal cells was as 
the same as the cells incubated with 10 jiM staurosporine or 100 \xM etoposide (Fig. 
4.34A). The ghrelin-stimulated [^H]-IP production was as the same as the cells 
incubated with 10 |xM staurosporine plus ghrelin or 100 ^M etoposide with ghrelin. 
These indicated that neither the basal nor the ghrelin-stimulated [^H]-IP production 
were affected by 10 jxM staurosporine or 100 |iM etoposide. 
The effect of staurosporine and etoposide on sbGHS-Rla activated [^H]-IP 
production were similar to that in HEK-2myc-hGHS-Rl a polyclonal cells, except the 
effect of staurosporine on the basal [^H]-IP production. When HEK-sbGHS-Rla cells 
were incubated with 10 i^M staurosporine, the basal [^H]-IP production was 
increased by 0.44 fold (Fig. 4.34B). This difference may be due to the low basal 
activity in the HEK-2myc-hGHS-Rl a polyclonal cells, so the effect of staurosporine 
on the basal [^H]-IP production cannot be observed. To confirm it, instead of using 
HEK-2myc-hGHS-Rl a polyclonal cells, the effect of staurosporine on basal [^H]-IP 
production should be studied in the HEK293 cells which transiently expressed 
2myc-tiGHS-Rla, which shows a better constitutive activity (Figs. 4.8，4.18，4.19 
and 4.22). Although there is a clue to suggest that staurosporine may affect the basal 
[^H]-IP production in sbGHS-Rla signaling, but since staurosporine always can 
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induce caspase-3 activity, it is still used in the later experiment as an internal positive 
control. 
4.5.1.2 BRET^ assay 
rs 
Besides colorimetric assay, BRET assay was used to monitor the caspase-3 activity 
in living HEK293 cells, which uptake and express the caspase-3 biosensor and the 
target receptor. HEK293 cells were transfected with 1 ^ig/ml caspase-3 biosensor or 
positive vector in 60 mm dish. After 24 h post-transfection, the transfected cells were 
transferred into white 96-well plate and left in the incubator overnight. The cells 
were incubated with 10 |iM staurosporine or 0.1% DMSO for different time periods, 
and then the caspase-3 activity was measured as described in Chapter 3. The positive 
vector transfected cells were used to show that the decrease in the BRET^ signal of 
the caspase-3 biosensor expressed cells, it is because of the activation of the 
caspase-3 and the cleavage of the biosensor. 
After incubation with staurosporine, the BRET signal in the caspase-3 biosensor 
transfected cells had a slight decrease at 4 h, and there was 28.57% decrease at 8 h, 
in which the BRET^ signal in the cells incubated with DMSO remains unchanged 
(Fig. 4.35), At 24 h, all the caspase-3 biosensor in the transfected cells was cleaved, 
as the BRET^ signal was decreased to zero. In the positive vector expressed cells, the 
BRET^ signal did not decrease in the staurosporine treatment groups, except at 24 h 
staurosporine treatment. There were decrease in the BRET^ signal in the caspase-3 
biosensor expressed cells after staurosporine treatment, it means staurosporine can 
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induce caspase-3 activity in HEK293 cells. However, the size of BRET^ signal 
reduction is small even incubated the cells with staurosporine for 8 h. This project is 
to study the role of GHS-R in apoptosis, within this small change in the BRET^ 
signal, it is very difficult to observe the effect of GHS-R in caspase-3 activity. In 
contrast to BRET� assay, in the colorimetric assay, HEK293 cells incubated with 
staurosporine for 8 h, there was larger fold increase in caspase-3 activity. 
4.5.1.3 FRET assay 
One of the methods which is similar to BRET^ assay was also used to study the 
caspase-3 activity, it is FRET assay. From other previous studies, there should be a 
very sharp decrease in the FRET signals, when there is an increase in the caspase-3 
activity (Luo et al” 2001b). HEK293 cells were transfected with 0.5 |ig/ml FRET 
biosensor plus 0.5 |ig/ml target plasmid DNA or 1 |xg/ml target plasmid DNA, and 
then on the assay day, the cells were incubated with 0.25% DMSO, 10 \iM 
. staurosporine or 100 \iM etoposide for different incubation times. The caspase-3 
assay was measured as described in Chapter 3. The cells transfected with 1 |ig/ml 
target plasmid DNA were used as a control, the FRET signal should remain 
unchanged for any treatments. From the preliminary data, the results were not 
reproducible, as the biosensor was cleaved at different time points for the same 
treatment between different independent experiments. 
4.5.1.4 Conclusions 
Before further examining the role of GHS-Rs in the regulation of apoptosis using 
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hGHS-Rs, it is necessary to optimize the conditions used in the colorimetric assay, in 
order to measure the caspase-3 activity effectively. In HEK293 cells, the optimal 
incubation time for staurosporine and etoposide is 8 and 24 h，respectively. In 
HEK-2myc-hGHS-Rl a polyclonal stable cell line, it seems stably expressed 
2myc-hGHS-Rla protected the cells against staurosporine-induced caspase-3 activity, 
but enhanced the cells undergo etoposide-induced caspase-3 activity. However, the 
effect of staurosporine- and etoposide-induced caspase-3 activity between HEK293 
and HEK-2myc-hGHS-Rl a is small, it might due to the use of polyclonal stable cell 
line. 
Since the use of polyclonal stable cell line may result in small difference in 
staurosporine- and etoposide-induced caspase-3 activity between HEK293 and 
HEK-2myc-hGHS-Rl a cells, so instead of using HEK-2myc-hGHS-Rla polyclonal 
stable cell line, HEK-sbGHS-Rla and HEK-sbGHS-Rlb monoclonal stable cell lines 
• were used. In HEK-sbGHS-Rla and HEK-sbGHS-Rlb cells, in order to have an 
optimal staurosporine- and etoposide-induced caspase-3 activity, it was necessary to 
incubate these cells with staurosporine and etoposide for 8 and 24 h. The 
staurosporine- or etoposide-induced caspase-3 activity was lower in these stable cell 
lines than in the non-transfected HEK293 cells, it showed that the stably expressed 
sbGHS-Rla and sbGHS-Rlb induced anti-apoptotic effect to the cells. However, in 
transiently transfected sbGHS-Rla or sbGHS-Rlb into HEK293, HEK-sbGHS-Rla 
and HEK-sbGHS-Rlb cells, there was no effect on the staurosporine-induced 
caspase-3 activity. These results are not expected, as in the preliminary study 
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described in section 4.5, transiently transfected HA-sbGHS-Rlb into HEK293 cells, 
the stauroporine-induced caspase-3 activity was higher than that in HEK293 cells. 
The difference between the epitope-tagged and non-tagged sbGHS-R in apoptosis 
regulation and the presence of serum in staurosporine-induced caspase-3 activity was 
investigated. The staurosporine-induced caspase-3 activity was larger in the absence 
of serum and the staurosporine-induced caspase-3 activity was larger in the HEK293 
cells transfected with HA-sbGHS-Rla or HA-sbGHS-Rlb than in the 
non-transfected HEK293 cells. When HEK293 and HEK-sbGHS-Rla cells were 
transfected with HA-sbGHS-Rlb and incubated with staurosporine in the absence of 
serum, it showed that the HA-sbGHS-Rlb caused an increase in the 
staurosporine-induced caspase-3 activity and this pro-apoptotic effect of 
HA-sbGHS-Rlb was inhibited by stably expressed sbGHS-Rla. It indicated that 
sbGHS-Rla is anti-apoptotic. These results matched the preliminary results 
described in section 4.5, except there was no increase in the basal caspase-3 activity 
in the HA-sbGHS-Rlb transfected cells. 
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Figure 4.23 Effect of sbGHS-R on staurosporine-induced caspase-3 activity. 
HEK293 and HEK-sbGHS-Rla cells were transfected with 1 ^ig/ml 
pcDNA3.1(+)/Zeo (Zeo) or HA-sbGHS-Rlb, and then the cells were incubated with 
10 |iM staurosporine or 0.1% DMSO for 4 h or 8 h. At the end of the incubation time, 
the cells were lysed and the protein was collected for caspase-3 activity measurement 
as described in Chapter 3. Results in figure A represents mean 士 S.D.，n=2, of 
experiments performed in duplicate. Results in figure B come from one experiment 
performed in duplicate, data shown are mean 土 S.D. (These experiments were 
performed by Chris Leung.) 
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Figure 4.24 Activation of caspase-3 activity by (A) 10 |xM staurosporine and (B) 100 
(xM etoposide with different incubation time in HEK293 cells. At the end of each 
incubation time, the cells were lys'ed and the protein was collected for caspase-3 
activity measurement as described in Chapter 3. (A) 4 caspase-3 substrate was 
used and results in figure represent mean 土 S.D.，n=2, of experiments performed in 
duplicate. (B) 200 |xM caspase-3 substrate was used and results come from one 
experiment performed in duplicate, data shown are mean 士 S.D. 
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Figure 4.25 Activation of caspase-3 activity by different concentrations of etoposide 
in HEK293 cells. HEK293 cells incubated with different DMSO concentrations, to 
match each etoposide concentration for 24 h. At the end of each incubation time, the 
cells were lysed and the protein was collected for caspase-3 activity measurement as 
described in Chapter 3. Results come from one experiment performed in duplicate, 
data shown are mean 士 S.D. 
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Figure 4.26 Lack of serum starvation induced caspase-3 activity in HEK293 cells. 
HEK293 cells were incubated in plain DMEM for different time periods as stated in 
the graph. At the end of each incubation time, the cells were lysed and the protein 
„ was collected for caspase-3 activity measurement as described in Chapter 3. Results 
come from one experiment performed in duplicate, data shown are mean 士 S.D. 
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Figure 4.27 Effect of 2myc-hGHS-Rla on (A) 10 [M staurosporine- and (B) 100 jiM 
etoposide-induce caspase-3 activity in HEK293 cells. HEK293 cells incubated with 
different DMSO concentrations, which respected for staurosporine or etoposide 
concentration, act as a control. HEK293 cells and HEK-2myc-hGHS-Rl a polyclonal 
stable cell line were incubated with (A) staurosporine for 24 h or (B) etoposide for 24 
h and (C) 48 h. At the end of each incubation time, the cells were lysed and the 
protein was collected for caspase-3 activity measurement as described in Chapter 3. 
Results in figure A and C come from one experiment performed in duplicate, data 
showed are mean 士 S.D. Results in figure B represent mean 士 S.D.，n=2, of 
experiments performed in duplicate. 
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Figure 4.28 Activation of caspase-3 activity by 10 jiM staurosporine with different 
incubation time in ( • ) HEK293 cells,(參）HEK-sbGHS-Rla monoclonal stable cell 
line and ( • ) HEK-sbGHS-Rlb monoclonal stable cell line. The open symbols 
represent the cells incubated with 0.1% DMSO as the control for staurosporine. At 
the end of each incubation time, the cells were lysed and the protein was collected 
for caspase-3 activity measurement as described in Chapter 3. Results in figure come 
from one experiment performed in duplicate, data showed are mean 士 S.D. 
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Figure 4.29 Activation of caspase-3 activity by 100 \iM etoposide with different 
incubation time in ( • ) HEK293 cells, ( # ) HEK-sbGHS-Rla monoclonal stable cell 
line and ( • ) HEK-sbGHS-Rlb monoclonal stable cell line. The open symbols 
represent the cells incubated with 0.23% DMSO as the control for etoposide. At the 
end of each incubation time, the cells were lysed and the protein was collected for 
caspase-3 activity measurement as described in Chapter 3. Results in figure come 
from one experiment performed in duplicate, data shown are mean 土 S.D. 
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Figure 4.30 Effect of sbGHS-Rla and sbGHS-Rlb on (A) staurosporine- and (B) 
etoposide-induced caspase-3 activity. HEK293 cells were transiently transfected with 
1 |j,g/ml pBK-CMV，sbGHS-Rla or sbGHS-Rlb and incubated with 10 i^M 
staurosporine or 100 \iM etoposide for 8 h and 48 h, respectively. At the end of 
incubation time, the cells were lysed and the protein was collected for caspase-3 
activity measurement as described in Chapter 3. Results in figure come from one 
experiment performed in duplicate, data shown are mean 士 S.D. In figure A, two 
experiments were performed and one set of data is shown. ‘ 
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Figure 4.31 Effect of sbGHS-Rla and sbGHS-Rlb on staurosporine-induced 
caspase-3 activity in HEK293, HEK-sbGHS-Rla and HEK-sbGHS-Rlb cells. These 
three types of cells were transfected with (A) 1 |ig/ml pBK-CMV or (B) 1 |ig/ml 
sbGHS-Rla or (C) 1 |ig/ml sbGHS-Rlb. After 48 h post-transfection, these cells 
were incubated with 10 |iM staurosporine or 0.1% DMSO for 8 h. At the end of the 
incubation time, the cells were lysed and the protein was collected for caspase-3 
activity measurement as described in Chapter 3. Results in figure come from one 
experiment performed in duplicate, data shown are mean 士 S.D. 
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Figure 4.33 Effect of sbGHS-R on staurosporine-induced caspase-3 activity. 
HEK293" and HEK-sbGHS-Rla cells were transfected with 1 \ig/m\ 
pcDNA3.1(+)/Zeo (Zeo) or HA-sbGHS-Rlb, and then the cells were incubated with 
10 |iM staurosporine or 0.1% DMSO for 8 hours. At the end of the incubation time, 
the cells were lysed and the protein was collected for caspase-3 activity measurement 
as described in Chapter 3. Results in figure come from one experiment performed in 
- duplicate, data shown are mean 士 S.D. 
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Figure 4.34 Effect of 10 jiM staurosporine and 100 i^M etoposide on agonist 
stimulated [^H]-IP production in (A) HEK-2myc-hGHS-Rl a polyclonal cells and (B) 
HEK-sbGHS-Rla monoclonal cells. The cells were labeled with 2 ^Ci/ml 
w>^o-[^H]-inositol and incubated overnight, and then [^H]-IP production was 
measured as described in Chapter 3. The cells were lysed following 1 h incubation 
with staurosporine or etoposide alone or together with ghrelin or GHRP-6. Results 
come from one experiment performed in duplicate, data shown are mean 土 S.D. 
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Figure 4.35 Determination of the sensitivity of BRET^ assay for staurosporine in 
HEK293 cells. HEK293 cells were transfected with (A) 1 jig/ml caspase-3 biosensor 
or (B) .1 |ag/ml positive vector, and then the cells were incubated with 10 
staurosporine or 0.1% DMSO for different incubation times. The BRET� signal was 
measured as described in chapter 3. The positive vector transfected cells were used as 
a negative control. Results in figure come from one experiment performed in 
duplicate, data shown are mean 士 S.D. 
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4.6 Determination of GHS-R amount in terms of mRNA 
4.6.1 Determination of GHS-R amount in stable cell lines 
To determine the amount of sbGHS-Rla and sbGHS-Rlb expressed in the 
HEK-sbGHS-Rla and HEK-sbGHS-Rlb cells respectively, real-time RT-PCR was 
performed. Total RNA was extracted from HEK-sbGHS-Rla and HEK-sbGHS-Rlb 
cells and the first-strand were produced from them, and then real-time PGR was 
performed as described in Chapter 3. The standard curve using sbGHS-Rla and 
sbGHSR-lb plasmid DNA was constructed (Fig. 4.36), to determine the amount of 
sbGHS-Rla and sbGHS-lb in the stable cell lines respectively, as described in 
Chapter 3. From the corresponding standard curve, it was determined that there are 
4.38 X 108士 1.83x108 mRNA copy/昭 total RNA sbGHS-Rla and 7.78 x lO;士 3.83 x 
109 mRNA copy/^ig total RNA sbGHS-Rlb, n=3, in HEK-sbGHS-Rla and 
HEK-sbGHS-Rlb, respectively. 
4.6.2 Transfected DNA amount match with stable cell lines 
In order to have a fair comparison, we need to have the same expression level of 
sbGHS-R in both transiently transfected cells and the stable cell lines. Therefore, it is 
necessary to determine how much of the sbGHS-R needs to be transfected into the 
HEK293 cells, hence, there is an equal amount of sbGHS-R between the transfected 
cells and the stable cell lines. The experimental design was similar to section 4.6.1， 
except there involved transfection, which is 48 h before the total RNA extraction. 
HEK293 cells were transfected with 0.25 |ig/ml, 0.5 |ig/ml，0.75 |xg/ml and 1 ^ig/ml 
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concentrations of HA-sbGHS-Rla or HA-sbGHS-Rlb and the plasmid DNA 
concentrations was balanced to 1 |ig/ml with empty vector. The amount of 
HA-sbGHS-R in the transiently transfected cells were much higher than in the stable 
cell lines. HEK293 cells transfected with only 0.75 \ig/m\ empty vector plus 0.25 
|ag/ml HA-sbGHS-Rla or 0.25 ^ig/ml HA-sbGHS-Rlb, the amount of the transiently 
expressed sbGHS-Rla or sbGHS-Rlb was already similar to that in the 
HEK-sbGHS-Rla and HEK-sbGHS-Rlb, respectively (Fig. 4.37). 
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Figure 4.36 Real-time PCR standard curves for (A) sbGHS-Rla and (B) sbGHS-Rlb. 
“ T h e standard curves were constructed by sbGHS-Rla and sbGHS-Rlb plasmid DNA 
using real-time PCR as described in chapter 3. The amount of mRNA was reflected 
by the Ct value, which was recorded by the PCR machine. Ct value means the 
threshold cycle at which a significantly increase in PCR products was detected. 
Three independent standard curves were constructed, one set of data is shown. 
Results in figure come from one experiment performed in duplicate, data shown are 
mean 土 S.D. 
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Figure 4.37 Determination of HA-sbGHS-Rla and HA-sbGHS-Rlb plasmid DNA 
amount in transfection, to match with the mRNA amount present in 
HEK-sbGHS-Rla and HEK-sbGHS-Rlb, respectively. HEK293 cells were 
transfected with 0.25，0.5，0.75 and 1 ^g/ml HA-sbGHS-Rla or HA-sbGHS-Rlb 
plasmid DNA and the total DNA concentration was balanced to 1 j^g/ml by 
pcDNA3.1(+)/Zeo. After 48 hours post-transfection, the total RNA in these 
transfected cells, HEK-sbGHS-Rla and HEK-sbGHS-Rlb cells were extracted by 
TRIzol reagent and then the total RNA was converted to cDNA as described in 
Chapter 3. The amount of mRNA present in the transfected cells was determined by 
the Ct value recorded by PCR machine. From the standard curve, the amount of RNA 
presence in the sample can be found as described in Chapter 3. Results in figure 
come from one experiment performed in duplicate, data shown are mean 士 S.D. 
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Chapter 5 
Discussion, Conclusions and Future Plan 
5.1 General Discussion and Conclusions 
The aim of this project was to examine the role of GHS-R in apoptosis regulation and 
to define any functional relationship between GHS-R subtypes in transient 
transfection system and stable expression system in HEK293 cells. In this study, the 
caspase-3 activity was measured by a colorimetric assay, in order to reflect the 
apoptotic condition in the cells. BRET^ and FRET assay were also used to monitor 
the caspase-3 activity in living HEK293 cells, which uptake and express the target 
gene and the caspase-3 biosensor. 
GHS-R is a Gq-coupled receptor, so the measurement of inositol phosphate 
production was used to study the properties of GHS-R. In hGHS-Rla and 
sbGHS-Rla, there was a receptor concentration-dependent increase in the basal 
[^H]-IP production, it indicating that GHS-Rla is a constitutively active receptor. The 
constitutive activity of GHS-Rla was further confirmed by the effect of SPa which 
decreased the basal [^H]-IP production of hGHS-Rla. Upon incubation with GHS-R 
agonists, ghrelin and GHRP-6, there was a further increase in [^H]-IP production in 
hGHS-Rla or sbGHS-Rla expressing HEK293 cells, it indicating that GHS-Rla is 
responsive to agonists. These properties of GHS-Rla have also been observed in 
COS-7 cells (Hoist et al” 2003). In contrast to GHS-Rla, GHS-Rlb did not raise the 
basal and agonist-stimulated [ H]-IP production, indicating that GHS-Rlb is not a 
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constitutively active receptor and is unresponsive to agonists. The epitope-tagged 
hGHS-R also has these properties, indicating that the epitope tag did not alter the 
GHS-R signaling properties. 
GHS-Rla not only responds to agonist and inverse agonist, it also responds to the 
partial agonist, adenosine. In HEK293 cells transiently transfected with 
2myc-hGHS-Rla and and incubated with adenosine or ghrelin, there was adenosine-
and ghrelin-stimulated [^H]-IP production, but adenosine-stimulated [^H]-IP 
production was smaller than the ghrelin-stimulated [^H]-IP production, suggesting 
that adenosine is a partial agonist of hGHS-Rl a. Co-administration of adenosine and 
ghrelin caused a further increase in the ghrelin-stimulated [^H]-IP production. This 
result is not expected if adenosine is a partial agonist, as the concentration of 
adenosine that maximized activation of a receptor, another agonist does not provide 
an additional stimulation. In Smith et al. (2000)，at the submaximal concentrations of 
权 . adenosine and MK-0677, there was an additive activation of pig GHS-Rla. At the 
maximal concentration of adenosine, MK-0677 did not cause a further activation of 
GHS-Rla. This further suggested that GHS-R responds to adenosine and it is a 
partial agonist. From the high performance liquid chromatography (HPLC) study of 
the hGHS-R expressing BHK cells (BHK/GHS-R cells) and adenosine, it showed 
there was co-elution of adenosine and cell extract from GHS-R expressing cells, and 
the Fura-2 loaded BHK/GHS-R cells incubated with adenosine caused an increase in 
the Fura-2 signal, which is a calcium sensitive dye (Tullin et al, 2000). These data 
indicated that hGHS-Rl a responded to adenosine and caused intracellular calcium 
release. In addition, in the HEK293 cells stably expressing pig GHS-Rla responded 
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to adenosine, the agonist activation curve reached a plateau at a lower level of 
activation than that responded to GHSs, such as GHRP-6 (Smith et al., 2000). It 
indicated that adenosine is a partial agonist of pig GHS-Rla. In constrast to our data, 
Carreira et al. (2004) stated that in HEK293 cells stably expressed hGHS-Rla, they 
did not have adenosine-stimulated [^H]-IP production, and adenosine significantly 
reduced ghrelin-stimulated [^H]-IP production. 
Similar to ghrelin-stimulated [^H]-IP production, the adenosine-stimulated [^H]-IP 
production was iiAibited by co-administrated with SPa in 2myc-hGHS-Rla 
transiently expressed HEK293 cells. It also showed in BHK/hGHS-R cells, 
preincubation with SPa for 30 seconds before adding adenosine, SPa completely 
inhibited the adenosine-induced intracellular calcium release (Tullin et al., 2000). 
To confirm part of the ghrelin-stimulated production was due to the 
“ . endogenous adenosine, ADA was co-administrated with ghrelin or adenosine. In 
2myc-hGHS-Rla expressing cells, there were decreases in basal, ghrelin- and 
adenosine-stimulated [^H]-IP production. ADA also inhibited carbachol- and 
U46619-stimulated [^H]-IP production in HEK293 cells and hTPa expressing 
HEK293 cells, respectively. The constitutively active Gq protein-stimulated [^H]-IP 
production was also inhibited by ADA. Therefore, the specificity of the ADA was 
investigated using theophylline. Theophylline did not inhibit any agonist-stimulated 
[^H]-IP production, such as ghrelin, adenosine, U46619, carbachol and ATP, on 
different receptors. These data did not help in concluding that part of the ghrelin- and 
adenosine-stimulated [^H]-IP production in HEK293 cells transfected with 
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hGHS-Rla is due to the endogenous adenosine. Also, there is not enough evidence to 
show the activation of Gq-coupled receptor caused a release of endogenous adenosine 
or is just due to the non-specific activity of ADA. There are contradictory literature 
mentioned the effect of theophylline in GHS-R transfected cells. Theophylline has 
been shown to inhibit the activation of pig GHS-R by adenosine (Smith et al., 2000)， 
however, in BHK/GHS-R, theophylline did not show any effect on adenosine- or 
MK-0677-induced calcium response (Tullin et al” 2000). These contradictory 
information may be due to the different concentrations of adenosine and theophylline, 
different sensitivity in the two assays for calcium measurement and different 
GHS-Rla species. 
To investigate the functional relationship of GHS-R in apoptosis regulation, one of 
the methods is to co-express the GHS-Rla and GHS-Rlb in the cells by transient 
transfection. Therefore, it is necessary to determine whether co-transfection will alter 
- the result which is independent of the mnction of the target receptor. When HEK293 
cells were co-transfected hGHS-Rla with empty vector, the agonist-stimulated 
[^H]-IP production was greater than the cells transfected with hGHS-Rla alone. This 
was also observed in the cells co-transfected with sbGHS-Rla plus empty vector. 
These indicated that transfection with additional plasmid DNA potentiated the 
GHS-Rla agonist-stimulated [^H]-IP production, this property was not changed by 
the addition of epitope tag, as the 2myc-hGHS-Rla and HA-sbGHS-Rla constructs 
also demonstrated this co-transfection potentiating effect. The basal [^H]-IP 
production was also potentiated by cotransfecting GHS-Rla with empty vector, but 
seems did not observe in cells transfected with sbGHS-Rla plus empty vector, it 
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might due to the large variations in some data points, so it needs more experiments to 
confirm it. 
This co-transfection potentiating effect not only occurred with the addition of the 
empty vector, it also appeared with the addition of other plasmid DNA. When 
HEK293 cells were co-transfected with hGHS-Rla and hTPa or hGHS-Rlb, the 
ghrelin-stimulated [^H]-IP production was greater than when transfected with 
hGHS-Rla alone. However, the basal [^H]-IP production was not potentiated in the 
cells co-transfected hGHS-Rla plus hGHS-Rlb. Besides balancing the DNA 
concentration with empty vector and Gq-coupled receptor, Gi- and Gs-coupled 
receptors were tested. It was found that cotransfecting hGHS-Rla with Gi-coupled 
receptor (MOR) or Gs-coupled receptor (mDP), both the basal and ghrelin-stimulated 
[^H]-IP production was greater than the cells transfected with hGHS-Rla alone. 
Taken together, co-transfected HEK293 cells with GHS-Rla plus empty vector or 
" , other G protein-coupled receptors, the GHS-Rla agonist-stimulated [^H]-IP 
production was potentiated to a variable extent. In some cases, however, the basal 
[^H]-IP production was not potentiated. 
The co-transfection potentiating effect was also observed in hTPa agonist-stimulated 
[^H]-IP production. In HEK293 cells co-transfected with hTPa plus other plasmid 
DNA, such as empty vector or hGHS-Rla or hGHS-Rlb, there was a greater increase 
in U46619-stimulated [^H]-IP production. In contrast to GHS-Rla, the basal [^H]-IP 
production of hTPa was not affect, as hTPa is not a constitutively active receptor. In 
addition, the additional plasmid DNA in transfection caused a potentiated GHS-Rla 
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agonist-stimulated [^H]-IP production, was also observed using various transfection 
reagents, such as Lipofectamine, Lipofectamine2000, Fugene 6 and Genejuice. 
However, the additional plasmid DNA in transfection caused a potentiated GHS-Rla 
basal [^H]-IP production was only observed in Lipofectamine and 
Lipofectamine2000. 
Addition of empty vector in co-transfection results in variable potentiated [^H]-IP 
production. One of the possible explanations is the presence of an empty vector 
increased the transfection efficiency. The transfection efficiency was therefore 
measured by the expression of EGFP. HEK293 cells co-transfected with 0.1 ^ig/ml 
pEGFP plus different concentrations of hGHS-Rla, the fluorescent reading were 
similar in all groups, however, there was a greater fluorescent reading in the cells 
co-transfected with 0.1 ^ig/ml pEGFP plus different concentrations of hGHS-Rla 
when the concentration of hGHS-Rla was balanced to 1.1 |ig/ml by empty vector. In 
- addition, HEK293 cells co-transfected with 0.1 ^ig/ml pEGFP plus 1 ^g/ml empty 
vector, the fluorescent reading were higher than the cells co-transfected with 0.1 
Hg/ml pEGFP plus 1 ^ig/ml hGHS-Rla. 
Co-transfection results in a variable potentiating effect in [^H]-IP production, 
therefore, it is good for co-transfecting GHS-Rla plus empty vector, in order to get a 
greater agonist-stimulated [^H]-IP production, than the one transfected with 
GHS-Rla alone. However, for the study of the GHS-R subtypes flmctional 
relationship, co-transfection of two types of plasmid DNAs into HEK293 cells makes 
the data more complicated for interpretation. Another way to study the relationship of 
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GHS-R subtypes is to develop a stable cell line which expresses one type of GHS-R, 
and then only another type of GHS-R needs to be transfected into the cells. This 
method does not need the co-transfection process, so the potentiating effect in 
[^H]-IP production by co-transfection can be eliminated. Therefore, we tried to 
develop HEK293 cells stably expressing 2myc-hGHS-Rla or 2myc-hGHS-Rlb. The 
development of the polyclonal stable cell lines was successful, but was unsuccessful 
in monoclonal stable cell line development. It is unclear why the development of the 
stable cell line fail, as there are many literatures stated that they are developed a cells 
stably expressed GHS-Rla (Camina et al., 2004). Instead, HEK-sbGHS-Rla and 
HEK-sbGHS-Rlb cells were obtained from Dr. Chi-Bun Chan (Biochemistry 
Department, CUHK) and used to study the role of GHS-R in regulation of apoptosis. 
Three methods were used to monitor caspase-3 activity in order to study apoptosis, 
they are colorimetric assay, BRET� and FRET assay. The benefit of using BRET and 
" FRET assay rather than colorimetric assay, is they can monitor the caspase-3 activity 
in the cells which uptake and express the target gene and the caspase-3 biosensor. 
Also, they are less laborious. However, among these methods, colorimetric assay 
gave a relatively large increase in both etoposide- and staurosporine-induced 
caspase-3 activity in HEK293 cells, when compared to BERT� and FRET assay. In 
BRET^ assay, there was only slightly decrease in BRET� signal of the caspase-3 
biosensor expressed HEK293 cells, after incubation with staurosporine for 8 h. In 
FRET assay, the results were not reproducible. Therefore, the colorimetric assay was 
used in this project. 
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Preliminary study showed that sbGHS-Rla was anti-apoptotic, while 
HA-sbGHS-Rlb was pro-apoptotic. Therefore, the role of GHS-Rs in regulating 
apoptosis was further studied using hGHS-Rs. It is necessary to optimize the assay 
condition in measuring caspase-3 activity, in order to reflect apoptosis. In HEK293 
cells, the optimal incubation time for staurosporine and etoposide is 8 and 24 h, 
respectively. 
In the HEK-2myc-hGHS-Rl a polyclonal stable cell line, it seems stably expressed 
2myc-hGHS-Rla protected the cells against staurosporine-induced caspase-3 activity, 
but enhanced the cells undergo etoposide-induced caspase-3 activity. However, the 
staurosporine- and etoposide-induced caspase-3 activity between HEK293 and 
HEK-2myc-hGHS-Rla is small, it might due to the use of polyclonal stable cell line. 
Since the use of polyclonal stable cell line may result in small difference in 
- staurosporine- and etoposide-induced caspase-3 activity between HEK293 and 
HEK-2myc-hGHS-Rl a cells, so instead of using HEK-2myc-hGHS-Rl a polyclonal 
stable cell line, HEK-sbGHS-Rla and HEK-sbGHS-Rlb monoclonal stable cell lines 
were used. In HEK-sbGHS-Rla and HEK-sbGHS-Rlb cells, in order to have an 
optimal staurosporine- and etoposide-induced caspase-3 activity, it is needed to 
incubate these cells with staurosporine and etoposide for 8 and 24 h. The 
Staurosporine- or etoposide-induced caspase-3 activity was lower in these stable cell 
lines than in the non-transfected HEK293 cells, it showed that the stably expressed 
sbGHS-Rla and sbGHS-Rlb induced anti-apoptotic effect to the cells. However, 
transiently transfected sbGHS-Rla or sbGHS-Rlb into HEK293, HEK-sbGHS-Rla 
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and HEK-sbGHS-Rlb cells, there was no effect on the staurosporine-induced 
caspase-3 activity. These results are not expected, as in the preliminary study 
described in section 4.5, transiently transfected HA-sbGHS-Rlb into HEK293 cells, 
the stauroporine-induced caspase-3 activity was higher than that in HEK293 cells. 
The difference between the epitope-tagged and non-tagged sbGHS-R in apoptosis 
regulation and the presence of serum in staurosporine-induced caspase-3 activity was 
investigated. The staurosporine-induced caspase-3 activity was larger in the absence 
of serum and the staurosporine-induced caspase-3 activity was slightly larger in the 
HEK293 cells transfected with HA-sbGHS-Rla or HA-sbGHS-Rlb than in the 
non-transfected HEK293 cells. HEK293 and HEK-sbGHS-Rla cells transfected with 
HA-sbGHS-Rlb and incubated with staurosporine in the absence of serum. It 
showed that the HA-sbGHS-Rlb caused an increase in the staurosporine-induced 
caspase-3 activity and this pro-apoptotic effect of HA-sbGHS-Rlb was inhibited by 
- stably expressed sbGHS-Rla. It indicated that sbGHS-Rla is anti-apoptotic. These 
results matched the preliminary results described in section 4.5, except there was no 
increase in the basal caspase-3 activity in the HA-sbGHS-Rlb transfected cells. 
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5.2 Future Plan and Experimental Design 
After this project, it shows that in order to study the functional relationship between 
GHS-Rla and GHS-Rlb in apoptosis regulation, using HEK-sbGHS-Rla and 
HEK-sbGHS-Rlb cells and then transfects either one of the GHS-R subtype into 
these stable cell lines is better than co-transfecting GHS-R subtypes, as 
co-transfection showed a variable potentiating effect in [^H]-IP production. Therefore, 
HEK-sbGHS-Rla and HEK-sbGHS-Rlb cells will be characterized by determining 
the effect of agonist, GHRP-6 on [^H]-IP production and the effect of SPa on basal, 
GHRP-6-stimulated [^H]-IP production. The expected result is HEK-sbGHS-Rla has 
basal and GHRP-6-stimulated [^H]-IP production, while HEK-sbGHS-Rlb is 
unresponsive to GHRP-6. 
In this project, two apoptotic inducers were used, staurosporine and etoposide. 
Although staurosporine gave a good induced caspase-3 activity in colorimetric assay, 
“ but staurosporine is a PKC inhibitor, it may affect the signaling of GHS-Rla, so it 
will just be use as an internal control in the future experiments. Etoposide does not 
affect the component of Gq-coupled signaling, but the size of etoposide-induced 
caspase-3 activity varied. From the preliminary data, 25 jiM cadium can induce 
caspase-3 activity in HEK293 cells. Although the cadium-induced caspase-3 activity 
was smaller than that induced by staurosporine, it was larger than that induced by 
etoposide. Therefore, in the future, cadium will also be used. 
It had been determined by real-time RT-PCR in Chapter 4 that transiently 
co-transfected 0.25 |ag/ml HA-sbGHS-Rla or HA-sbGHS-Rlb and 0.75 ^g/ml 
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empty vector into the cells, the mRNA amount was close to that in HEK-sbGHS-Rla 
and HEK-sbGHS-Rlb, respectively. Therefore, in the future experiments, the 
transfection groups will be as listed in table 6.1，in order to study the role of 
sbGHS-R subtypes in regulating apoptosis. HA-sbGHS-R plasmid DNA will be used 
in transfection because the receptor protein expression level will be quantified in 
addition to mRNA expression level by real-time RT-PCR. 
Briefly, the role of GHS-R in apoptosis regulation will be investigated as the 
following steps. HEK293, HEK-sbGHS-Rla and HEK-sbGHS-Rlb will be 
transfected with HA-sbGHS-Rla or HA-sbGHS-Rlb as described in table 6.1 and 
then these cells will be incubated with medium, GHRP-6 and SPa with or without 
apoptosis inducer and then the caspase-3 activity will be measured. At the same time, 
the total RNA from these transfected cells will be extracted and the amount of 
transiently expressed HA-sbGHS-Rla and HA-sbGHS-Rlb will be quantified by 
“ , r e a l - t i m e RT-PCR, as the transfection efficiency is slightly different between 
different experiments. In addition to real-time RT-PCR, Western blot will also be 
carried out, in order to semi-quantify the amount of HA-sbGHS-Rla and 
HA-sbGHS-Rlb present in the cells. 
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Cell lines Transfection plasmid DNA 
pcDNA3.1/Zeo HA-sbGHS-Rla HA-sbGHS-Rlb 
HEK293 1 ^ig/ml - -
0.75 |ig/ml 0.25 ^ig/ml : 
0.75 ^ig/ml - 0.25 ^g/ml 
HEK-sbGHS-Rla 1 ^ig/ml - - . 
0.75 \ig/m\ 0.25 {ig/ml -
0.75 \ig/m\ - 0.25 \ig/m\ 
HEK-sbGHS-Rlb 1 [ig/m\ - . -
0.75 |ig/ml 0.25 }ig/ml -
0.75 |ig/ml - 0.25 ^ig/ml 
Table 5.1.Transfection groups in apoptosis study. 
“ Page 170 
References 
References: 
ADAMS, J.M. (2003). Ways of dying: multiple pathways to apoptosis. Genes Dev, 17， 
2481-95. 
ANDREIS, P.G，MALENDOWICZ, L.K., TREJTER, M.，NERI, G, SPINAZZI, R•，ROSSI, 
GP. & NUSSDORFER, GG (2003). Ghrelin and growth hormone secretagogue 
receptor are expressed in the rat adrenal cortex: Evidence that ghrelin 
stimulates the growth, but not the secretory activity of adrenal cells. FEES 
Lett’ 536, 173-9. 
ASAKAWA, A., INUI, A” KA G A , T.，YUZURIHA, H.，NAGATA, T.，FUJIMIYA, M.， 
KATSUURA, G，MAKING, S.，FUJINO, M . A . & KASUGA，M. (2001). A role of 
ghrelin in neuroendocrine and behavioral responses to stress in mice. 
Neuroendocrinology, 74, 143-7. 
BALDANZI, G , FILIGHEDDU, N.，CUTRUPI, S.，CATAPANO, R , BONISSONI, S.，FUBINI, 
A. , MALAN, D.，BAJ, G , GRANATA, R.，BROGLIO, R , PAPOTTI, M.，SURICO, N.， 
BUSSOLINO, R, ISGAARD, J.，DEGHENGHI, R., SINIGAGLIA, R, PRAT, M.， 
MUCCIOLI, G , GHIGO, E. & GRAZIANI，A. ( 2 0 0 2 ) . Ghrelin and des-acyl 
ghrelin inhibit cell death in cardiomyocytes and endothelial cells through 
ERKl/2 and PI 3-kinase/AKT. J Cell Biol, 159，1029-37. 
BAR-YEHUDA, S.，MADI, L.，SILBERMAN, D.，GERY, S.，SHKAPENUK, M . & FISHMAN， 
P. (2005). CFlOl, an agonist to the A3 adenosine receptor, enhances the 
_ chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model. 
. Neoplasia, 7，85-90. 
BELLONI, A .S . , MACCHI, C.，REBUFFAT, P., CONCONI，M.T., MALENDOWICZ, L.K.， 
PARNIGOTTO, P.P. & NUSSDORFER，GG (2004). Effect of ghrelin on the 
apoptotic deletion rate of different types of cells cultured in vitro. Int J Mol 
Med, 14，165-7. 
BENSO, A ” BROGLIO, R , MARAFETTI, L.，LUCATELLO, B.，SEARDO, M . A ” GRANATA, 
R.，MARTINA, V.，PAPOTTI, M.，MUCCIOLI, G & GHIGO, E . (2004). Ghrelin 
and synthetic growth hormone secretagogues are cardioactive molecules with 
..identities and differences. Semin Vase Med’ 4，107-14. 
BRESSON-BEPOLDIN, L . & DUFY-BARBE，L. (1994). GHRP-6 induces a biphasic 
calcium response in rat pituitary somatotrophs. Cell Calcium, 15，247-58. 
BROGLIO, R , BENSO, A . , GOTTERO, C.，PRODAM, F.，GAUNA, C.，FILTRI, L.，ARVAT, E.， 
VAN DER LELY, A.J., DEGHENGHI, R . & GHIGO, E . (2003). Non-acylated • 
“ Page 171 
References 
ghrelin does not possess the pituitaric and pancreatic endocrine activity of 
acylated ghrelin in humans. J Endocrinol Invest, 26，192-6. 
CAMINA, J . R , CARREIRA, M.C.，ELMESSARI, S.，LLORENS-CORTES, C.，SMITH, R . G 
& CASANUEVA，F.F. (2004). Desensitization and endocytosis mechanisms of 
ghrelin-activated growth hormone secretagogue receptor 1 a. Endocrinology’ 
145，930-40. 
CARREIRA, M . C ” CAMINA, J .R, SMITH, R . G & CASANUEVA, F.F. (2004) . 
Agonist-specific coupling of growth hormone secretagogue receptor type 1 a 
to different intracellular signaling systems. Role of adenosine. 
Neuroendocrinology, 79 , 13-25. 
CASSONI, P., GHE, C.，MARROCCO, T.，TARABRA, E.，ALLIA, E.，CATAPANO, F.， 
DEGHENGHI, R., GHIGO，E.，PAPOTTI, M . & MUCCIOLI，G (2004). Expression 
of ghrelin and biological activity of specific receptors for ghrelin and des-acyl 
ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrinol, 
150，173-84. 
CASSONI, P., PAPOTTI, M.，GHE, C.，CATAPANO, R , SAPINO, A. , GRAZIANI, A. , 
DEGHENGHI, R. , REISSMANN, T., GHIGO, E. & MUCCIOLI, G (2001) . 
Identification, characterization, and biological activity of specific receptors 
for natural (ghrelin) and synthetic growth hormone secretagogues and analogs 
in human breast carcinomas and cell lines. J Clin Endocrinol Metab, 86, 
1738-45. 
.. CHAE，I.H.，PARK, K.W.，KIM, H.S . & OH，B.H. (2004). Nitric oxide-induced 
apoptosis is mediated by Bax/Bcl-2 gene expression, transition of cytochrome 
c，and activation of caspase-3 in rat vascular smooth muscle cells. Clin Chim 
Acta, 341，83-91. 
CHAN, C.B. & CHENG^ C.H. (2004a). Identification and functional characterization of 
two alternatively spliced growth hormone secretagogue receptor transcripts 
from the pituitary of black seabream Acanthopagrus schlegeli. Mol Cell 
Endocrinol, 214, 81-95. . 
CHAN, C.B.，LEUNG, P.K., WISE, H. & CHENG^ C.H. (2004b). Signal transduction 
.mechanism of the seabream growth hormone secretagogue receptor. FEBS 
Lett, 577，147-53. 
CHOI, K.，ROH, S . G , HONG, Y.H.，SHRESTHA, Y.B., HISHIKAWA, D.，CHEN, C.， 
KOJIMA, M.，KANGAWA, K . & SASAKI，S. (2003) . The role of ghrelin and 
growth hormone secretagogues receptor on rat adipogenesis. Endocrinology, 
“ Page 172 
References 
144，754-9. 
CHORNA, N.E., SANTIAGO-PEREZ, L.I.，ERB, L.，SEYE, C.I.，NEARY, J.T., SUN, GY., 
WEISMAN, G A . & GONZALEZ, F.A. (2004). P2Y receptors activate 
neuroprotective mechanisms in astrocytic cells. JNeurochem, 91，119-32. 
COHEN, J.J. (1993). Apoptosis. Immunol Today, 14, 126-30. 
COLIGAN，J.K., A M . ; MARGUL正S，DH.; SHEVACH，EM.; STROBER，W ( 1 9 9 5 ) . 
Related isolation procedures and functional assays. Current Protocols in 
Immunology, 1, 3.17.1. 
CRAIG, N丄.（1988). The mechanism of conservative site-specific recombination. 
Annu Rev Genet, 22，77-105. 
CRISTALLI, G , COSTANZI, S., LAMBERTUCCI, C.，LUPIDI, G , VITTORI, S.，VOLPINI, R . 
& CAMAIONI’ E. (2001). Adenosine deaminase: functional implications and 
different classes of inhibitors. Med Res Rev，21，105-28. 
DALBY, B.，GATES, S.，HARRIS, A.，OHKI, E . G . , TILKINS, ML.，PRICE, R J . & 
CiCCARONE，V.C. (2004). Advanced transfection with Lipofectamine 2000 
reagent: primary neurons, siRNA, and high-throughput applications. Methods, 
33，95-103. 
DAS, S.，CORDIS, GA.，MAULIK, N . & DAS, D .K . (2005). Pharmacological 
preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via 
adenosine A3 receptor activation. Am J Physiol Heart Circ Physiol, 288, 
H328-35. 
- DATTA，S.R., BRUNEI, A. & GREENBERG^ M . E . (1999). Cellular survival: a play in 
‘ three Akts. Genes Dev, 13，2905-27. 
DATTA, S.R.，DUDEK, H.，TAO, X.，MASTERS, S.，FU, H.，GOTOH, Y. & GREENBERG^ 
M.E. (1997). Akt phosphorylation of BAD couples survival signals to the 
cell-intrinsic death machinery. Cell, 91，231-41. 
DI loRio, P., BALLERINI, P., TRAVERSA, U.，NICOLETTI, R , D'ALMONTE, I., 
KLEYWEGT, S., WERSTIUK, E.S. , RATHBONE, M . R , CACIAGLI, F. & 
CICCARELLI, R. (2004). The antiapoptotic effect of guanosine is mediated by 
the activation of the PI 3-kinase/AKT/PKB pathway in cultured rat astrocytes. 
Glia, 46, 356-68. 
DJANANI, A.，KANEIDER, N.C., STURN, D . & WIEDERMANN，C.J. (2003). Agonist 
function of the neurokinin receptor antagonist, 
[D-Argl ,D-Phe5,D-Trp7,9,Leul 1 Jsubstance P, in monocytes. Regul Pept, 115， 
123-9. . 
“ Page 173 
References 
DUXBURY, M.S. , WASEEM, T.，ITO, H.，ROBINSON, M.K. , ZINNER, M.J.’ ASHLEY, S.W. 
& WHANQ E.E. (2003) . Ghrelin promotes pancreatic adenocarcinoma cellular 
proliferation and invasiveness. Biochem Biophys Res Commun, 309，464-8. 
EHLERS, R.A.，ZHANG, Y.，HELLMICH, M R . & EVERS，B.M. (2000) . 
Neurotensin-mediated activation of MAPK pathways and AP-1 binding in the 
human pancreatic cancer cell line, MIA PaCa-2. Biochem Biophys Res 
Commun, 269, 704-8. 
FEOKTISTOV，I., RYZHOV, S.，GOLDSTEIN, A .E . & BIAGGIONI，I. (2003). Mast 
cell-mediated stimulation of angiogenesis: cooperative interaction between 
A2B and A3 adenosine receptors. Circ Res, 92，485-92. 
FERNANDEZ-RUIZ, J.，GOMEZ, M.，HERNANDEZ, M.，DE MIGUEL, R. & RAMOS，J.A. 
(2004). Cannabinoids and gene expression during brain development. 
Neuwtox Res, 6，389-401. 
Fiscus, R.R.，YUEN;'J.P.，CHAN, S丄.，KWONG, J .H. & CHEW，S.B. (2002). Nitric 
oxide and cyclic GMP as pro- and anti-apoptotic agents. J Card Surg, 17， 
336-9. 
FOLEY, J.F., KELLEY, L.P. & KINSELLA, B.T. (2001). Prostaglandin D(2) 
receptor-mediated desensitization of the alpha isoform of the human 
thromboxane A(2) receptor. Biochem Pharmacol, 62, 229-39. 
GAVRIELI, Y., SHERMAN, Y. & BEN-SASSON，S.A. (1992). Identification of 
programmed cell death in situ via specific labeling of nuclear DNA 
. fragmentation. J Cell Biol, 119，493-501. 
‘ G E R M A C K , R. & DICKENSON，J.M. (2004a). Characterization of ERKl/2 signalling 
pathways induced by adenosine receptor subtypes in newborn rat 
cardiomyocytes. Br J Pharmacol, 141，329-39. 
GERMACK, R.，GRIFFIN, M . & DICKENSON, J . M . (2004b). Activation of protein kinase 
B by adenosine Al and A3 receptors in newborn rat cardiomyocytes. JMol 
Cell Cardiol, 37,989-99. 
GHE, C., CASSONI, P., CATAPANO, R^ MARROCCO, T., DEGHENGHI, R. , GHIGO, E., 
MUCCIOLI, G & PAPOTTI，M. (2002). The antiproliferative effect of synthetic 
peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. 
Endocrinology, 143，484-91. 
GHIGO, E.，BROGLIO, R , ARVAT, E.，MACCARIO, M.，PAPOTTI, M . & Mucciou’ G 
(2005). Ghrelin: more than a natural GH secretagogue and/or an orexigenic 
factor. Clin Endocrinol (OxJ), 62,1-17. 
‘ “ ‘ Page 174 
References 
GLAVASKI-JOKSIMOVIC, A. , JEFTINIJA, K. , SCANES, C . G , ANDERSON, L.L. & 
JEFTINIJA, S. (2003). Stimulatory effect of ghrelin on isolated porcine 
somatotropes. Neuroendocrinology, 77, 367-79. 
GNANAPAVAN, S.，KOLA, B.，BUSTIN, S.A., MORRIS, D . G , MCGEE, P., FAIRCLOUGH, 
p., BHATTACHARYA, S.，CARPENTER, R.’ GROSSMAN, A.B. & KORBONITS，M. 
(2002). The tissue distribution of the mRNA of ghrelin and subtypes of its 
receptor, GHS-R, in humans. J Clin Endocrinol Metab, 87,2988. 
HAMMAR, S.P. & MOTTET，N.K. (1971). Tetrazolium salt and electron-microscopic 
studies of cellular degeneration and necrosis in the interdigital areas of the 
developing chick limb. J Cell Sci, 8，229-51. 
HATTORI, N.，SAITO, T.，YAGYU, T.，JIANG, B . H . , KITAGAWA, K . & INAGAKI, C . 
(2001). GH, GH receptor, GH secretagogue receptor, and ghrelin expression 
in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab, 86, 
4284-91. ’ 
HEMMINGS, B.A. (1997). Akt signaling: linking membrane events to life and death 
decisions. Science, 275, 628-30. 
HENGARTNER, M.O. (2000). The biochemistry of apoptosis. Nature, 407 , 770-6. 
HOLST, B., CYGANKIEWICZ, A. , JENSEN, T.H., ANKERSEN, M . & SCHWARTZ, T.W. 
(2003). High constitutive signaling of the ghrelin receptor-identification of a 
potent inverse agonist. Mol Endocrinol, 17, 2201-10. 
HOLST, B.，HOLLIDAY, N.D.，BACH, A . , ELLING, C.E.，COX, H . M . & SCHWARTZ, T . W . 
_ (2004). Common structural basis for constitutive activity of the ghrelin 
‘ receptor family. J Biol Chem, 279, 53806-17. 
HOSODA, H.，KOJIMA, M.，MATSUO, H . & KANGAWA，K. (2000). Ghrelin and 
des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal 
tissue. Biochem Biophys Res Commun, 279，909-13. 
HOWARD, A.D. , FEIGHNER, S.D., CULLY, D.F., ARENA, J.P.，LIBERATOR, P.A.， 
ROSENBLUM, C.I., HAMELIN, M.，HRENIUK, D 丄PALYHA, O.C.，ANDERSON, 
J., PARESS, P.S., DIAZ, C., CHOU, M. , LIU, K.K. , MCKEE, K.K.，PONG, S.S. , 
CHAUNG, L.Y. , ELBRECHT, A . , DASHKEVICZ, M.，HEAVENS, R.，RIGBY, M . , 
..SIRINATHSINGHJI, D.J.，DEAN, D.C. , MELILLO, D . G , PATCHETT, A . A ” 
NARGUND, R.，GRIFFIN, P.R., DEMARTINO, J .A. , GUPTA, S.K. , SCHAEFFER, 
J.M., SMITH, R . G & VAN DER PLOEG, L.H. (1996). A receptor in pituitary and 
hypothalamus that functions in growth hormone release. Science’ 273，974-7. 
Hu, D.E. & BRINDLE, K.M. (2005). Immune cell-induced synthesis of NO and . 
“ Page 175 
References 
reactive oxygen species in lymphoma cells causes their death by apoptosis. 
FEBS Lett, 579，2833-41. 
IWAI-KANAI, E. & HASEGAWA，K. (2004). Intracellular signaling pathways for 
norepinephrine- and endothelin-1 -mediated regulation of myocardial cell 
apoptosis. Mol Cell Biochem, 259，163-8. 
JALEEL, M.A. , TSAI，A.C.，SARKAR, S.，FREEDMAN, P.V. & RUBIN，L.P. (2004). 
Stromal cell-derived factor-1 (SDF-1) signalling regulates human placental 
trophoblast cell survival. Mol Hum Reprod, 10，901-9. 
JEFFERY, P.L., HERINGTON, A.C. & CHOPIN, L.K. (2002). Expression and action of 
the growth hormone releasing peptide ghrelin and its receptor in prostate 
cancer cell lines. J Endocrinol, 172，R7-11. 
JIANG, X.Q. , CHEN, J . G , GITTENS, S.，CHEN, C.J.，ZHANG, X丄.& ZHANG» Z.Y. 
(2005). The ectopic study of tissue-engineered bone with hBMP-4 gene 
modified bone marrow stromal cells in rabbits. Chin Med J (Engl), 118， 
281-8. 
KANAMOTO, N.，AKAMIZU, T.，HOSODA, H . , HATAYA, Y.，ARIYASU, H.，TAKAYA, K . , 
HOSODA, K.，SAIJO, M.，MORIYAMA, K.，SHIMATSU, A . , KOJIMA, M.， 
KANGAWA, K. & NAKAO, K. (2001). Substantial production of ghrelin by a 
human medullary thyroid carcinoma cell line. J Clin Endocrinol Metab, 86， 
4984-90. 
KATSUMA, S., HATAE, N. , YANO, T.，RUIKE, Y.，KIMURA, M.，HIRASAWA, A . & 
. TSUJIMOTO, G (2005). Free fatty acids inhibit serum deprivation-induced 
apoptosis through GPR120 in a murine enteroendocrine cell line STC-1. J 
Biol Chem’ 280, 19507-15. 
KATUGAMPOLA, S.D. , PALLKAROS, Z . & DAVENPORT，A.P. (2001) . 
[125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan 
receptors in human and rat tissue: up-regulation of receptors with 
athersclerosis. Br J Pharmacol, 134，143-9. 
KIM, M.S.，YOON，C.Y.，JANG, R G , PARK, Y.J., SHIN, C.S. , PARK, H.S.’ RYU, J.W., 
PAK, Y.K., PARK, J.Y., LEE, K.U.，KIM, S.Y.，LEE, H.K., KIM, Y.B. & PARK， 
K.S. (2004). The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 
adipocytes. Mol Endocrinol, 18，2291-301. 
KINSELLA, B.T., O'MAHONY, D.J . & FITZGERALD, G A . (1997). The human 
thromboxane A2 receptor alpha isoforai (TP alpha) functionally couples to 
the G proteins Gq and G i l in vivo and is activated by the isoprostane 8-epi 
“ Page 176 
References 
prostaglandin F2 alpha. J Pharmacol Exp Ther, 281, 957-64. 
KIPPENBERGER, S.，LOITSCH, S.，GUSCHEL, M.，MULLER, J., KNIES, Y.，KAUFMANN, 
R. & BERND，A. (2005). Mechanical stretch stimulates protein kinase B/Akt 
phosphorylation in epidermal cells via angiotensin II type 1 receptor and 
epidermal growth factor receptor. J Biol Chem, 280, 3060-7. 
KOJIMA, M.，HOSODA, H., DATE, Y.，NAKAZATO, M. , MATSUO, H. & KANGAWA, K. 
(1999). Ghrelin is a growth-hormone-releasing acylated peptide from 
stomach. Nature, 402，656-60. 
KOJIMA, M.，HOSODA, H. & KANGAWA，K. (2001). Purification and distribution of 
ghrelin: the natural endogenous ligand for the growth hormone secretagogue 
receptor. Horm Res, 56 Suppl 1，93-7. 
KORBONITS, M. , GOLDSTONE，A.R, GUEORGUIEV, M . & GROSSMAN，A.B. (2004) . 
Ghrelin~a hormone with multiple functions. Front Neuroendocrinol, 25， 
27-68. “ 
KUMAR, M.，Liu, Z.R.，THAPA, L , WANG, D.Y.，TIAN, R. & QIN’ R.Y. (2004). 
Mechanisms of inhibition of growth of human pancreatic carcinoma 
implanted in nude mice by somatostatin receptor subtype 2. Pancreas, 29, 
141-51. 
LIU, Y.Z., BOXER, L.M. & LATCHMAN，D.S. (1999) . Activation of the Bcl-2 promoter 
by nerve growth factor is mediated by the p42/p44 MAPK cascade. Nucleic 
Acids Res’ 27，2086-90. 
. Luo, D.，BROAD, L.M.，BIRD, G S . & PUTNEY，J.W., JR. (2001a). Signaling pathways 
. underlying muscarinic receptor-induced [Ca2+]i oscillations in HEK293 cells. 
J Biol Chem, 276, 5613-21. 
Luo, K.Q., YU，V.C., Pu, Y. & CHANQ D.C. (2001b). Application of the fluorescence 
resonance energy transfer method for studying the dynamics of caspase-3 
activation during UV-induced apoptosis in living HeLa cells. Biochem 
Biophys Res Commun, 283 , 1054-60. 
MALAGON, M.M.，LUQUE, R.M. , RUIZ-GUERRERO, E., RODRIGUEZ-PACHECO, R , 
GARCIA-NAVARRO, S.，CASANUEVA, F.F., GRACIA-NAVARRO, R & CASTANO, 
J.R (2003). Intracellular signaling mechanisms mediating ghrelin-stimulated 
growth hormone release in somatotropes. Endocrinology, 144，5372-80. 
MOUNIER, C.M. , GHOMASHCHI, F.，LINDSAY, M.R . , JAMES, S.，SINGER, A . G , PARTON， 
R.G & GELB，M.H. (2004). Arachidonic acid release from mammalian cells 
transfected with human groups IIA and X secreted phospholipase A(2) occurs 
“ Page 177 
References 
predominantly during the secretory process and with the involvement of 
cytosolic phospholipase A(2)-alpha. J Biol Chem, 279,25024-38. 
MUCCIOLI, G , PAPOTTI, M. , LOCATELLI, V., GHIGO, E. & DEGHENGHI，R. (2001) . 
Binding of 1251-labeled ghrelin to membranes from human hypothalamus 
and pituitary gland. J Endocrinol Invest, 24，RC7-9. 
MURATA, M.，OKIMURA, Y.，IIDA, K. , MATSUMOTO, M.，SOWA, H., KAJI, H. , KOJIMA, 
M.，KANGAWA, K. & CHIHARA，K. (2002). Ghrelin modulates the downstream 
molecules of insulin signaling in hepatoma cells. J Biol Chem, 277，5667-74. 
NANZER, A.M., KHALAF, S.，MOZID, A.M., FOWKES, R.C.，PATEL，M.V., BURRIN, 
J.M., GROSSMAN, A.B. & KORBONITS，M. (2004). Ghrelin exerts a 
proliferative effect on a rat pituitary somatotroph cell line via the 
mitogen-activated protein kinase pathway. Eur J Endocrinol, 151，233-40. 
PALMA, C. & MAGGI，C.A. (2000). The role of tachykinins via NKL receptors in 
progression of human gliomas. Life Sci, 67,985-1001. 
PALYHA, O.C. , FEIGHNER, S.D., TAN, C .R , MCKEE, K.K. , HRENIUK, D丄.’ GAO, Y.D.， 
SCHLEIM, K.D. , YANG, L., MORRIELLO, G J . , NARGUND, R. , PATCHETT, A.A. , 
HOWARD, A .D. & SMITH, R . G (2000). Ligand activation domain of human 
orphan growth hormone (GH) secretagogue receptor (GHS-R) conserved 
from Pufferfish to humans. Mol Endocrinol, 14，160-9. 
PAPOTTI, M. , GHE, C., CASSONI, P., CATAPANO, R , DEGHENGHI, R. , GHIGO, E. & 
MUCCIOLI, G (2000). Growth hormone secretagogue binding sites in 
_ peripheral human tissues. J Clin Endocrinol Metab, 85，3803-7. 
• PETTERSSON，I.，MUCCIOLI, G , GRANATA, R. , DEGHENGHI, R. , GHIGO, E., OHLSSON, 
C. & ISGAARD，J. (2002). Natural (ghrelin) and synthetic (hexarelin) GH 
secretagogues stimulate H9c2 cardiomyocyte cell proliferation. J Endocrinol’ 
175，201-9. 
POMES, A., PONG, S.S. & SCHAEFFER，J.M. (1996). Solubilization and 
characterization of a growth hormone secretagogue receptor from porcine 
anterior pituitary membranes. Biochem Biophys Res Commun，225，939-45. 
RANG, H.P., DALE, M . M . , RTTTER, J .M. , MOORE, P.K. (2003) . Pharmacology: 
..CHURCHZLL LIVINGSTONE. 
RENVOIZE, C. , BIOLA, A., PALLARDY, M . & BREARD，J. (1998). Apoptosis: 
identification of dying cells. Cell Biol Toxicol, 14，111-20. 
RIBBLE, D.，GOLDSTEIN, N.B.，NORRIS, D . A . & SHELLMAN，Y.G (2005). A simple 
technique for quantifying apoptosis in 96-well plates. BMC Biotechnol，5，12. 
“ P a g e 178 
References 
ROMASHKOVA, J.A. & MAKAROV，S.S. (1999). NF-kappaB is a target ofAKT in 
anti-apoptotic PDGF signalling. Nature, 401，86-90. 
RUSSELL, J.S.A.D.W. (1998). Molecular Cloning: A laboratory manual. Cold Spring 
Harbor Laboratory (CSHL) Press. 
SAI KRISHNA, A.D., PANDA, G & KONDAPI，A.K. (2005). Mechanism of action of 
ferrocene derivatives on the catalytic activity of topoisomerase Ilalpha and 
beta-Distinct mode of action of two derivatives. Arch Biochem Biophys’ 438, 
206-16. 
SAUER, B. (1994). Site-specific recombination: developments and applications. Curr 
Opin Biotechnol, 5，521-7. 
SINGH, K., XIAO, L.，REMONDINO, A.，SAWYER, D.B. & COLUCCI, W.S. (2001). 
Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol, 189， 
257-65. 
SMITH, R.G (2005). Development of growth hormone secretagogues. Endocr Rev, 26， 
346-60. 
SMITH, R . G , GRIFFIN, P.R., X u , Y., SMITH, A . G , LIU, K.，CALACAY, J., FEIGHNER, 
S.D.，PONG, C.，LEONG, D.，POMES, A., CHENG, K.，VAN DER PLOEG, L.H., 
HOWARD, A.D., SCHAEFFER, J. & LEONARD，R.J. (2000). Adenosine: A partial 
agonist of the growth hormone secretagogue receptor. Biochem Biophys Res 
Commun, 276, 1306-13. 
SMITH, R . G , VAN DER PLOEG, L.H., HOWARD, A.D., FEIGHNER, S.D” CHENG, K., 
.. HICKEY, GJ . , WYVRATT, M J . , JR., FISHER, M.H.，NARGUND, R.P. & 
‘ PATCHETT, A. A. (1997). Peptidomimetic regulation of growth hormone 
secretion. Endocr Rev, 18, 621-45. 
SNUSTAD，D.R & SIMMONS, M.J . (1997). Principles of genetics. 
SOMAI, S., COMPEL, A., ROSTENE, W. & FORGEZ，P. (2002). Neurotensin counteracts 
apoptosis in breast cancer cells. Biochem Biophys Res Commun, 295，482-8. 
SUGDEN, RH. & CLERK，A. (1997). Regulation of the ERK subgroup of MAP kinase 
cascades through G protein-coupled receptors. Cell Signal, 9, 337-51. 
TEJERA, N.，GOMEZ-GARRE, D.’ LAZARO, A., GALLEGO-DELGADO, J., ALONSO, C., 
- BLANCO, J., ORTIZ, A. & EGIDO，J. (2004). Persistent proteinuria up-regulates 
angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells. 
Am J Pathol, 164, 1817-26. 
THOMPSON, N.M. , GILL, D.A. , DAVIES, R., LOVERIDGE，N., HOUSTON, P.A., 
ROBINSON, I.C. & WELLS, T. (2004). Ghrelin and des-octanoyl ghrelin • 
“ Page 179 
References 
promote adipogenesis directly in vivo by a mechanism independent of the 
type la growth hormone secretagogue receptor. Endocrinology, 145，234-42. 
TOMEI, L.D. & COPE, F.O. (1991). Apoptosis: The Molecular Basis of the Cell Death. 
TRACEY, K.J. & WARREN，H.S. (2004). Human genetics: an inflammatory issue. 
Nature, 429，35-7. 
TULLIN, S.，HANSEN, B . S . , ANKERSEN, M.，MOLLER, J . , VON CAPPELEN, K . A . & 
THIM, L. (2000). Adenosine is an agonist of the growth hormone 
secretagogue receptor. Endocrinology, 141,3397-402. 
TURNER, P.R.，MEFFORD, S.，CHRISTAKOS, S. & NISSENSON，R.A. (2000). Apoptosis 
mediated by activation of the G protein-coupled receptor for parathyroid 
hormone (PTH)/PTH-related protein (PTHrP). Mol Endocrinol, 14，241-54. 
UNGRIN, M . D , SINGH, L.M., STOCCO, R.，SAS, D.E. & ABRAMOVITZ，M. (1999). An 
automated aequorin luminescence-based functional calcium assay for 
G-protein-coupled receptors. Anal Biochem, 272, 34-42. 
VAN DER LELY, A.J., TSCHOP，M.，HEIMAN, M.L . & GHIGO, E. (2004). Biological, 
physiological, pathophysiological, and pharmacological aspects of ghrelin. 
Endocr Rev, 25,426-57. 
VASSILIOU, E.，SHARMA, V., JING, H.，SHEIBANIE, F. & GANEA, D. (2004) . 
Prostaglandin E2 promotes the survival of bone marrow-derived dendritic 
cells. J Immunol, 173，6955-64. 
VOLANTE, M.，ALLIA, E., FULCHERI, E. , CASSONI, P., GHIGO, E., MUCCIOLI, G & 
_ PAPOTTI, M . (2003). Ghrelin in fetal thyroid and follicular tumors and cell 
. lines: expression and effects on tumor growth. Am J Pathol, 162, 645-54. 
VOLANTE, M.，ALLIA, E.，GUGLIOTTA, P., FUNARO, A . , BROGLIO, F.，DEGHENGHI, R.， 
MUCCIOLI, G , GHIGO, E. & PAPOTTI, M. (2002). Expression of ghrelin and of 
the GH secretagogue receptor by pancreatic islet cells and related endocrine 
tumors. J Clin Endocrinol Metab, 87, 1300-8. 
WANG, Y.K. & HUANG^ Z.Q. (2005). Protective effects of icariin on human umbilical 
vein endothelial cell injury induced by H(2)0(2) in vitro. Pharmacol Res, 52， 
174-82. 
WIDMANN, C.，GIBSON, S ” JARPE, M . B . & JOHNSON，GL. (1999) . Mitogen-activated 
protein kinase: conservation of a three-kinase module from yeast to human. 
Physiol Rev, 79, 143-80. 
Wu-WONG, J .R. , CHIOU，W.J. & WANG^ J. (2000) . Extracellular signal-regulated 
kinases are involved in the antiapoptotic effect of endothelin-1. J Pharmacol 
“ ‘ Page 180 
References 
ExpTher，293,514-21. 
Wu, D.，CLARKE, U . & CHEN，C. ( 1 9 9 7 ) . The role of protein kinase C in GH 
secretion induced by GH-releasing factor and GH-releasing peptides in 
cultured ovine somatotrophs. J Endocrinol, 154, 219-30. 
ZHANG, G , GURTU，V.，SMITH, T.H.，NELSON, P. & KAIN, S . R . (1997). A cationic 
lipid for rapid and efficient delivery of plasmid DNA into mammalian cells. 
Biochem Biophys Res Commun, 236, 126-9. 
ZHU, W.Z.，ZHENG, M . , KOCH, W.J . , LEFKOWTTZ, R.J.，KOBILKA, B . K . & XIAO，R.R 
(2001). Dual modulation of cell survival and cell death by beta(2)-adrenergic 
signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci U SA, 98, 
1607-12. 
“ Page 181 




• . - • 
• • 
‘ . ,, I 
• . 、 • . .. ： 
• . • • 
： • - . -
• . Z 
• •- . 
i 
— • • 
� . I. ‘ 
• >； • . • . . . 
. ‘！ • 
. V �� 
•• .1 
, � t 
• � . � ' ) -
• ./ 
• r • • ‘ • ‘ 
“ . “ ‘ I “ 
^ * . • 
. » i • , ‘ ‘ -
• , . � - . . • 
.*�.. j . . . • -
； , > • . • 
....... ... • -丨 
‘ . . . . . ^ V • , . 
� ’ . ‘ - • 
, 、’ -、. 乂 
‘ , � . . . . - ‘ - ‘- - ‘ 
� -.V - , • . . . 
� - • . 
- . ‘ ‘ 
• ‘ - . - — - • • . ： . - . --
‘ . . • • . 0 ^ , 
‘‘ 、、•、，'）： ,、： J 
\ - _、——―：怨涵誠d 
I C U H K L i b r a r i e s 
圓•lilllllll 
‘ 004278851 
